DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	DDX39A; CASC3; SART1; DHX16; SNRNP200; PRPF6; SNRNP70; SNRPA; HNRNPL; POLR2E; POLR2A; U2AF2; PTBP1; GTF2F1; HNRNPM; SRSF4; CPSF1; ELAVL2; HNRNPA0; SF3B2; DDX39B; DHX8; SART3; EFTUD2; RNPS1; SF3B4; SF3A2; SF3A1; SF1; ELAVL1; USP39; PRPF8; CHERP; SRRM1; CPSF7; CACTIN; DHX38; PRCC; SYMPK; RBM17; HNRNPUL1; DDX23; SRRT; WDR33; XAB2; RBM22; TFIP11; PUF60; RALY; PRPF19; SRRM2; WBP11; RAVER1; SFPQ; NONO;	GO:0000398~mRNA splicing, via spliceosome	55	246	22.3577235772358	0	0	0	0	0	0	0
down	SUPT5H; TAF4; DVL2; NCOR1; TAF5L; NFATC1; FOS; NFIC; PARP1; IRF1; POLR2E; ERCC3; PAX3; GATA3; POLR2A; ARRB2; GTF2F1; HOXD13; LHX1; TAF6; CDK9; ELL; GTF2I; POU5F1; CREB5; MLLT1; SSRP1; NFATC3; RUNX3; TFDP1; NFE2L1; IRF3; NFIX; TAF5; TAF1C; POU2AF1; SNAPC4; TAF3; NFRKB; SUPT6H; NCAPG2; NELFB; RTF1; MNT; EPAS1; NELFA; SCAF1; ASH1L; PHRF1; MBD1; GMEB2; MED16; CTDP1; TAF6L; RPAP1;	GO:0006366~transcription by RNA polymerase II	55	266	20.6766917293233	0	0	0	0	0	0	0
down	SCAF4; PRKACA; SON; SFPQ; U2AF2; PTBP1; AFF2; ADAR; ADARB1; HSF1; KHDRBS1; SRSF4; SF3B2; RRP1B; NONO; SF3B4; SF3A2; SF3A1; USP39; ZC3H13; PRPF8; ALKBH5; SUPT6H; RBM23; CCAR2; CLASRP; RBM15B; CELF1; KHSRP; SCAF1; RBM28; CDK12; PHRF1; PPARGC1A; ACIN1; AKAP8L; TTF2; THRAP3; RBM38; HNRNPA0;	GO:0006397~mRNA processing	40	152	26.3157894736842	0	0	0	0	0	0	0
down	HIP1; TRAF5; MAP2K7; AXIN1; SIAH2; DAPK3; TNFSF12; TNFSF14; BUB1; PHLPP1; HIP1R; MFN2; TIAF1; NTN1; PAK4; ITGB2; PRKCB; CD14; PARP1; CGB7; GZMB; IRF1; PRF1; ERCC3; CSNK2A2; CAPN3; CDK11B; C5AR1; PAX3; GRK5; LTBR; BRCA1; CASP2; HTT; BAG6; MCM2; TAF6; DAP; BMX; DAPK1; CXCR4; PSME3; PPARD; NOTCH2; ZBTB16; PRKCD; EP300; TRAF3; PAK2; ROCK1; TCIRG1; SEMA3A; IRF3; RRP1B; MFSD10; ARHGEF6; RABEP1; RPS6KA1; STEAP3; MAP1S; XAF1; TMEM214; BRAT1; PACS2; THOC6; TNS4; PCSK9; MZB1; PPP1R13L; DPF2; INPP5D; RELT; CYFIP2; CLPTM1L; BCL7B; TCHP; BCL2L13; NUAK2; CDIP1; UBE2Z; BCL2L12; NEK6; PAK6; DIABLO; RNF216; DAXX; PUF60; TAOK2; TPX2; EDAR; TRIM35; NISCH; NOC2L; IKBKG;	GO:0006915~apoptotic process	94	552	17.0289855072464	0	0	0	0	0	0	0
down	MCIDAS; GAK; SIAH2; SUV39H1; EPB41L2; STK10; PAK4; SRC; CSNK2A2; RGS2; MKI67; LIG3; RASSF2; HCFC1; PSME3; PRKCD; SMARCB1; CHAF1A; CHAF1B; CAMK1; E2F2; RPS6KA1; TERF2; ERCC6L; USP39; DAB2IP; STEAP3; CDCA2; PYHIN1; MIS18BP1; STOX1; MAEA; MICAL3; NCAPG2; CCAR2; HJURP; DBF4B; URGCP; CHTF18; UHRF1; CABLES2; RBM38; KMT5A; RCC2; APEX2; ANAPC2; FZR1; USP22;	GO:0007049~cell cycle	48	248	19.3548387096774	0	0	0	0	0	0	0
down	PODXL; EFS; PSTPIP1; DSCAM; PLXNC1; SORBS3; FARP2; CLSTN1; CD4; APP; ITGB3; ITGB2; GP1BA; HCK; PTPRF; ITGAM; CCL4; NCAM1; SELL; ATP2A2; CD36; PRKCA; CD22; ITGAL; ITGAX; CD72; IL32; TNC; AZGP1; ITGB7; EPHA8; L1CAM; CCR1; COL18A1; MCAM; PXN; CX3CR1; BCAM; BMX; CDH8; DGCR2; COL4A3; COL7A1; DDR1; LGALS3BP; TROAP; ITGA9; PKP1; DSG2; SELPLG; NECTIN1; THEMIS2; MAEA; MUC16; TM9SF4; PTPRU; SYMPK; SEMA4D; FERMT1; EMILIN2; PRKD2; CDHR5; LY9; FLRT1; CNTNAP2; ADGRE2; AJAP1; ADGRG1; SRC; PCDHA11; ICAM2; FES; SIGLEC9; PCDHGC3; ICAM5; NINJ1;	GO:0007155~cell adhesion	76	454	16.7400881057269	0	0	0	0	0	0	0
down	ACKR2; AXIN1; SIAH2; PRICKLE3; LMX1B; CLPTM1; CSF3; EN2; HOXA10; HOXA11; HOXC12; TLX1; HOXD13; CUX1; MEOX1; PLXNA3; HMGA2; PRDM15; DCAF7; FGD1; NOTCH2; TLE1; FOXL1; NFATC3; FLII; DGKD; ODF2; ZC3H13; TSSK4; TPGS1; LDB1; ERC1; MINK1; ZFP41; VANGL1; CCHCR1; CACTIN; CCDC120; RADIL; MNT; WDR18; LSM14B; TSSK6; NELFA; HMX1; PLEKHB1; PLXNA1; ANGPTL2; SPATA2; CEP131; RBM19; POMT1; EPHB2; EPHA8; CDH23; DDR1; VDR; NTRK1; CDH8; NR1I3; RARA; EGFR; BCL11B; MST1R; FGFR4; CDH26; CDH1; ROS1; CDH24; EPHB1; EPHB3; PPARD;	GO:0007275~multicellular organism development	72	513	14.0350877192982	0	0	0	0	0	0	0
down	MEN1; IFIT3; HGS; CLDN3; UTP20; GDF11; GAS8; LMNA; NTRK1; APP; FABP3; ADORA3; RARA; IRF1; VDR; SKI; IFITM1; EIF2AK2; WT1; GATA3; AZGP1; PTPN6; PML; NF2; SSTR5; NUP62; COL18A1; NOTCH1; CTCF; TSC2; CDKN2D; HDAC4; ADARB1; HSF1; TFAP4; COL4A3; ZBTB16; DDR1; TMEM115; PTPRJ; ZBTB17; CTBP1; FZD5; TOB2; CDK10; STK11; DAB2IP; ZBTB49; CHERP; DIS3L2; DLG5; ING5; BAP1; TSC1; PTPRU; NACC2; DNAJA3; TSPAN32; MNT; EIF2AK1; LZTS2; BCL11B; ATP8A2; SH3BP4; PIM2; WNK2; ADGRG1; CLMN;	GO:0008285~negative regulation of cell population proliferation	68	396	17.1717171717172	0	0	0	0	0	0	0
down	LIN7A; AP5Z1; ACTN4; AKAP8; EXOC3; CCDC22; MYO1D; APBA3; ARRB2; MYH9; CORO7; TMEM115; COG2; ACAP1; MLC1; RABEP1; STXBP2; DGKD; DUOXA1; AP5B1; VPS53; DENND4C; RHBDF2; MAMDC4; DNAJC14; ATG9A; SNX32; ERC1; SLC15A3; FAM160A2; ARFGAP2; ARFGAP1; ATG16L2; DENND1A; COG1; CHMP7; GBF1; VPS33A; RHBDF1; SLC7A6OS; ANKRD27; GORASP1; RBSN; NUP62CL; PTPN23; MVB12B; EIF4ENIF1; AP5S1; BET1L; RRBP1; AGAP1; EXOC7; ATG4B; SNX10; SCAMP4;	GO:0015031~protein transport	55	310	17.741935483871	0	0	0	0	0	0	0
down	POM121C; TAF4; SUV39H1; BUB1; BRD4; AP1G2; STAU1; HLA-B; HLA-C; SRC; IL2RB; PLCG1; POLR2E; ERCC3; POLR2A; BRD2; PSMB9; SHC1; PML; LTBR; NUP62; PSMB10; CX3CR1; TUFM; TSC2; IRAK1; USP11; RAD23A; EIF4A1; PSME3; GRB2; FOXK1; HSF1; RELA; EIF4G1; SSRP1; VAC14; EP300; GPS2; TRIM28; SF3B2; IL16; IKBKE; TRIM25; IRF3; RRP1B; CUL7; TAF5; CRTC2; NUP188; UBR4; E4F1; CRTC1; SRCAP; SUPT6H; SND1; MAVS; SERINC5; PACS2; CARM1; RPTOR; RBM15B; NUP210; GBF1; CREBBP; KAT2A; UPF1; KAT5; POM121; CDK5RAP3; SPEN; GFI1; WRAP53; SETD2; ULBP3; RBM38; CCDC86; COPS7B; MOV10; RNF216; UCKL1; DNAJB12; NXF1; DAXX; ZC3H7B; AKAP8L; TLN1; DCAF1; YTHDF2; IKBKG;	GO:0016032~viral process	90	456	19.7368421052632	0	0	0	0	0	0	0
down	WWP2; SOCS7; SOCS1; CCDC22; RNF40; PEX14; HERC2; UBA1; CBL; AKT1; ARRB2; BRCA1; CCNF; PEX5; RNF144A; PLK1; VCP; DCAF7; PRKDC; ZBTB16; CDC20; TRIM28; OS9; CUL7; LRRC41; UBR4; RNF220; RNF123; RNF213; E4F1; RFWD3; KLHL17; RNF111; BRAP; SYVN1; ZNF598; CUL9; UBE2J2; FBXL6; WDTC1; LZTR1; TRIML2; TRIM41; RAB40A; KCTD13; RTF1; MED12; TRIM52; TRIM11; TSPAN17; NEURL4; EPAS1; RNF26; TRIM8; KCTD10; UBE2Z; MAGEF1; JADE2; ASB6; FBXO5; ZNRF3; FBXO7; DCAF1; ASB1; MGRN1; HUWE1; CHFR; DCAF15; RNF126; UHRF1;	GO:0016567~protein ubiquitination	70	444	15.7657657657658	0	0	0	0	0	0	0
down	LAMA5; SOCS1; TIMP1; FOS; CD4; IGHG1; ITGB2; HCK; IL6R; ALOX5; CSF3; ITGAM; CCL4; CCL5; MMP9; IL2RB; ALOX15; CD36; PRKACA; TNFRSF1B; ITGAX; CBL; GATA3; IL32; PTAFR; PTPN6; SHC1; TYK2; AKT1; CCR1; CSF2RB; TXLNA; CD86; STAT6; PIK3CB; IL12RB1; FLT3LG; STAT5B; JAK3; GRB2; RELA; IL10RA; RAPGEF1; IL16; IL13RA2; IL31RA; INPP5D; OSMR; DUOX1; IRAK1;	GO:0019221~cytokine-mediated signaling pathway	50	278	17.9856115107914	0	0	0	0	0	0	0
down	HIP1; SUV39H1; TNFSF12; TLL1; SOX15; ZIC2; CLPTM1; ROS1; INHBB; MDK; YY1; PTPN6; AKT1; STX2; BAG6; SRPK2; FOXK1; HSPG2; GNA12; NXN; ALKBH5; HUWE1; ZFP41; ANGPTL6; CCHCR1; PTPRU; DAZAP1; ZIC5; NOTCH4; BCL7B; SPATA25; RBM38; USP42; CDHR5; SH2D2A; PRMT7; ASF1B; DHCR7; EDAR; CEP131; JAG2; NHSL2; PRRC2C; ELK1; DLX2; RARA; LCK; HES7; RXRA; FLI1; VDR; NR1I3; ETV4; SOX1; TNK2; POU5F1; PRRC2A; FOXI3; ERF; FOXL1; FGR; PRRC2B; ONECUT3; FOXC2; PPARD; NR2E1; EGFR; FES; FOXD3; FOXD1; FOXD2; SRC; TNK1; HES2; SOX21; ELF4; HCK; HES4;	GO:0030154~cell differentiation	78	572	13.6363636363636	0	0	0	0	0	0	0
down	SH2B2; SOCS7; CIT; SOCS1; PDPK1; PLXNB1; EFS; DAPK3; DEPDC5; RPS6KA4; NFATC1; MCF2; SRC; PRKCSH; PTPN6; TYK2; PRKAR2B; AKT1; ADRA1B; BMX; JAK3; DAPK1; SRPK2; BTK; MAP4K2; ARHGEF7; CDC42BPG; DNMBP; MARK2; LAX1; PREX1; DLG5; DEPDC1B; ARHGAP45; INPP5D; DVL3; SIPA1; MAP3K3; MKNK1; GNB1L; PRKD2; LAT2; SIK2; MLXIPL; TREM1; ASB6; GMIP; TP53TG5; WNK2; ASB1; CDC42BPB; MAST3; PRKCA; DGKD; PKN3; STK32C; RPS6KA1; MAST2; PRKCB; AKT2; NLRC5; BRSK2; SH2B1; TSSK6; NUAK2; DGKQ; PRKCD; TSSK4; DGKZ; SIK3; IRAK1; MAPK12;	GO:0035556~intracellular signal transduction	72	371	19.4070080862534	0	0	0	0	0	0	0
down	SIRPB1; MAN2B1; PDXK; PSMD3; MGAM; GMFG; DIAPH1; STK10; TMEM63A; AP2A2; CYB5R3; SERPINA1; HLA-B; HLA-H; PPBP; ITGB2; GPI; CAPN1; GUSB; CD14; FGR; ALOX5; HLA-C; ITGAM; IGF2R; CYBA; SELL; MMP9; ARSB; PECAM1; CD36; HSPA6; CR1; TNFRSF1B; ITGAL; ITGAX; C5AR1; CXCR2; PTAFR; CTSS; CFP; GCA; PTPN6; FCER1G; GALNS; SLC11A1; VCP; LYZ; HBB; ADAM8; ATP11A; PRKCD; BST1; PTPRJ; KCNAB2; ROCK1; TCIRG1; IQGAP2; SPTAN1; PKP1; COTL1; DYNC1H1; FGL2; STXBP2; C3AR1; UBR4; LAIR1; NBEAL2; UNC13D; DOK3; RAB44; HUWE1; TBC1D10C; SLC44A2; MCEMP1; STK11IP; PLEKHO2; NCSTN; DOCK2; ARHGAP45; RAB37; HVCN1; CPNE1; ARHGAP9; CRACR2A; AP1M1; PTGES2; CTSZ; DPP7; PADI2; SIGLEC9;	GO:0043312~neutrophil degranulation	91	483	18.8405797101449	0	0	0	0	0	0	0
down	CCL24; AGRN; DVL2; ARHGEF11; PLXNB1; SRGAP3; SIPA1L3; DEPDC5; NTRK1; NF1; RGS2; ARHGAP25; RGS3; TSC2; ARHGDIA; ARHGAP4; ARHGAP1; NPRL3; MYO9B; RAPGEF1; ARHGEF7; GIT2; ACAP1; ARHGEF6; RABEP1; ARHGAP11B; ARHGAP15; ARHGAP21; DAB2IP; RAP1GAP2; IQSEC1; ARHGAP11A; RASGRP2; RASAL3; TAGAP; ARFGAP2; ARFGAP1; RIN3; PREX1; DENND1A; SMAP2; DEPDC1B; ARAP3; RGP1; DOCK2; ARHGAP45; SEMA4D; ARHGEF1; DVL3; SIPA1; PGAM5; ANKRD27; AGAP3; ARAP1; SYNGAP1; ARHGAP9; TBCD; RANBP3; RIC8A; ARHGAP35; RGS18; GMIP; ARHGAP23; TBC1D24; AGAP1; CCL26; GIT1; SH3BP1; CCL4; CCL5; FLCN;	GO:0043547~positive regulation of GTPase activity	71	322	22.0496894409938	0	0	0	0	0	0	0
down	AURKA; EPB41L2; BUB1; TPPP; HAUS5; LIG1; MAP4; CCND3; CDC25B; CCNF; NCAPD3; LIG3; HMGA2; NSUN2; CDC20; CKAP5; DCTN1; DYNC1H1; SMC1A; NUMA1; NCAPH; NCAPD2; ERCC6L; USP39; SGO1; E4F1; CDCA2; MIS18BP1; PSRC1; BORA; STOX1; MAEA; MICAL3; CLASP1; NCAPG2; KIF18B; PHF13; MISP; BRSK2; DIS3L2; KNL1; CHFR; KIF2C; HAUS8; CABLES2; KATNB1; KIFC1; CDT1; CENPJ; NEK6; KMT5A; NDE1; RCC2; ANAPC2; FBXO5; INO80; TPX2; FZR1; VPS4A; TIMELESS; CEP164; CTDP1; TACC3; MAD1L1; MAU2;	GO:0051301~cell division	65	347	18.7319884726225	0	0	0	0	0	0	0
down	STK25; ARHGDIA; STK11; PLXNC1; PLXNB1; PLXNA1; PLXNB2; PLXNA3; PLXND1;	GO:0050772~positive regulation of axonogenesis	9	33	27.2727272727273	0.00010219498404007	0.00201374378387157	0.583124578932648	0.61419185408083	0.35727366420409	0.583124578932648	0.018684479178048
down	GATA2; EPHB2; LHX1; EPHB3; PAX8; AMH;	GO:0001655~urogenital system development	6	12	50	0.00010839483088576	0.00210146107620459	0.618175720541494	0.651452933623422	0.36618796276904	0.617958930879722	0.0194983622227916
down	NF1; PIK3CB; DDR1; BST1; MINK1; TSC1;	GO:0001952~regulation of cell-matrix adhesion	6	12	50	0.00010839483088576	0.00210146107620459	0.618175720541494	0.651452933623422	0.36618796276904	0.617958930879722	0.0194983622227916
down	TERF2; SMG6; UPF1; PIF1; SMG5; YLPM1;	GO:0032204~regulation of telomere maintenance	6	12	50	0.00010839483088576	0.00210146107620459	0.618175720541494	0.651452933623422	0.36618796276904	0.617958930879722	0.0194983622227916
down	CHST15; CHST3; CHPF; XYLT2; CHST11; CHST12; CHST7; CHPF2;	GO:0030206~chondroitin sulfate biosynthetic process	8	26	30.7692307692308	0.00012314412638758	0.0023215035548946	0.701305799777305	0.740096199589395	0.386912866994904	0.701305799777305	0.0215400217150758
down	NCAPH; NCAPD2; INCENP; NCAPD3; NCAPH2;	GO:0010032~meiotic chromosome condensation	5	7	71.4285714285714	0.00012387719679218	0.0023215035548946	0.705356758534719	0.744501952721051	0.387735625959549	0.705109004141135	0.0215400217150758
down	MTOR; LARP1; RPTOR; CARD11; NPRL3;	GO:0038202~TORC1 signaling	5	7	71.4285714285714	0.00012387719679218	0.0023215035548946	0.705356758534719	0.744501952721051	0.387735625959549	0.705109004141135	0.0215400217150758
down	BRD1; BRPF1; ING5; KAT2A; BRPF3;	GO:0044154~histone H3-K14 acetylation	5	7	71.4285714285714	0.00012387719679218	0.0023215035548946	0.705356758534719	0.744501952721051	0.387735625959549	0.705109004141135	0.0215400217150758
down	CD4; LCK; TCIRG1; RUNX2; LFNG; PREX1; PATZ1; JAG2; CD3E;	GO:0030217~T cell differentiation	9	34	26.4705882352941	0.00012399378388039	0.0023215035548946	0.705648624063322	0.745202641121168	0.387852555977872	0.705524630279442	0.0215400217150758
down	SIAH2; LMNA; SRC; HTT; PSME3; RELA; CTTN; PELI3; TCF7L2;	GO:2001237~negative regulation of extrinsic apoptotic signaling pathway	9	34	26.4705882352941	0.00012399378388039	0.0023215035548946	0.705648624063322	0.745202641121168	0.387852555977872	0.705524630279442	0.0215400217150758
down	ARID1A; SMARCA4; SMARCB1; SMARCC2; SMARCC1; SMARCD1; GRWD1;	GO:0006337~nucleosome disassembly	7	19	36.8421052631579	0.00013136176743078	0.00243667969833025	0.747185733146289	0.789484222259	0.396301311614448	0.747054371378858	0.0226086811299761
down	ACTN4; MYO1F; MYO1G; MYO1D; MYO19; MYO1E; MYO1C;	GO:0030050~vesicle transport along actin filament	7	19	36.8421052631579	0.00013136176743078	0.00243667969833025	0.747185733146289	0.789484222259	0.396301311614448	0.747054371378858	0.0226086811299761
down	CD74; PRKCD; TCIRG1; IL13RA2; INPP5D; FCER1G;	GO:0016064~immunoglobulin mediated immune response	6	13	46.1538461538462	0.00015225426275156	0.00270038493555662	0.864195195377861	0.915048119136882	0.420164008975876	0.864042941115109	0.0250554646053919
down	CD4; IL2RB; SHC1; STAT5B; JAK3; GRB2;	GO:0035723~interleukin-15-mediated signaling pathway	6	13	46.1538461538462	0.00015225426275156	0.00270038493555662	0.864195195377861	0.915048119136882	0.420164008975876	0.864042941115109	0.0250554646053919
down	BRD4; APP; MECP2; STOX1; DBF4B; RCC2; FBXO5; CDC25B;	GO:0010971~positive regulation of G2/M transition of mitotic cell cycle	8	27	29.6296296296296	0.00015321651631028	0.00270038493555662	0.869350513544551	0.920831263024806	0.42124678871276	0.86873764747931	0.0250554646053919
down	MGRN1; CD3E; VCP; PTCH1; RUNX2; KIF7; MEGF8; IFT172;	GO:0045879~negative regulation of smoothened signaling pathway	8	27	29.6296296296296	0.00015321651631028	0.00270038493555662	0.869350513544551	0.920831263024806	0.42124678871276	0.86873764747931	0.0250554646053919
down	PDPK1; SRC; ARHGEF7; CTTN; WHAMM; AJUBA; RCC2; TAOK2;	GO:0048041~focal adhesion assembly	8	27	29.6296296296296	0.00015321651631028	0.00270038493555662	0.869350513544551	0.920831263024806	0.42124678871276	0.86873764747931	0.0250554646053919
down	SUPT5H; POLR2E; POLR2A; GTF2F1; CDK9; NELFB; NELFA; CTDP1;	GO:0050434~positive regulation of viral transcription	8	27	29.6296296296296	0.00015321651631028	0.00270038493555662	0.869350513544551	0.920831263024806	0.42124678871276	0.86873764747931	0.0250554646053919
down	WFS1; CCL4; CCL5; ARRB2; CCR1; ORAI1; CRACR2A; STIM2;	GO:0051928~positive regulation of calcium ion transport	8	27	29.6296296296296	0.00015321651631028	0.00270038493555662	0.869350513544551	0.920831263024806	0.42124678871276	0.86873764747931	0.0250554646053919
down	EGFR; TFEB; GATA2; PKD1; HSF1; BPTF; EPAS1;	GO:0001892~embryonic placenta development	7	20	35	0.0001703104929468	0.00291614262851931	0.96480894254363	1	0.438038587859173	0.963957390078896	0.0270573678037792
down	SRC; EXOSC10; TERF2; CTC1; ACD; NAT10; PIF1;	GO:0032211~negative regulation of telomere maintenance via telomerase	7	20	35	0.0001703104929468	0.00291614262851931	0.96480894254363	1	0.438038587859173	0.963957390078896	0.0270573678037792
down	RPS6KA4; ADCY1; CRTC2; TSSK4; CRTC1; CAMK1D; PRKD2;	GO:0032793~positive regulation of CREB transcription factor activity	7	20	35	0.0001703104929468	0.00291614262851931	0.96480894254363	1	0.438038587859173	0.963957390078896	0.0270573678037792
down	NF1; NF2; PRDM15; DAG1; LEMD2; P2RX7; ASH1L;	GO:0043409~negative regulation of MAPK cascade	7	20	35	0.0001703104929468	0.00291614262851931	0.96480894254363	1	0.438038587859173	0.963957390078896	0.0270573678037792
down	BAG3; PRKACA; EMD; CAMK1; TCF7L2; RBM22; GTSE1;	GO:0046827~positive regulation of protein export from nucleus	7	20	35	0.0001703104929468	0.00291614262851931	0.96480894254363	1	0.438038587859173	0.963957390078896	0.0270573678037792
down	AURKA; PLXNA3; DDR1; CPNE1; PAK6; FLRT1; PLXNA1;	GO:1990138~neuron projection extension	7	20	35	0.0001703104929468	0.00291614262851931	0.96480894254363	1	0.438038587859173	0.963957390078896	0.0270573678037792
down	PRKCB; CD22; TXLNA; HDAC4; BTK; LAX1; BANK1; LAT2;	GO:0042113~B cell activation	8	28	28.5714285714286	0.0001890815290606	0.00319207862262432	1	1	0.455308321977945	0.985614356857844	0.0296176340986386
down	STAU1; CCL5; NOTCH1; RAD23A; ADAR; SRPK2; ADARB1; LARP1;	GO:0045070~positive regulation of viral genome replication	8	28	28.5714285714286	0.0001890815290606	0.00319207862262432	1	1	0.455308321977945	0.985614356857844	0.0296176340986386
down	SKI; NF1; EMD; DAB2IP; MED25; C1QL4; B4GALT7; DACH1;	GO:0048147~negative regulation of fibroblast proliferation	8	28	28.5714285714286	0.0001890815290606	0.00319207862262432	1	1	0.455308321977945	0.985614356857844	0.0296176340986386
down	TERT; TYMS; LIG1; POLD1; LIG3; POLG; SMPD3; POLL;	GO:0071897~DNA biosynthetic process	8	28	28.5714285714286	0.0001890815290606	0.00319207862262432	1	1	0.455308321977945	0.985614356857844	0.0296176340986386
down	STIM1; ORAI1; CRACR2A; STIM2; ORAI2;	GO:0002115~store-operated calcium entry	5	8	62.5	0.00019365817466132	0.00323301563809603	1	1	0.458969873947344	0.985614356857844	0.0299974673322996
down	GATA2; CTCF; FLCN; PYGO2; SETD5;	GO:0035065~regulation of histone acetylation	5	8	62.5	0.00019365817466132	0.00323301563809603	1	1	0.458969873947344	0.985614356857844	0.0299974673322996
down	GATA3; GFI1; PYGO2; KMT2B; ZNF335;	GO:0051569~regulation of histone H3-K4 methylation	5	8	62.5	0.00019365817466132	0.00323301563809603	1	1	0.458969873947344	0.985614356857844	0.0299974673322996
down	SCD; KDM6B; KDM1A; PLOD3; PHF2; KDM4B; CYB5R3; G6PD; IFI30; CYBA; PDIA4; NCF2; TBXAS1; FASN; DIO3; KCNAB2; CTBP1; GLYR1; ASPHD1; NXN; OGFOD2; DUS1L; OGFOD3; QSOX2; KDM3B; MICAL3; FOXRED2; KDM8; CYB561D1; PDPR; CHDH; KDM2B; TXNRD2; GPHN; DUOX1; HIF1AN; DUS2; MSRB1; DHCR7; NDOR1; SARDH; PHF8; KDM2A; CYP2D7; CYP26A1; STEAP3;	GO:0055114~oxidation-reduction process	46	526	8.74524714828897	0.00020727193353054	0.00342331481974595	1	1	0.46913327859013	0.985614356857844	0.0317631542710329
down	PRKCSH; GANAB; MGAT4B; MAN1B1; MAN1C1; MAN2A2;	GO:0006491~N-glycan processing	6	14	42.8571428571429	0.00020904434922575	0.00342331481974595	1	1	0.470476584904218	0.985614356857844	0.0317631542710329
down	PAK4; EPHB2; EPHB3; EPHB1; PAK2; ARID1B;	GO:0060996~dendritic spine development	6	14	42.8571428571429	0.00020904434922575	0.00342331481974595	1	1	0.470476584904218	0.985614356857844	0.0317631542710329
down	NSUN2; ZC3H13; METTL16; CMTR1; TRMT61A; PCIF1;	GO:0080009~mRNA methylation	6	14	42.8571428571429	0.00020904434922575	0.00342331481974595	1	1	0.470476584904218	0.985614356857844	0.0317631542710329
down	CNOT3; HMGA2; ELAVL1; ZC3H13; KAT2A; SMO;	GO:2000036~regulation of stem cell population maintenance	6	14	42.8571428571429	0.00020904434922575	0.00342331481974595	1	1	0.470476584904218	0.985614356857844	0.0317631542710329
down	LRP5; ABL1; AKT1; TESK1; DAB2IP; RPTOR; CDK5RAP3;	GO:0071901~negative regulation of protein serine/threonine kinase activity	7	21	33.3333333333333	0.00021808830070546	0.00348593267882939	1	1	0.477216796553911	0.985614356857844	0.0323441527543499
down	AP3D1; HGS; CAPN3; AGER; HPS6; ABHD17A; TM9SF4;	GO:0072657~protein localization to membrane	7	21	33.3333333333333	0.00021808830070546	0.00348593267882939	1	1	0.477216796553911	0.985614356857844	0.0323441527543499
down	DVL2; AXIN1; FRAT2; FZD5; FRAT1; DVL3; FZD1;	GO:1904886~beta-catenin destruction complex disassembly	7	21	33.3333333333333	0.00021808830070546	0.00348593267882939	1	1	0.477216796553911	0.985614356857844	0.0323441527543499
down	REC8; SBF1; HERC2; SLC4A2; ROS1; RARA; IGF2R; CSNK2A2; BRD2; YY1; HOXA10; HOXA11; NUP62; RGS2; BAG6; NOTCH1; LIMK2; CDK16; HSF1; KHDRBS1; GOLGA3; PUM1; TESK1; STK11; ALKBH5; ZFP41; KDM2B; TMEM203; SPATA25; KIFC1; WDR33; USP42; PATZ1; ASF1B; SPATA2; CEP131; JAG2; DAZAP1;	GO:0007283~spermatogenesis	38	407	9.33660933660934	0.00022060863548134	0.00351686445422516	1	1	0.479161956265482	0.985614356857844	0.032631152579229
down	PLOD3; NF1; NOTCH1; PKD1; ITPK1; STIL; C2CD3; DCHS1;	GO:0021915~neural tube development	8	29	27.5862068965517	0.00023155993342038	0.00363361670980819	1	1	0.486275860182817	0.985614356857844	0.0337144359174088
down	EPB41L2; FMNL1; PLEK; ROCK1; STRIP1; EHD2; TLN1; CIT;	GO:0030866~cortical actin cytoskeleton organization	8	29	27.5862068965517	0.00023155993342038	0.00363361670980819	1	1	0.486275860182817	0.985614356857844	0.0337144359174088
down	ZFP36L2; STAT5B; PRKDC; FZD5; NCAPH2; PRR7; DNAJA3; BCL11B;	GO:0033077~T cell differentiation in thymus	8	29	27.5862068965517	0.00023155993342038	0.00363361670980819	1	1	0.486275860182817	0.985614356857844	0.0337144359174088
down	PDPK1; CAPN3; DAB2IP; CPNE1; SPHK2; TRAF5; IKBKG; TRAF3;	GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling	8	29	27.5862068965517	0.00023155993342038	0.00363361670980819	1	1	0.486275860182817	0.985614356857844	0.0337144359174088
down	MCIDAS; NUP62; E2F4; RBM14;	GO:0098534~centriole assembly	4	4	100	0.00026945124169852	0.00413112745563302	1	1	0.507905848500604	0.985614356857844	0.0383305788675051
down	ADCY6; DRD4; ARRB2; GSK3A; NCSTN; KLF16;	GO:0007212~dopamine receptor signaling pathway	6	15	40	0.00028128720422881	0.0042408169896732	1	1	0.51364932550691	0.985614356857844	0.0393483308929805
down	AGRN; CHRM3; GRK2; GNA11; GNB1; CDK5R1;	GO:0007213~G protein-coupled acetylcholine receptor signaling pathway	6	15	40	0.00028128720422881	0.0042408169896732	1	1	0.51364932550691	0.985614356857844	0.0393483308929805
down	LCK; CCR7; RELA; NECTIN2; CARD11; PRKD2;	GO:0050862~positive regulation of T cell receptor signaling pathway	6	15	40	0.00028128720422881	0.0042408169896732	1	1	0.51364932550691	0.985614356857844	0.0393483308929805
down	PML; TRIM28; TRIM25; TRIM11; TRIM8; TRIM35;	GO:1902187~negative regulation of viral release from host cell	6	15	40	0.00028128720422881	0.0042408169896732	1	1	0.51364932550691	0.985614356857844	0.0393483308929805
down	ZNF609; MDK; DAB2IP; FBXO31; NSMF; SEMA3A;	GO:2001224~positive regulation of neuron migration	6	15	40	0.00028128720422881	0.0042408169896732	1	1	0.51364932550691	0.985614356857844	0.0393483308929805
down	AXIN1; APP; CALM3; GSK3A; PLK1; STOX1; RPTOR; TNKS1BP1;	GO:0010800~positive regulation of peptidyl-threonine phosphorylation	8	30	26.6666666666667	0.00028154508799993	0.0042408169896732	1	1	0.513819785599881	0.985614356857844	0.0393483308929805
down	AGRN; ITGB2; ITGAL; ITGB7; SYNGAP1; PICK1; DLG4; SCRIB;	GO:0043113~receptor clustering	8	30	26.6666666666667	0.00028154508799993	0.0042408169896732	1	1	0.513819785599881	0.985614356857844	0.0393483308929805
down	UBTF; SMARCA4; SMARCB1; TAF1C; BAZ2A;	GO:0001188~RNA polymerase I preinitiation complex assembly	5	9	55.5555555555556	0.00028982309267222	0.004322175650025	1	1	0.517909865602052	0.985614356857844	0.0401032155051502
down	HLA-B; HLA-H; HLA-C; HLA-G; HLA-F;	GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent	5	9	55.5555555555556	0.00028982309267222	0.004322175650025	1	1	0.517909865602052	0.985614356857844	0.0401032155051502
down	CCDC78; PRICKLE3; PLEK; AKT1; HAP1; CDK10; TSC1; TCHP; WRAP73;	GO:0030030~cell projection organization	9	39	23.0769230769231	0.00029977393909241	0.00445950835135008	1	1	0.522793335422198	0.985614356857844	0.0413774540745874
down	KIF3B; MYBL2; CDC20; CLASP1; MISP; KIFC1; WRAP73; TPX2;	GO:0090307~mitotic spindle assembly	8	31	25.8064516129032	0.00034000457325045	0.00498396947618345	1	1	0.542506869659017	0.985614356857844	0.0462436555472518
down	RAC2; CSNK2A2; GSK3A; SREBF2; FZD5; HUWE1; UBE2J2; BAP1;	GO:1903955~positive regulation of protein targeting to mitochondrion	8	31	25.8064516129032	0.00034000457325045	0.00498396947618345	1	1	0.542506869659017	0.985614356857844	0.0462436555472518
down	KDM1A; NOTCH1; CX3CR1; FOXG1; DMRTA2; SMO; ZNF335;	GO:0002052~positive regulation of neuroblast proliferation	7	23	30.4347826086957	0.00034589689818476	0.00502135352195752	1	1	0.545426834503823	0.985614356857844	0.0465905226265949
down	TERT; WRAP53; TNKS1BP1; SMG6; SMG5; SMG7; TELO2;	GO:0007004~telomere maintenance via telomerase	7	23	30.4347826086957	0.00034589689818476	0.00502135352195752	1	1	0.545426834503823	0.985614356857844	0.0465905226265949
down	SRC; PRKACA; PLK1; HDAC4; CAMK1; LDLRAP1; PRMT7;	GO:0043393~regulation of protein binding	7	23	30.4347826086957	0.00034589689818476	0.00502135352195752	1	1	0.545426834503823	0.985614356857844	0.0465905226265949
down	TYMS; GATA3; HOXA11; DMBX1; PYGO2; CHST11; ZMIZ1;	GO:0048589~developmental growth	7	23	30.4347826086957	0.00034589689818476	0.00502135352195752	1	1	0.545426834503823	0.985614356857844	0.0465905226265949
down	S100A4; NOTCH1; HMGA2; FOXF2; TRIM28; CUL7; AKNA; DLG5; NOTCH4;	GO:0001837~epithelial to mesenchymal transition	9	40	22.5	0.00035234698824604	0.00510266361291259	1	1	0.54860426069909	0.985614356857844	0.0473449565886426
down	MECP2; CARM1; EHMT2; NSD1; EHMT1; PRMT7;	GO:0016571~histone methylation	6	16	37.5	0.0003717515647561	0.00533228378086921	1	1	0.557891713902552	0.985614356857844	0.0494754824685522
down	PTAFR; PLCB3; PLCL2; PLCH2; PLCG1; PLCB2;	GO:0032959~inositol trisphosphate biosynthetic process	6	16	37.5	0.0003717515647561	0.00533228378086921	1	1	0.557891713902552	0.985614356857844	0.0494754824685522
down	DNMT1; BRCA1; WDR5; AUTS2; RTF1; DNMT3B;	GO:0051571~positive regulation of histone H3-K4 methylation	6	16	37.5	0.0003717515647561	0.00533228378086921	1	1	0.557891713902552	0.985614356857844	0.0494754824685522
down	ADCY6; AKAP8; AKT1; PTGER2; GNB1; ACACA;	GO:0071380~cellular response to prostaglandin E stimulus	6	16	37.5	0.0003717515647561	0.00533228378086921	1	1	0.557891713902552	0.985614356857844	0.0494754824685522
down	SOCS1; PRKCB; GSK3A; RELA; PRKCD; NCOA5; TSC1; TSC2;	GO:0046627~negative regulation of insulin receptor signaling pathway	8	32	25	0.0004079814693958	0.00579661614909874	1	1	0.572805983031706	0.985614356857844	0.0537837805426987
down	HK1; MAN2C1; MAN2B2; MAN2B1; MAN2A2;	GO:0006013~mannose metabolic process	5	10	50	0.00041826984978743	0.00583248676849763	1	1	0.577099537861934	0.985614356857844	0.0541166053273759
down	AP2A2; AP2A1; AP2B1; PCSK9; AP2M1;	GO:0032802~low-density lipoprotein particle receptor catabolic process	5	10	50	0.00041826984978743	0.00583248676849763	1	1	0.577099537861934	0.985614356857844	0.0541166053273759
down	GATA3; ECE1; DDR1; TCF15; SHROOM2;	GO:0043583~ear development	5	10	50	0.00041826984978743	0.00583248676849763	1	1	0.577099537861934	0.985614356857844	0.0541166053273759
down	MTOR; ELL; RPTOR; BRF1; CHD8;	GO:0045945~positive regulation of transcription by RNA polymerase III	5	10	50	0.00041826984978743	0.00583248676849763	1	1	0.577099537861934	0.985614356857844	0.0541166053273759
down	G6PD; YY1; RGS2; GSK3A; CTDP1;	GO:0061052~negative regulation of cell growth involved in cardiac muscle cell development	5	10	50	0.00041826984978743	0.00583248676849763	1	1	0.577099537861934	0.985614356857844	0.0541166053273759
down	KDM4B; KDM8; KDM2B; PHF8; KDM2A;	GO:0070544~histone H3-K36 demethylation	5	10	50	0.00041826984978743	0.00583248676849763	1	1	0.577099537861934	0.985614356857844	0.0541166053273759
down	TLR4; CD14; CD36; TIRAP; RELA;	GO:0071223~cellular response to lipoteichoic acid	5	10	50	0.00041826984978743	0.00583248676849763	1	1	0.577099537861934	0.985614356857844	0.0541166053273759
down	PHLPP1; GRB2; LBH; SYNGAP1; HRH4; WDR54; NTRK1;	GO:0043408~regulation of MAPK cascade	7	24	29.1666666666667	0.00042913175955072	0.00597009693263859	1	1	0.581495168995449	0.985614356857844	0.0553934183296915
down	DYNC1H1; NUMA1; MLC1; CAPN10;	GO:0032388~positive regulation of intracellular transport	4	5	80	0.00046729993442418	0.00638289228611211	1	1	0.59676979928045	0.985614356857844	0.0592235313006388
down	LRP4; APP; SHANK2; SHANK3;	GO:0051124~synaptic growth at neuromuscular junction	4	5	80	0.00046729993442418	0.00638289228611211	1	1	0.59676979928045	0.985614356857844	0.0592235313006388
down	ADAR; TCIRG1; UBAP2L; NLE1;	GO:0061484~hematopoietic stem cell homeostasis	4	5	80	0.00046729993442418	0.00638289228611211	1	1	0.59676979928045	0.985614356857844	0.0592235313006388
down	SLC26A4; CA1; SLC4A2; SLC4A3; HBB; SLC4A8; SLC26A6; SLC39A8; SLC26A1;	GO:0015701~bicarbonate transport	9	42	21.4285714285714	0.00048038504476388	0.0065000327921707	1	1	0.600000920910095	0.985614356857844	0.0603104170126582
down	WWP2; ZBTB7A; EGFR; GATA2; AKT1; DLX2; HIF1AN; YTHDF2; JAG2;	GO:0045746~negative regulation of Notch signaling pathway	9	42	21.4285714285714	0.00048038504476388	0.0065000327921707	1	1	0.600000920910095	0.985614356857844	0.0603104170126582
down	MEPCE; TRMT2A; RBM15B; NSUN2; NSUN5; FTSJ1;	GO:0001510~RNA methylation	6	17	35.2941176470588	0.00048344669851918	0.0065000327921707	1	1	0.600761595525721	0.985614356857844	0.0603104170126582
down	CCL5; CXCR2; CCR1; CCR7; CXCR4; TRPM4;	GO:0002407~dendritic cell chemotaxis	6	17	35.2941176470588	0.00048344669851918	0.0065000327921707	1	1	0.600761595525721	0.985614356857844	0.0603104170126582
down	NTN1; ARHGAP4; PTPRS; CDK5R1; TRIM46; DRAXIN;	GO:0030517~negative regulation of axon extension	6	17	35.2941176470588	0.00048344669851918	0.0065000327921707	1	1	0.600761595525721	0.985614356857844	0.0603104170126582
down	SMARCA4; TFAP4; EP300; SMARCB1; RRP1B; CTDP1;	GO:0043923~positive regulation by host of viral transcription	6	17	35.2941176470588	0.00048344669851918	0.0065000327921707	1	1	0.600761595525721	0.985614356857844	0.0603104170126582
down	CSNK2A2; GSK3A; SREBF2; FZD5; CTTN; ATP13A2;	GO:1903146~regulation of autophagy of mitochondrion	6	17	35.2941176470588	0.00048344669851918	0.0065000327921707	1	1	0.600761595525721	0.985614356857844	0.0603104170126582
down	VAV2; ARHGEF7; ARHGEF6; WHAMM; AJUBA; PARVB; SH2B1; DMTN;	GO:0030032~lamellipodium assembly	8	33	24.2424242424242	0.00048659526581706	0.00652776238294774	1	1	0.601474157859361	0.985614356857844	0.060567705435167
down	PRPF6; SRPK2; DDX39B; SF1; USP39; PRPF19; SF3A2;	GO:0000245~spliceosomal complex assembly	7	25	28	0.00052760406967011	0.00701526650158719	1	1	0.611493116747667	0.985614356857844	0.0650910021062158
down	PRPF6; SRSF4; SF3B4; PRPF8; SRRM1; KHSRP; DDX23;	GO:0000375~RNA splicing, via transesterification reactions	7	25	28	0.00052760406967011	0.00701526650158719	1	1	0.611493116747667	0.985614356857844	0.0650910021062158
down	FLCN; HDAC7; TLN1; CDH1; CDH8; CDH24; PKP1; CDH23; CDH26;	GO:0007043~cell-cell junction assembly	9	43	20.9302325581395	0.00055743699240506	0.00729890266743892	1	1	0.618755061569627	0.985614356857844	0.0677227142820365
down	TUBG1; STMN3; IFT172; TUBGCP3; TUBGCP6; TUBGCP2; DYNC1H1; CCDC88C; CCDC88B;	GO:0031122~cytoplasmic microtubule organization	9	43	20.9302325581395	0.00055743699240506	0.00729890266743892	1	1	0.618755061569627	0.985614356857844	0.0677227142820365
down	CDH1; SRC; PVR; CDH8; NECTIN1; CDH24; NECTIN2; CDH26; CDH23;	GO:0034332~adherens junction organization	9	43	20.9302325581395	0.00055743699240506	0.00729890266743892	1	1	0.618755061569627	0.985614356857844	0.0677227142820365
down	IFITM1; CCL5; EIF2AK2; APOBEC3A; SRPK2; ILF3; MAVS; ISG20; OAS3;	GO:0045071~negative regulation of viral genome replication	9	43	20.9302325581395	0.00055743699240506	0.00729890266743892	1	1	0.618755061569627	0.985614356857844	0.0677227142820365
down	ADCY6; ADCY3; WFS1; PRKACA; PRKAR1B; PRKAR2B; ADCY7; ADCY1;	GO:0003091~renal water homeostasis	8	34	23.5294117647059	0.00057704239098876	0.00747419131431574	1	1	0.623586576083935	0.985614356857844	0.069349126290828
down	TLR4; HCK; CCL5; PTAFR; AKT1; IRAK1; IRF3; CD14;	GO:0031663~lipopolysaccharide-mediated signaling pathway	8	34	23.5294117647059	0.00057704239098876	0.00747419131431574	1	1	0.623586576083935	0.985614356857844	0.069349126290828
down	EGFR; FOS; MMP9; AKT1; PXN; BTK; AGAP3; CAMKK2;	GO:0034614~cellular response to reactive oxygen species	8	34	23.5294117647059	0.00057704239098876	0.00747419131431574	1	1	0.623586576083935	0.985614356857844	0.069349126290828
down	SCD; MBTPS2; FASN; SREBF2; ACACA; MBTPS1; ABCA2; DHCR7;	GO:0045540~regulation of cholesterol biosynthetic process	8	34	23.5294117647059	0.00057704239098876	0.00747419131431574	1	1	0.623586576083935	0.985614356857844	0.069349126290828
down	LRPAP1; DLG4; ANKRD13D; ANKRD13B; WDR54;	GO:0002091~negative regulation of receptor internalization	5	11	45.4545454545455	0.00058537884640652	0.00750133660320516	1	1	0.625633907673399	0.985614356857844	0.0696009932806103
down	CDK5R1; DAB2IP; MBOAT7; NR2E1; ADGRG1;	GO:0021819~layer formation in cerebral cortex	5	11	45.4545454545455	0.00058537884640652	0.00750133660320516	1	1	0.625633907673399	0.985614356857844	0.0696009932806103
down	SRC; EPHB3; ADAM8; MINK1; CELSR2;	GO:0022407~regulation of cell-cell adhesion	5	11	45.4545454545455	0.00058537884640652	0.00750133660320516	1	1	0.625633907673399	0.985614356857844	0.0696009932806103
down	CD74; ITPKB; STK11; DOCK2; CD3E;	GO:0045059~positive thymic T cell selection	5	11	45.4545454545455	0.00058537884640652	0.00750133660320516	1	1	0.625633907673399	0.985614356857844	0.0696009932806103
down	CYBA; HSF1; RELA; PRKCD; ARID1B;	GO:1904385~cellular response to angiotensin	5	11	45.4545454545455	0.00058537884640652	0.00750133660320516	1	1	0.625633907673399	0.985614356857844	0.0696009932806103
down	TAF4; TCF4; TAF6; NCOA6; TAF5; BRF1;	GO:0006352~DNA-templated transcription, initiation	6	18	33.3333333333333	0.00061961381172226	0.00774861960026191	1	1	0.633872448732925	0.985614356857844	0.0718954033473712
down	NOTCH1; EP300; MAML1; CREBBP; NOTCH4; PLXND1;	GO:0007221~positive regulation of transcription of Notch receptor target	6	18	33.3333333333333	0.00061961381172226	0.00774861960026191	1	1	0.633872448732925	0.985614356857844	0.0718954033473712
down	SMAD7; CALM3; DGKQ; EIF4G1; DMTN; PPP2R5D;	GO:0010801~negative regulation of peptidyl-threonine phosphorylation	6	18	33.3333333333333	0.00061961381172226	0.00774861960026191	1	1	0.633872448732925	0.985614356857844	0.0718954033473712
down	EOMES; SKI; LHX2; DLX2; SEMA3A; NR2E1;	GO:0021772~olfactory bulb development	6	18	33.3333333333333	0.00061961381172226	0.00774861960026191	1	1	0.633872448732925	0.985614356857844	0.0718954033473712
down	PML; TIRAP; ZBTB16; NCOA6; KAT6A; KAT8;	GO:0030099~myeloid cell differentiation	6	18	33.3333333333333	0.00061961381172226	0.00774861960026191	1	1	0.633872448732925	0.985614356857844	0.0718954033473712
down	ARID1A; CARM1; DDX54; ESR2; PADI2; SAFB;	GO:0030520~intracellular estrogen receptor signaling pathway	6	18	33.3333333333333	0.00061961381172226	0.00774861960026191	1	1	0.633872448732925	0.985614356857844	0.0718954033473712
down	TTI1; ROS1; ARAF; GNA12; FLCN; TELO2;	GO:0032006~regulation of TOR signaling	6	18	33.3333333333333	0.00061961381172226	0.00774861960026191	1	1	0.633872448732925	0.985614356857844	0.0718954033473712
down	TLR4; ITGB2; CD14; ITGAM; PIK3AP1; IRAK1;	GO:0034142~toll-like receptor 4 signaling pathway	6	18	33.3333333333333	0.00061961381172226	0.00774861960026191	1	1	0.633872448732925	0.985614356857844	0.0718954033473712
down	EPHB2; EPHB3; EPHB1; DLG4; SHANK3; SHANK2;	GO:0060997~dendritic spine morphogenesis	6	18	33.3333333333333	0.00061961381172226	0.00774861960026191	1	1	0.633872448732925	0.985614356857844	0.0718954033473712
down	CALM3; PTBP1; PRKCD; PPP2R5D; CDCA2; NSMF; SYMPK;	GO:0035307~positive regulation of protein dephosphorylation	7	26	26.9230769230769	0.00064323595550952	0.00796781079018672	1	1	0.639704882372492	0.985614356857844	0.0739291641748226
down	ATRN; NF1; EN1; SZT2; BLOC1S3; VANGL1; EDAR;	GO:0043473~pigmentation	7	26	26.9230769230769	0.00064323595550952	0.00796781079018672	1	1	0.639704882372492	0.985614356857844	0.0739291641748226
down	ADCY6; ADCY3; PRKACA; PRKAR1B; PRKAR2B; ADCY7; ADCY1;	GO:0071377~cellular response to glucagon stimulus	7	26	26.9230769230769	0.00064323595550952	0.00796781079018672	1	1	0.639704882372492	0.985614356857844	0.0739291641748226
down	PLXNB2; SOCS1; ITPKB; PML; FLCN; PPP1R9B; SMPD3; CELSR3; CCDC88C;	GO:0001932~regulation of protein phosphorylation	9	44	20.4545454545455	0.00064431880932291	0.00796781079018672	1	1	0.63991404550991	0.985614356857844	0.0739291641748226
down	HDAC4; MIER2; HDAC10; RBM14; BAZ2A; MTA2; MTA1; SIN3B;	GO:0016575~histone deacetylation	8	35	22.8571428571429	0.00068059635834738	0.00834772268095466	1	1	0.648763708394509	0.985614356857844	0.0774541686313971
down	ARHGEF11; CFL1; EPHB1; PKD1; TCIRG1; STK11; MARK2; BRSK2;	GO:0030010~establishment of cell polarity	8	35	22.8571428571429	0.00068059635834738	0.00834772268095466	1	1	0.648763708394509	0.985614356857844	0.0774541686313971
down	EXOSC6; DIS3L2; DIS3L; ISG20; DCPS; TOE1; ISG20L2; ANGEL1;	GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic	8	35	22.8571428571429	0.00068059635834738	0.00834772268095466	1	1	0.648763708394509	0.985614356857844	0.0774541686313971
down	ABL1; TNFRSF1B; BRCA1; CASP2; CRIP1; IKBKE; PML; PRKDC; BCL2A1;	GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage	9	45	20	0.00074194953740269	0.00891329818188651	1	1	0.661292390573478	0.985614356857844	0.082701848974553
down	KDM6B; CYBA; CBL; MTOR; CXCR4; PRKDC; HSF1; PPARD; DNMT3B;	GO:0014823~response to activity	9	45	20	0.00074194953740269	0.00891329818188651	1	1	0.661292390573478	0.985614356857844	0.082701848974553
down	SELL; AJUBA; DCHS1; CDH23; PCDHGC3; CDH1; CDH26; CDH24; CDH8;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	9	45	20	0.00074194953740269	0.00891329818188651	1	1	0.661292390573478	0.985614356857844	0.082701848974553
down	CYBA; IL2RB; GATA2; SLC11A1; TUB; CAMK1D; DOCK2; FCER1G; SIRPB1;	GO:0050766~positive regulation of phagocytosis	9	45	20	0.00074194953740269	0.00891329818188651	1	1	0.661292390573478	0.985614356857844	0.082701848974553
down	ACTN4; ADD1; ADD2; DMTN; SHROOM2; BAIAP2; FSCN2; ESPN; RHOBTB2;	GO:0051017~actin filament bundle assembly	9	45	20	0.00074194953740269	0.00891329818188651	1	1	0.661292390573478	0.985614356857844	0.082701848974553
down	POM121B; MYO1C; IGF2BP3; HSF1; NCBP3; SUPT6H; ZC3H3; KHSRP; IGF2BP1;	GO:0051028~mRNA transport	9	45	20	0.00074194953740269	0.00891329818188651	1	1	0.661292390573478	0.985614356857844	0.082701848974553
down	MECP2; MPP2; ITPR3; SHANK2; NR2E1; SHANK3; GRIN2C; CRHR2; GRIN2D;	GO:0060291~long-term synaptic potentiation	9	45	20	0.00074194953740269	0.00891329818188651	1	1	0.661292390573478	0.985614356857844	0.082701848974553
down	TBC1D10B; TBC1D9B; TBC1D10C; TBC1D16; TBC1D22A; IFT140; TBC1D13; TBC1D14; TBC1D24;	GO:1902017~regulation of cilium assembly	9	45	20	0.00074194953740269	0.00891329818188651	1	1	0.661292390573478	0.985614356857844	0.082701848974553
down	POLD1; POLG; POLE; POLL;	GO:0006287~base-excision repair, gap-filling	4	6	66.6666666666667	0.00075043741764302	0.00891329818188651	1	1	0.662787709943923	0.985614356857844	0.082701848974553
down	AURKA; KIF3B; NUP62; NDE1;	GO:0007100~mitotic centrosome separation	4	6	66.6666666666667	0.00075043741764302	0.00891329818188651	1	1	0.662787709943923	0.985614356857844	0.082701848974553
down	PODXL; CD3E; CCL5; PIEZO1;	GO:0033634~positive regulation of cell-cell adhesion mediated by integrin	4	6	66.6666666666667	0.00075043741764302	0.00891329818188651	1	1	0.662787709943923	0.985614356857844	0.082701848974553
down	GTF3C1; GTF3C2; GTF3C4; GTF3C5;	GO:0042791~5S class rRNA transcription by RNA polymerase III	4	6	66.6666666666667	0.00075043741764302	0.00891329818188651	1	1	0.662787709943923	0.985614356857844	0.082701848974553
down	KMT2D; SETD1A; KMT2B; SETD1B;	GO:0044648~histone H3-K4 dimethylation	4	6	66.6666666666667	0.00075043741764302	0.00891329818188651	1	1	0.662787709943923	0.985614356857844	0.082701848974553
down	KDM1A; DNMT1; BRCA1; DNMT3B;	GO:0051573~negative regulation of histone H3-K9 methylation	4	6	66.6666666666667	0.00075043741764302	0.00891329818188651	1	1	0.662787709943923	0.985614356857844	0.082701848974553
down	MEN1; PARP1; CBL; GATA3; PML; POLG; PRKDC;	GO:0010332~response to gamma radiation	7	27	25.9259259259259	0.00077807457785139	0.00895461635097125	1	1	0.667687021757882	0.985614356857844	0.0830852187339643
down	FES; DCTN1; NUMA1; CDK5R1; PSRC1; CLASP1; CDK5RAP2;	GO:0031116~positive regulation of microtubule polymerization	7	27	25.9259259259259	0.00077807457785139	0.00895461635097125	1	1	0.667687021757882	0.985614356857844	0.0830852187339643
down	CD36; GATA2; RARA; SREBF2; VDR; PPARD; NR1I3;	GO:0033993~response to lipid	7	27	25.9259259259259	0.00077807457785139	0.00895461635097125	1	1	0.667687021757882	0.985614356857844	0.0830852187339643
down	MYH9; MYO1E; MYO9B; WIPF1; TIGD5; WIPF2;	GO:0030048~actin filament-based movement	6	19	31.5789473684211	0.00078371517481046	0.00895461635097125	1	1	0.668710369136774	0.985614356857844	0.0830852187339643
down	LDLR; LCAT; CD36; STARD3; LDLRAP1; OSBPL5;	GO:0030301~cholesterol transport	6	19	31.5789473684211	0.00078371517481046	0.00895461635097125	1	1	0.668710369136774	0.985614356857844	0.0830852187339643
down	MYO1G; SORBS3; ITGB3; EPHB1; PPARD; FAT2;	GO:0031589~cell-substrate adhesion	6	19	31.5789473684211	0.00078371517481046	0.00895461635097125	1	1	0.668710369136774	0.985614356857844	0.0830852187339643
down	GATA3; AKT1; MTOR; LARP1; RPTOR; FLCN;	GO:0031929~TOR signaling	6	19	31.5789473684211	0.00078371517481046	0.00895461635097125	1	1	0.668710369136774	0.985614356857844	0.0830852187339643
down	CYP26A1; TYMS; RARA; GATA4; PPARD; DNMT3B;	GO:0033189~response to vitamin A	6	19	31.5789473684211	0.00078371517481046	0.00895461635097125	1	1	0.668710369136774	0.985614356857844	0.0830852187339643
down	RNF126; PTPN23; MVB12B; VPS4A; VPS37C; UBAP1L;	GO:0043162~ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	6	19	31.5789473684211	0.00078371517481046	0.00895461635097125	1	1	0.668710369136774	0.985614356857844	0.0830852187339643
down	FGR; RAC2; TSC1; GCN1; CAMKK2; ANKRD54;	GO:0045859~regulation of protein kinase activity	6	19	31.5789473684211	0.00078371517481046	0.00895461635097125	1	1	0.668710369136774	0.985614356857844	0.0830852187339643
down	SELL; ITGB7; ADD2; CX3CR1; ROCK1; SELPLG;	GO:0050901~leukocyte tethering or rolling	6	19	31.5789473684211	0.00078371517481046	0.00895461635097125	1	1	0.668710369136774	0.985614356857844	0.0830852187339643
down	HOXD10; KCNAB2; DCTN1; POMK; OPA3; HOXC10;	GO:0050905~neuromuscular process	6	19	31.5789473684211	0.00078371517481046	0.00895461635097125	1	1	0.668710369136774	0.985614356857844	0.0830852187339643
down	AURKA; CSNK1D; STIL; C2CD3; CEP131; SNX10;	GO:0071539~protein localization to centrosome	6	19	31.5789473684211	0.00078371517481046	0.00895461635097125	1	1	0.668710369136774	0.985614356857844	0.0830852187339643
down	DAPK3; GMFG; ABL1; MDK; ARHGDIA; NOTCH2;	GO:2000249~regulation of actin cytoskeleton reorganization	6	19	31.5789473684211	0.00078371517481046	0.00895461635097125	1	1	0.668710369136774	0.985614356857844	0.0830852187339643
down	ABL1; FES; HCK; CSF3; STAP1; BAIAP2;	GO:2000251~positive regulation of actin cytoskeleton reorganization	6	19	31.5789473684211	0.00078371517481046	0.00895461635097125	1	1	0.668710369136774	0.985614356857844	0.0830852187339643
down	CTDNEP1; PRKCB; PRKCA; PLK1; NEK6;	GO:0007077~mitotic nuclear envelope disassembly	5	12	41.6666666666667	0.00079795588496034	0.00900493661001467	1	1	0.670511716770016	0.985614356857844	0.0835521141949763
down	C1QL1; FARP2; APP; EPHA8; ANKS1A;	GO:0016322~neuron remodeling	5	12	41.6666666666667	0.00079795588496034	0.00900493661001467	1	1	0.670511716770016	0.985614356857844	0.0835521141949763
down	TNRC6A; AJUBA; MOV10; TNRC6C; LIMD1;	GO:0035195~gene silencing by miRNA	5	12	41.6666666666667	0.00079795588496034	0.00900493661001467	1	1	0.670511716770016	0.985614356857844	0.0835521141949763
down	PTPN6; PRKCD; DMTN; LRRK1; SEMA4D;	GO:0050732~negative regulation of peptidyl-tyrosine phosphorylation	5	12	41.6666666666667	0.00079795588496034	0.00900493661001467	1	1	0.670511716770016	0.985614356857844	0.0835521141949763
down	NCAM1; EPHB2; PTCH1; DAG1; SMO;	GO:0071679~commissural neuron axon guidance	5	12	41.6666666666667	0.00079795588496034	0.00900493661001467	1	1	0.670511716770016	0.985614356857844	0.0835521141949763
down	TERT; KDM1A; EPCAM; HMGA2; NR2E1;	GO:2000648~positive regulation of stem cell proliferation	5	12	41.6666666666667	0.00079795588496034	0.00900493661001467	1	1	0.670511716770016	0.985614356857844	0.0835521141949763
down	GAS8; EVC; KIF7; ARMC9; DLG5; STK36; IFT172; SMO;	GO:0045880~positive regulation of smoothened signaling pathway	8	36	22.2222222222222	0.00079860752298466	0.00900493661001467	1	1	0.670649793037427	0.985614356857844	0.0835521141949763
down	TLR4; SASH3; CD3E; CD14; IL12RB1; SLC11A1; FZD5; IL18R1; SCRIB;	GO:0032729~positive regulation of interferon-gamma production	9	46	19.5652173913043	0.0008512989375542	0.00952757283929376	1	1	0.676447669925598	0.985614356857844	0.0884013834127734
down	LAMA5; LRP4; EGFR; LHX2; RELA; ALX4; EDAR; SOX21;	GO:0001942~hair follicle development	8	37	21.6216216216216	0.00093250244905895	0.0103028944038756	1	1	0.684487458009693	0.985614356857844	0.0955951881786754
down	SRC; PEX5; HSF1; EP300; TMC8; TRAF3IP1; SOST; TFIP11;	GO:0031333~negative regulation of protein-containing complex assembly	8	37	21.6216216216216	0.00093250244905895	0.0103028944038756	1	1	0.684487458009693	0.985614356857844	0.0955951881786754
down	EP300; ING5; KAT5; EP400; DMAP1; USP22; TRRAP; HCFC1;	GO:0043967~histone H4 acetylation	8	37	21.6216216216216	0.00093250244905895	0.0103028944038756	1	1	0.684487458009693	0.985614356857844	0.0955951881786754
down	TLR4; SFPQ; PRKDC; NONO; MAVS; RBM14; PYHIN1;	GO:0002218~activation of innate immune response	7	28	25	0.0009342890931967	0.0103028944038756	1	1	0.684781699859006	0.985614356857844	0.0955951881786754
down	FANCG; LRP5; NTRK1; BACE1; SMC1A; PNKP; MECP2;	GO:0009314~response to radiation	7	28	25	0.0009342890931967	0.0103028944038756	1	1	0.684781699859006	0.985614356857844	0.0955951881786754
down	TFEB; MYH9; HPS6; PLEKHM2; FLCN; VPS33A; KXD1;	GO:0032418~lysosome localization	7	28	25	0.0009342890931967	0.0103028944038756	1	1	0.684781699859006	0.985614356857844	0.0955951881786754
down	SASH3; GATA2; ADD1; NOTCH1; FLT3LG; P2RX7; SMO;	GO:0048873~homeostasis of number of cells within a tissue	7	28	25	0.0009342890931967	0.0103028944038756	1	1	0.684781699859006	0.985614356857844	0.0955951881786754
down	SMAD7; ABL1; SKI; NOTCH1; HTRA3; RBPMS2; SOST; FZD1; LEMD2;	GO:0030514~negative regulation of BMP signaling pathway	9	47	19.1489361702128	0.00097338746545538	0.0106752895390272	1	1	0.688623056238807	0.985614356857844	0.0990504485769812
down	EPHB2; EPHB3; SEMA3A; CDK5R1; ARHGAP35; CELSR3;	GO:0007413~axonal fasciculation	6	20	30	0.00097942119704752	0.0106829789369431	1	1	0.689267183017194	0.985614356857844	0.0991217944931807
down	APP; NF1; RAB8A; DLG4; SYNPO; SYNGAP1;	GO:0048169~regulation of long-term neuronal synaptic plasticity	6	20	30	0.00097942119704752	0.0106829789369431	1	1	0.689267183017194	0.985614356857844	0.0991217944931807
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.00101555995991565	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	CASQ2; ATP2A1; ATP2A2; CLCN2; CLCN6; CLCN7; ATP6V0D1; TCIRG1; LASP1; ZACN; ATP13A5; TMC8; SFXN5; ATP2A3; TSC22D3; TMEM109; TTYH3; ANO8; ATP13A1; ATP13A2; ANO2; ASIC3;	GO:0034220~ion transmembrane transport	22	208	10.5769230769231	0.00102913376351244	0.0112048802875176	1	1	0.694205114911339	0.985614356857844	0.103964245154435
down	EXOSC10; DHX34; UPF1; AGO1; THRAP3;	GO:0000956~nuclear-transcribed mRNA catabolic process	5	13	38.4615384615385	0.00106317167501457	0.0113695049231986	1	1	0.697528658250233	0.985614356857844	0.105491711360518
down	CR1; C3AR1; CMKLR1; C5AR1; C5AR2;	GO:0002430~complement receptor mediated signaling pathway	5	13	38.4615384615385	0.00106317167501457	0.0113695049231986	1	1	0.697528658250233	0.985614356857844	0.105491711360518
down	SMAD7; DAG1; CLASP1; PHLDB2; POFUT2;	GO:0010717~regulation of epithelial to mesenchymal transition	5	13	38.4615384615385	0.00106317167501457	0.0113695049231986	1	1	0.697528658250233	0.985614356857844	0.105491711360518
down	KDM1A; HMBOX1; MED25; PYGO2; CDT1;	GO:0035563~positive regulation of chromatin binding	5	13	38.4615384615385	0.00106317167501457	0.0113695049231986	1	1	0.697528658250233	0.985614356857844	0.105491711360518
down	CDK11B; SUPT6H; SAFB; SAFB2; SRPK2;	GO:0050684~regulation of mRNA processing	5	13	38.4615384615385	0.00106317167501457	0.0113695049231986	1	1	0.697528658250233	0.985614356857844	0.105491711360518
down	SPTBN2; SPTB; SPTBN1; DMTN; SPTAN1;	GO:0051693~actin filament capping	5	13	38.4615384615385	0.00106317167501457	0.0113695049231986	1	1	0.697528658250233	0.985614356857844	0.105491711360518
down	IKBKE; IRF3; MAVS; NLRC5; ZBP1;	GO:0060340~positive regulation of type I interferon-mediated signaling pathway	5	13	38.4615384615385	0.00106317167501457	0.0113695049231986	1	1	0.697528658250233	0.985614356857844	0.105491711360518
down	AKT1; AKT2; PTCH1; LBH; SMO;	GO:0060644~mammary gland epithelial cell differentiation	5	13	38.4615384615385	0.00106317167501457	0.0113695049231986	1	1	0.697528658250233	0.985614356857844	0.105491711360518
down	CYTH3; SIPA1L3; CLASP1; FBF1; FERMT1;	GO:0090162~establishment of epithelial cell polarity	5	13	38.4615384615385	0.00106317167501457	0.0113695049231986	1	1	0.697528658250233	0.985614356857844	0.105491711360518
down	ACTN4; PXN; SND1; SGF29; RALY;	GO:1903506~regulation of nucleic acid-templated transcription	5	13	38.4615384615385	0.00106317167501457	0.0113695049231986	1	1	0.697528658250233	0.985614356857844	0.105491711360518
down	MEN1; EP300; STK11; FLCN; CREBBP; FERMT1; RNF111;	GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway	7	29	24.1379310344828	0.00111416678110154	0.011830640202156	1	1	0.702727127900416	0.985614356857844	0.109770345309361
down	DEPDC5; TSC2; GSK3A; NPRL3; FLCN; TSC1; SH3BP4;	GO:0032007~negative regulation of TOR signaling	7	29	24.1379310344828	0.00111416678110154	0.011830640202156	1	1	0.702727127900416	0.985614356857844	0.109770345309361
down	NTRK1; ITPKB; SHC1; NOTCH1; GRB2; NOTCH2; RAPGEF1;	GO:0046579~positive regulation of Ras protein signal transduction	7	29	24.1379310344828	0.00111416678110154	0.011830640202156	1	1	0.702727127900416	0.985614356857844	0.109770345309361
down	MELTF; SLC11A1; STEAP3; EPAS1; EIF2AK1; SLC25A37; TFR2;	GO:0055072~iron ion homeostasis	7	29	24.1379310344828	0.00111416678110154	0.011830640202156	1	1	0.702727127900416	0.985614356857844	0.109770345309361
down	BRF1; GTF3C4; GTF3C5; GTF3C1;	GO:0006384~transcription initiation from RNA polymerase III promoter	4	7	57.1428571428571	0.00113633487877252	0.0118771697763875	1	1	0.704864694410938	0.985614356857844	0.110202068981387
down	NSUN2; SUPT6H; SETD2; AKAP8L;	GO:0010793~regulation of mRNA export from nucleus	4	7	57.1428571428571	0.00113633487877252	0.0118771697763875	1	1	0.704864694410938	0.985614356857844	0.110202068981387
down	HOXD10; ISL2; HOXC10; LHX3;	GO:0021520~spinal cord motor neuron cell fate specification	4	7	57.1428571428571	0.00113633487877252	0.0118771697763875	1	1	0.704864694410938	0.985614356857844	0.110202068981387
down	CHAF1A; CHAF1B; CDAN1; NOC2L;	GO:0031497~chromatin assembly	4	7	57.1428571428571	0.00113633487877252	0.0118771697763875	1	1	0.704864694410938	0.985614356857844	0.110202068981387
down	TERF2; SMG6; SMG5; SMG7;	GO:0032210~regulation of telomere maintenance via telomerase	4	7	57.1428571428571	0.00113633487877252	0.0118771697763875	1	1	0.704864694410938	0.985614356857844	0.110202068981387
down	IL18BP; ALOX5; AKT1; IL18R1;	GO:0035655~interleukin-18-mediated signaling pathway	4	7	57.1428571428571	0.00113633487877252	0.0118771697763875	1	1	0.704864694410938	0.985614356857844	0.110202068981387
down	GTF3C1; GTF3C2; GTF3C4; GTF3C5;	GO:0042797~tRNA transcription by RNA polymerase III	4	7	57.1428571428571	0.00113633487877252	0.0118771697763875	1	1	0.704864694410938	0.985614356857844	0.110202068981387
down	BRCA1; KAT2A; RBM14; CDK5RAP2;	GO:0046600~negative regulation of centriole replication	4	7	57.1428571428571	0.00113633487877252	0.0118771697763875	1	1	0.704864694410938	0.985614356857844	0.110202068981387
down	BIN3; WIPF2; TIGD5; WIPF1;	GO:0051666~actin cortical patch localization	4	7	57.1428571428571	0.00113633487877252	0.0118771697763875	1	1	0.704864694410938	0.985614356857844	0.110202068981387
down	PDPK1; MDK; GATA4; HSF1; PAX8; PPP1R10;	GO:0010667~negative regulation of cardiac muscle cell apoptotic process	6	21	28.5714285714286	0.00121059568385706	0.0124370599315914	1	1	0.712292410187375	0.985614356857844	0.115396997964253
down	GAK; OBSL1; CSNK1D; COG7; PACS1; GBF1;	GO:0034067~protein localization to Golgi apparatus	6	21	28.5714285714286	0.00121059568385706	0.0124370599315914	1	1	0.712292410187375	0.985614356857844	0.115396997964253
down	DVL2; DVL3; CCDC88C; FZD9; FZD5; FZD1;	GO:0035567~non-canonical Wnt signaling pathway	6	21	28.5714285714286	0.00121059568385706	0.0124370599315914	1	1	0.712292410187375	0.985614356857844	0.115396997964253
down	HNRNPL; U2AF2; PTBP1; SRSF4; SFSWAP; RNPS1;	GO:0048025~negative regulation of mRNA splicing, via spliceosome	6	21	28.5714285714286	0.00121059568385706	0.0124370599315914	1	1	0.712292410187375	0.985614356857844	0.115396997964253
down	LRP4; MCF2; EPHB2; ARHGDIA; LINGO1; SYNGAP1;	GO:0050771~negative regulation of axonogenesis	6	21	28.5714285714286	0.00121059568385706	0.0124370599315914	1	1	0.712292410187375	0.985614356857844	0.115396997964253
down	OBSL1; CUX1; CUL7; FBXO31; ANKRD27; ANAPC2;	GO:0050775~positive regulation of dendrite morphogenesis	6	21	28.5714285714286	0.00121059568385706	0.0124370599315914	1	1	0.712292410187375	0.985614356857844	0.115396997964253
down	ARSB; TFEB; MTOR; MBTPS1; FAM160A2; HPS1; VPS18; CLN6;	GO:0007040~lysosome organization	8	39	20.5128205128205	0.00125402438009492	0.0127957326389991	1	1	0.716648029800187	0.985614356857844	0.118724935106489
down	NF1; PTPN6; NUP62; RGS2; PRKCD; PTPRJ; DAB2IP; CDK5RAP3;	GO:0043407~negative regulation of MAP kinase activity	8	39	20.5128205128205	0.00125402438009492	0.0127957326389991	1	1	0.716648029800187	0.985614356857844	0.118724935106489
down	DVL2; CCL5; DLG4; PAK2; UNC119; DOK7; NCAPG2; GHRL;	GO:0061098~positive regulation of protein tyrosine kinase activity	8	39	20.5128205128205	0.00125402438009492	0.0127957326389991	1	1	0.716648029800187	0.985614356857844	0.118724935106489
down	HLA-G; BRCA1; TFDP1; PPP2R5B; DAB2IP; L3MBTL2; EHMT2; EHMT1;	GO:0070317~negative regulation of G0 to G1 transition	8	39	20.5128205128205	0.00125402438009492	0.0127957326389991	1	1	0.716648029800187	0.985614356857844	0.118724935106489
down	LHX1; LHX3; NTN1; RNF165; SEMA3A; RAC2; AGRN;	GO:0008045~motor neuron axon guidance	7	30	23.3333333333333	0.00132010837880681	0.0133804895952663	1	1	0.723359893216148	0.985614356857844	0.124150590177953
down	EGFR; PTAFR; AKT1; GJA5; TRPM4; ADRA1B; TBXA2R;	GO:0045907~positive regulation of vasoconstriction	7	30	23.3333333333333	0.00132010837880681	0.0133804895952663	1	1	0.723359893216148	0.985614356857844	0.124150590177953
down	EPCAM; HMGA2; RUNX2; PUM1; NELFB; SETD2; SOX21;	GO:0048863~stem cell differentiation	7	30	23.3333333333333	0.00132010837880681	0.0133804895952663	1	1	0.723359893216148	0.985614356857844	0.124150590177953
down	CTCF; HDAC4; MTA1; ZNF335; KLF2;	GO:0040029~regulation of gene expression, epigenetic	5	14	35.7142857142857	0.00138849932224716	0.0139780250028567	1	1	0.729423337547053	0.985614356857844	0.129694809840201
down	CD4; CD3E; CD86; STAT5B; CARD11;	GO:0045086~positive regulation of interleukin-2 biosynthetic process	5	14	35.7142857142857	0.00138849932224716	0.0139780250028567	1	1	0.729423337547053	0.985614356857844	0.129694809840201
down	FLNB; SVIL; NF1; HOXD10; EP300; TAZ; IGSF8; ZBTB18; POPDC3;	GO:0007519~skeletal muscle tissue development	9	50	18	0.00142704679998129	0.0142704679998129	1	1	0.732767057050396	0.985614356857844	0.132408236012467
down	MBTPS2; EIF2AK2; VCP; MBTPS1; CDK5RAP3; TBL2; SYVN1; RHBDD2; WFS1;	GO:0030968~endoplasmic reticulum unfolded protein response	9	50	18	0.00142704679998129	0.0142704679998129	1	1	0.732767057050396	0.985614356857844	0.132408236012467
down	FANCG; FANCA; RAD51D; FANCC; FAAP100; RFWD3; SLX4; ATRIP; RAD51AP1;	GO:0036297~interstrand cross-link repair	9	50	18	0.00142704679998129	0.0142704679998129	1	1	0.732767057050396	0.985614356857844	0.132408236012467
down	MFNG; NOTCH1; EP300; LFNG; MAML1; CREBBP; NOTCH4; ZMIZ1; JAG2;	GO:0045747~positive regulation of Notch signaling pathway	9	50	18	0.00142704679998129	0.0142704679998129	1	1	0.732767057050396	0.985614356857844	0.132408236012467
down	MBD3; NTRK1; MMP7; SRC; MTOR; KAT2A; MBD1; PPARD;	GO:0031667~response to nutrient levels	8	40	20	0.0014448744685871	0.0144008218179245	1	1	0.734216265660986	0.985614356857844	0.133617721161368
down	BAG3; CDH1; PRKCD; TRIM28; MAVS; SMO; DMAP1; RBM22;	GO:0042307~positive regulation of protein import into nucleus	8	40	20	0.0014448744685871	0.0144008218179245	1	1	0.734216265660986	0.985614356857844	0.133617721161368
down	MTOR; VAV2; RAP1GAP2; IQGAP3; RPTOR; WDTC1;	GO:0008361~regulation of cell size	6	22	27.2727272727273	0.00148127951567156	0.0146663754352324	1	1	0.737528340485576	0.985614356857844	0.136081654792342
down	TNFSF14; CCND3; PSMB10; TNFRSF4; NCSTN; P2RX7;	GO:0042098~T cell proliferation	6	22	27.2727272727273	0.00148127951567156	0.0146663754352324	1	1	0.737528340485576	0.985614356857844	0.136081654792342
down	STAU1; APP; EPHB2; ADCY1; CRTC1; SHANK3;	GO:1900273~positive regulation of long-term synaptic potentiation	6	22	27.2727272727273	0.00148127951567156	0.0146663754352324	1	1	0.737528340485576	0.985614356857844	0.136081654792342
down	PLK1; SMC1A; KIFC1; INCENP; INO80; TUBG1; KIF18B;	GO:0000070~mitotic sister chromatid segregation	7	31	22.5806451612903	0.00155462267036632	0.0151430830614289	1	1	0.743685903604993	0.985614356857844	0.140504776436228
down	HTT; PLK1; DCTN1; NUMA1; MISP; CDK5RAP2; NDE1;	GO:0000132~establishment of mitotic spindle orientation	7	31	22.5806451612903	0.00155462267036632	0.0151430830614289	1	1	0.743685903604993	0.985614356857844	0.140504776436228
down	MCM3; MCM2; POLE; POLA2; ORC1; MCM5; CDC45;	GO:0006270~DNA replication initiation	7	31	22.5806451612903	0.00155462267036632	0.0151430830614289	1	1	0.743685903604993	0.985614356857844	0.140504776436228
down	TNFSF12; PTP4A3; ABL1; ITGB2; PECAM1; PXN; PLXND1;	GO:0043542~endothelial cell migration	7	31	22.5806451612903	0.00155462267036632	0.0151430830614289	1	1	0.743685903604993	0.985614356857844	0.140504776436228
down	EGFR; SRC; CCND3; AKT1; PKD1; CDK5R1; PSRC1;	GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity	7	31	22.5806451612903	0.00155462267036632	0.0151430830614289	1	1	0.743685903604993	0.985614356857844	0.140504776436228
down	ABL1; APP; PRKCA; CDC25B; STAT5B; HSF1; USP22;	GO:0045931~positive regulation of mitotic cell cycle	7	31	22.5806451612903	0.00155462267036632	0.0151430830614289	1	1	0.743685903604993	0.985614356857844	0.140504776436228
down	RBM23; RBM28; MSI1; SF3B4; DAZAP1; HNRNPA0; RBM38;	GO:0051252~regulation of RNA metabolic process	7	31	22.5806451612903	0.00155462267036632	0.0151430830614289	1	1	0.743685903604993	0.985614356857844	0.140504776436228
down	MYO1C; ITGB2; ITGAM; AKT2; CDK5R1; MIEF1; TCAF1;	GO:0090314~positive regulation of protein targeting to membrane	7	31	22.5806451612903	0.00155462267036632	0.0151430830614289	1	1	0.743685903604993	0.985614356857844	0.140504776436228
down	CALM3; SRC; HMGA2; CAMK1; DAB2IP; RPTOR; DBF4B; TELO2; INCENP;	GO:0071902~positive regulation of protein serine/threonine kinase activity	9	51	17.6470588235294	0.00161129847071473	0.0156668118736605	1	1	0.748618110808547	0.985614356857844	0.14536418316188
down	CCR7; MYH9; SCRIB; DOCK2;	GO:0001768~establishment of T cell polarity	4	8	50	0.00164256371976812	0.0157194394200739	1	1	0.751223429936231	0.985614356857844	0.145852486740036
down	TGFBRAP1; VPS39; ANKFY1; VPS4A;	GO:0034058~endosomal vesicle fusion	4	8	50	0.00164256371976812	0.0157194394200739	1	1	0.751223429936231	0.985614356857844	0.145852486740036
down	CDH1; SRC; CBL; GRB2;	GO:0035635~entry of bacterium into host cell	4	8	50	0.00164256371976812	0.0157194394200739	1	1	0.751223429936231	0.985614356857844	0.145852486740036
down	MFNG; LFNG; POFUT1; POFUT2;	GO:0036066~protein O-linked fucosylation	4	8	50	0.00164256371976812	0.0157194394200739	1	1	0.751223429936231	0.985614356857844	0.145852486740036
down	PPM1F; ADAR; ADARB1; CDK5RAP3;	GO:0044387~negative regulation of protein kinase activity by regulation of protein phosphorylation	4	8	50	0.00164256371976812	0.0157194394200739	1	1	0.751223429936231	0.985614356857844	0.145852486740036
down	TLR4; IRF1; RELA; LTB;	GO:0045084~positive regulation of interleukin-12 biosynthetic process	4	8	50	0.00164256371976812	0.0157194394200739	1	1	0.751223429936231	0.985614356857844	0.145852486740036
down	KMT2D; SETD1A; KMT2B; SETD1B;	GO:0097692~histone H3-K4 monomethylation	4	8	50	0.00164256371976812	0.0157194394200739	1	1	0.751223429936231	0.985614356857844	0.145852486740036
down	SETD1A; MKI67; SSRP1; SETD5;	GO:1902275~regulation of chromatin organization	4	8	50	0.00164256371976812	0.0157194394200739	1	1	0.751223429936231	0.985614356857844	0.145852486740036
down	GATA3; BRCA1; SMARCB1; SPHK2;	GO:2000617~positive regulation of histone H3-K9 acetylation	4	8	50	0.00164256371976812	0.0157194394200739	1	1	0.751223429936231	0.985614356857844	0.145852486740036
down	CALM3; PLK1; ZFYVE26; FLCN; MYO19; SETD2; GIT1; AURKA;	GO:0032465~regulation of cytokinesis	8	41	19.5121951219512	0.00165805056218771	0.0157922089996008	1	1	0.752754955233219	0.985614356857844	0.146527677747132
down	TLR4; NTRK1; APP; PARP1; CD36; BACE1; CACNB1; AGER;	GO:1904646~cellular response to amyloid-beta	8	41	19.5121951219512	0.00165805056218771	0.0157922089996008	1	1	0.752754955233219	0.985614356857844	0.146527677747132
down	ABCC2; SLCO3A1; SLCO2A1;	GO:0015732~prostaglandin transport	3	3	100	0.00175129666746976	0.0165492027853668	1	1	0.760519609566202	0.985614356857844	0.153551428604285
down	MCM3AP; SETD2; SUPT6H;	GO:0034728~nucleosome organization	3	3	100	0.00175129666746976	0.0165492027853668	1	1	0.760519609566202	0.985614356857844	0.153551428604285
down	GATA3; CARD11; JAG2;	GO:0045061~thymic T cell selection	3	3	100	0.00175129666746976	0.0165492027853668	1	1	0.760519609566202	0.985614356857844	0.153551428604285
down	HIP1; HIP1R; SRC;	GO:2000588~positive regulation of platelet-derived growth factor receptor-beta signaling pathway	3	3	100	0.00175129666746976	0.0165492027853668	1	1	0.760519609566202	0.985614356857844	0.153551428604285
up	UGT1A9; CYP2C18; UGT1A3; UGT1A8; ADH1B; ADH1C; ADH1A;	GO:0042573~retinoic acid metabolic process	7	25	28	0.00175214976339066	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	CCL5; C5AR1; MDK; C3AR1; CMKLR1;	GO:0010759~positive regulation of macrophage chemotaxis	5	15	33.3333333333333	0.0017816509799069	0.0165498027654412	1	1	0.763149736696902	0.985614356857844	0.153556995506738
down	KDM1A; PHF2; KDM4B; PHF8; KDM3B;	GO:0033169~histone H3-K9 demethylation	5	15	33.3333333333333	0.0017816509799069	0.0165498027654412	1	1	0.763149736696902	0.985614356857844	0.153556995506738
down	CD74; APP; PTAFR; TIRAP; AGER;	GO:0045410~positive regulation of interleukin-6 biosynthetic process	5	15	33.3333333333333	0.0017816509799069	0.0165498027654412	1	1	0.763149736696902	0.985614356857844	0.153556995506738
down	SRC; GATA3; HOXA10; HOXA11; LHX1;	GO:0060065~uterus development	5	15	33.3333333333333	0.0017816509799069	0.0165498027654412	1	1	0.763149736696902	0.985614356857844	0.153556995506738
down	ROCK1; PUM1; METTL16; MEX3D; YTHDF2;	GO:0061157~mRNA destabilization	5	15	33.3333333333333	0.0017816509799069	0.0165498027654412	1	1	0.763149736696902	0.985614356857844	0.153556995506738
down	BRINP1; DLG4; SHANK3; CNTNAP2; SHANK2;	GO:0071625~vocalization behavior	5	15	33.3333333333333	0.0017816509799069	0.0165498027654412	1	1	0.763149736696902	0.985614356857844	0.153556995506738
down	NF1; AGER; NCSTN; SHANK3; YTHDF1;	GO:1900271~regulation of long-term synaptic potentiation	5	15	33.3333333333333	0.0017816509799069	0.0165498027654412	1	1	0.763149736696902	0.985614356857844	0.153556995506738
down	KDM1A; PARP1; PPM1F; TRIM46; DVL3;	GO:1903827~regulation of cellular protein localization	5	15	33.3333333333333	0.0017816509799069	0.0165498027654412	1	1	0.763149736696902	0.985614356857844	0.153556995506738
down	SRC; FGFR4; ARRB2; DDX39B; PRKD2;	GO:2000573~positive regulation of DNA biosynthetic process	5	15	33.3333333333333	0.0017816509799069	0.0165498027654412	1	1	0.763149736696902	0.985614356857844	0.153556995506738
down	NOTCH1; ZFP36L2; LBH; NELFB; CDK12;	GO:2000737~negative regulation of stem cell differentiation	5	15	33.3333333333333	0.0017816509799069	0.0165498027654412	1	1	0.763149736696902	0.985614356857844	0.153556995506738
down	MYH9; BACE1; DAG1; SPPL2B; NCSTN; P2RX7;	GO:0006509~membrane protein ectodomain proteolysis	6	23	26.0869565217391	0.00179567298186889	0.0165521389893129	1	1	0.764499610768394	0.985614356857844	0.153578672110601
down	SLC26A4; SLC4A2; SLC4A3; LRRC8D; LRRC8A; SLC39A8;	GO:0015698~inorganic anion transport	6	23	26.0869565217391	0.00179567298186889	0.0165521389893129	1	1	0.764499610768394	0.985614356857844	0.153578672110601
down	MCIDAS; E2F4; CCDC40; DNAAF3; CENPJ; RSPH9;	GO:0044458~motile cilium assembly	6	23	26.0869565217391	0.00179567298186889	0.0165521389893129	1	1	0.764499610768394	0.985614356857844	0.153578672110601
down	SRC; RAC2; TCIRG1; LRRK1; NCDN; SNX10;	GO:0045453~bone resorption	6	23	26.0869565217391	0.00179567298186889	0.0165521389893129	1	1	0.764499610768394	0.985614356857844	0.153578672110601
down	SMAD7; LDLR; NF1; GJA5; FOXC2; ZMIZ1;	GO:0048844~artery morphogenesis	6	23	26.0869565217391	0.00179567298186889	0.0165521389893129	1	1	0.764499610768394	0.985614356857844	0.153578672110601
down	TLR4; CD14; CD36; IRAK1; TIRAP; BTK; TAB1;	GO:0002755~MyD88-dependent toll-like receptor signaling pathway	7	32	21.875	0.00182032037915258	0.0166770205468095	1	1	0.766354879623238	0.985614356857844	0.154737383004934
down	BAG3; NF1; AKT1; MTOR; PKD1; PTPRS; MED12;	GO:0021510~spinal cord development	7	32	21.875	0.00182032037915258	0.0166770205468095	1	1	0.766354879623238	0.985614356857844	0.154737383004934
down	MYH9; MYO18A; CDC42BPB; EPB41L2; CIT; ROCK1; CDC42BPG;	GO:0031032~actomyosin structure organization	7	32	21.875	0.00182032037915258	0.0166770205468095	1	1	0.766354879623238	0.985614356857844	0.154737383004934
down	TPPP; ROCK1; MARK2; CLASP1; PHLDB2; TRAF3IP1; MAP6D1;	GO:0070507~regulation of microtubule cytoskeleton organization	7	32	21.875	0.00182032037915258	0.0166770205468095	1	1	0.766354879623238	0.985614356857844	0.154737383004934
down	LAMA5; WT1; HOXA11; HOXD11; LHX1; PAX8; PTCH1; DCHS1;	GO:0001658~branching involved in ureteric bud morphogenesis	8	42	19.047619047619	0.00189533743575088	0.0172852473275611	1	1	0.773127066790538	0.985614356857844	0.160380802347307
down	POM121C; ZBTB7A; NUP62; EP300; NUP188; NUP210; POM121; SLC2A6;	GO:0006110~regulation of glycolytic process	8	42	19.047619047619	0.00189533743575088	0.0172852473275611	1	1	0.773127066790538	0.985614356857844	0.160380802347307
down	LONP1; TUB; NCOA6; RBM14; FOXC2; GHRL; PIAS3; TIMP1;	GO:0009725~response to hormone	8	42	19.047619047619	0.00189533743575088	0.0172852473275611	1	1	0.773127066790538	0.985614356857844	0.160380802347307
down	PSMD3; BAG3; CAPN1; PARP1; CAPN3; DNAJA3; CBX8; SH3BP4; GPSM3;	GO:0050790~regulation of catalytic activity	9	53	16.9811320754717	0.00203687674190722	0.0185448952552825	1	1	0.783623100818294	0.985614356857844	0.172068419046951
down	SUPT5H; POLR2E; ERCC3; POLR2A; GTF2F1; NCBP3; CMTR1;	GO:0006370~7-methylguanosine mRNA capping	7	33	21.2121212121212	0.00211990742046586	0.0191300954909907	1	1	0.789068589004521	0.985614356857844	0.17749818707735
down	HIP1; HIP1R; ABL1; CD22; TSC2; ARFGAP1; RAB20;	GO:0030100~regulation of endocytosis	7	33	21.2121212121212	0.00211990742046586	0.0191300954909907	1	1	0.789068589004521	0.985614356857844	0.17749818707735
down	FGR; HOXD8; HOXC8; TCF15; ANKRD11; P2RX7; NLE1;	GO:0048705~skeletal system morphogenesis	7	33	21.2121212121212	0.00211990742046586	0.0191300954909907	1	1	0.789068589004521	0.985614356857844	0.17749818707735
down	APP; SRC; CYBA; PRKCA; IRAK1; HDAC4; RELA;	GO:0070555~response to interleukin-1	7	33	21.2121212121212	0.00211990742046586	0.0191300954909907	1	1	0.789068589004521	0.985614356857844	0.17749818707735
down	TERT; MFN2; MMP9; DNMT1; DDX39B; LDLRAP1; FOXJ2;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	7	33	21.2121212121212	0.00211990742046586	0.0191300954909907	1	1	0.789068589004521	0.985614356857844	0.17749818707735
down	TLR4; NF1; TOB2; LILRB4; INPP5D; PIAS3;	GO:0045671~negative regulation of osteoclast differentiation	6	24	25	0.00215811700273716	0.0194165915964825	1	1	0.791955244113274	0.985614356857844	0.180156435142732
down	BRCA1; CTCF; GSK3A; MECP2; PRMT7;	GO:0006349~regulation of gene expression by genetic imprinting	5	16	31.25	0.00225051465983639	0.0200379157120247	1	1	0.79809064347334	0.985614356857844	0.185921377829407
down	FZD9; PLXNB2; ARTN; DAGLB; NDE1;	GO:0007405~neuroblast proliferation	5	16	31.25	0.00225051465983639	0.0200379157120247	1	1	0.79809064347334	0.985614356857844	0.185921377829407
down	HCFC1; WDR5; KAT8; JADE2; KANSL3;	GO:0043981~histone H4-K5 acetylation	5	16	31.25	0.00225051465983639	0.0200379157120247	1	1	0.79809064347334	0.985614356857844	0.185921377829407
down	HCFC1; WDR5; KAT8; JADE2; KANSL3;	GO:0043982~histone H4-K8 acetylation	5	16	31.25	0.00225051465983639	0.0200379157120247	1	1	0.79809064347334	0.985614356857844	0.185921377829407
down	PHLPP1; EGFR; EPHB1; RAPGEF1; MAPK8IP3;	GO:0046328~regulation of JNK cascade	5	16	31.25	0.00225051465983639	0.0200379157120247	1	1	0.79809064347334	0.985614356857844	0.185921377829407
down	CCR7; RASSF2; SART3; ASXL1; CARD11;	GO:0048872~homeostasis of number of cells	5	16	31.25	0.00225051465983639	0.0200379157120247	1	1	0.79809064347334	0.985614356857844	0.185921377829407
down	NTRK1; ARRB2; EPHB1; CXCR4; ASIC3;	GO:0050965~detection of temperature stimulus involved in sensory perception of pain	5	16	31.25	0.00225051465983639	0.0200379157120247	1	1	0.79809064347334	0.985614356857844	0.185921377829407
down	TPPP; LIMK2; NUMA1; CLASP1;	GO:0030953~astral microtubule organization	4	9	44.4444444444444	0.00228652173984967	0.020120052205705	1	1	0.800282608947384	0.985614356857844	0.186683479551691
down	WT1; COL4A4; COL4A3; MYO1E;	GO:0032836~glomerular basement membrane development	4	9	44.4444444444444	0.00228652173984967	0.020120052205705	1	1	0.800282608947384	0.985614356857844	0.186683479551691
down	DLG5; AJUBA; LIMD1; WWC3;	GO:0035331~negative regulation of hippo signaling	4	9	44.4444444444444	0.00228652173984967	0.020120052205705	1	1	0.800282608947384	0.985614356857844	0.186683479551691
down	BUB1; MKI67; PUM1; KIF2C;	GO:0051983~regulation of chromosome segregation	4	9	44.4444444444444	0.00228652173984967	0.020120052205705	1	1	0.800282608947384	0.985614356857844	0.186683479551691
down	TLR4; CD74; CD36; HLA-G;	GO:0060907~positive regulation of macrophage cytokine production	4	9	44.4444444444444	0.00228652173984967	0.020120052205705	1	1	0.800282608947384	0.985614356857844	0.186683479551691
down	GP1BA; PLEK; DGKQ; IQGAP2;	GO:0070493~thrombin-activated receptor signaling pathway	4	9	44.4444444444444	0.00228652173984967	0.020120052205705	1	1	0.800282608947384	0.985614356857844	0.186683479551691
down	PODXL; NOTCH2; MYO1E; ASXL1;	GO:0072015~glomerular visceral epithelial cell development	4	9	44.4444444444444	0.00228652173984967	0.020120052205705	1	1	0.800282608947384	0.985614356857844	0.186683479551691
down	ADGRL1; CDC20; DAB2IP; ANAPC2;	GO:0090129~positive regulation of synapse maturation	4	9	44.4444444444444	0.00228652173984967	0.020120052205705	1	1	0.800282608947384	0.985614356857844	0.186683479551691
up	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.00242772594698071	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
up	UGT1A9; UGT1A3; UGT1A8; UGT1A10;	GO:0052696~flavonoid glucuronidation	4	7	57.1428571428571	0.00242772594698071	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	LAMA5; CFL1; GBX2; SMO; SEMA4C; SEMA3A; SEMA3D; SEMA4D;	GO:0001755~neural crest cell migration	8	44	18.1818181818182	0.0024497021016654	0.0214247129105215	1	1	0.811409185581666	0.985614356857844	0.198788746353159
down	ABL1; GATA3; EPHB3; PRKDC; CTC1; ASXL1; BCL11B; MAD1L1;	GO:0048538~thymus development	8	44	18.1818181818182	0.0024497021016654	0.0214247129105215	1	1	0.811409185581666	0.985614356857844	0.198788746353159
down	VGF; FOS; THBD; BSG; DGKQ; RELA; CARM1; DUOX1;	GO:0051591~response to cAMP	8	44	18.1818181818182	0.0024497021016654	0.0214247129105215	1	1	0.811409185581666	0.985614356857844	0.198788746353159
down	GATA4; NOTCH1; NOTCH2; NUMA1; FOXD1; UBE2O; RNF165;	GO:0030513~positive regulation of BMP signaling pathway	7	34	20.5882352941176	0.00245617756994165	0.0214247129105215	1	1	0.812041095250221	0.985614356857844	0.198788746353159
down	DVL2; FZD5; AGER; MAP3K11; DAB2IP; FGD2; DVL3;	GO:0043507~positive regulation of JUN kinase activity	7	34	20.5882352941176	0.00245617756994165	0.0214247129105215	1	1	0.812041095250221	0.985614356857844	0.198788746353159
down	HERC2; BRCA1; PRKDC; MDC1; PIAS4; KAT5; POLL; PRPF19; KDM2A;	GO:0006303~double-strand break repair via nonhomologous end joining	9	55	16.3636363636364	0.00254753293446275	0.0221572690826644	1	1	0.817952187267886	0.985614356857844	0.205585753328316
down	GTF3C1; SNAPC4; GTF3C2; BRF1; GTF3C4; GTF3C5;	GO:0006383~transcription by RNA polymerase III	6	25	24	0.00257307346110924	0.0223027831665396	1	1	0.820016751943378	0.985614356857844	0.206935902682993
down	MEN1; VDR; BSG; PPARD; ASH1L; GHRL;	GO:0046697~decidualization	6	25	24	0.00257307346110924	0.0223027831665396	1	1	0.820016751943378	0.985614356857844	0.206935902682993
down	MAPKBP1; CCDC22; ABL1; TLE1; USP10; DAB2IP; CACTIN; ASH1L;	GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling	8	45	17.7777777777778	0.00277065913139662	0.0238282647312131	1	1	0.830396005608731	0.985614356857844	0.221090051169966
down	CSNK1D; DCTN1; C2CD3; IFT140; CEP89; CEP250; CENPJ; IFT172;	GO:1905515~non-motile cilium assembly	8	45	17.7777777777778	0.00277065913139662	0.0238282647312131	1	1	0.830396005608731	0.985614356857844	0.221090051169966
down	KDM1A; SFPQ; HNRNPM; SFSWAP; RBM17;	GO:0000380~alternative mRNA splicing, via spliceosome	5	17	29.4117647058824	0.00280309204076001	0.0238282647312131	1	1	0.831688450753648	0.985614356857844	0.221090051169966
down	GATA2; GATA3; NOTCH2; PTCH1; NOTCH4;	GO:0001709~cell fate determination	5	17	29.4117647058824	0.00280309204076001	0.0238282647312131	1	1	0.831688450753648	0.985614356857844	0.221090051169966
down	CYTH3; IQSEC1; GBF1; CYTH4; ARFGAP1;	GO:0032012~regulation of ARF protein signal transduction	5	17	29.4117647058824	0.00280309204076001	0.0238282647312131	1	1	0.831688450753648	0.985614356857844	0.221090051169966
down	G6PD; GATA3; NSMF; PCSK9; SIGMAR1;	GO:0043523~regulation of neuron apoptotic process	5	17	29.4117647058824	0.00280309204076001	0.0238282647312131	1	1	0.831688450753648	0.985614356857844	0.221090051169966
down	HMGA2; TRIM28; SETDB1; MORC2; APOBEC3A;	GO:0045869~negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	5	17	29.4117647058824	0.00280309204076001	0.0238282647312131	1	1	0.831688450753648	0.985614356857844	0.221090051169966
down	SON; SRPK2; RBM23; METTL16; KHDRBS1;	GO:0048024~regulation of mRNA splicing, via spliceosome	5	17	29.4117647058824	0.00280309204076001	0.0238282647312131	1	1	0.831688450753648	0.985614356857844	0.221090051169966
down	EGFR; APP; C5AR1; AGER; SMO;	GO:0048143~astrocyte activation	5	17	29.4117647058824	0.00280309204076001	0.0238282647312131	1	1	0.831688450753648	0.985614356857844	0.221090051169966
down	LDLR; ITGB2; CD36; FCER1G; SREBF2;	GO:0071404~cellular response to low-density lipoprotein particle stimulus	5	17	29.4117647058824	0.00280309204076001	0.0238282647312131	1	1	0.831688450753648	0.985614356857844	0.221090051169966
down	CD247; FCER1G; AKT1; TM9SF4; RANGRF;	GO:2000010~positive regulation of protein localization to cell surface	5	17	29.4117647058824	0.00280309204076001	0.0238282647312131	1	1	0.831688450753648	0.985614356857844	0.221090051169966
down	AXIN1; CCDC22; PYHIN1; CDK5RAP3; MAGEF1;	GO:2000060~positive regulation of ubiquitin-dependent protein catabolic process	5	17	29.4117647058824	0.00280309204076001	0.0238282647312131	1	1	0.831688450753648	0.985614356857844	0.221090051169966
down	RARA; FLT3LG; HCFC1; RAD23A; FOXG1; SRPK2; NR2E1;	GO:0045787~positive regulation of cell cycle	7	35	20	0.00283200460577837	0.0239386043329508	1	1	0.832609354098841	0.985614356857844	0.222113834834846
down	CD36; AMPD2; EIF4G1; CRTC1; FLCN; MLXIPL; PPARGC1A;	GO:0097009~energy homeostasis	7	35	20	0.00283200460577837	0.0239386043329508	1	1	0.832609354098841	0.985614356857844	0.222113834834846
down	TERT; FOS; WT1; GATA2; SMARCA4; RELA; SREBF2;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	7	35	20	0.00283200460577837	0.0239386043329508	1	1	0.832609354098841	0.985614356857844	0.222113834834846
down	SLC37A4; G6PD; AKT1; AKT2; PPARD; BRAT1; WDTC1; GHRL; NISCH;	GO:0006006~glucose metabolic process	9	56	16.0714285714286	0.00283829491776266	0.0239580792917888	1	1	0.833011426098838	0.985614356857844	0.222294532829207
down	ITGAL; FGL2; APBB1IP;	GO:0002291~T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell	3	4	75	0.00295988855894613	0.0246725800822001	1	1	0.837656298553944	0.985614356857844	0.22892401332621
down	LMNA; CKAP5; KIF2C;	GO:0030951~establishment or maintenance of microtubule cytoskeleton polarity	3	4	75	0.00295988855894613	0.0246725800822001	1	1	0.837656298553944	0.985614356857844	0.22892401332621
down	DENND4B; DENND1A; MADD;	GO:0032483~regulation of Rab protein signal transduction	3	4	75	0.00295988855894613	0.0246725800822001	1	1	0.837656298553944	0.985614356857844	0.22892401332621
down	CD247; FCER1G; SLC11A1;	GO:0032623~interleukin-2 production	3	4	75	0.00295988855894613	0.0246725800822001	1	1	0.837656298553944	0.985614356857844	0.22892401332621
down	TIRAP; TRAF3; RNF216;	GO:0032648~regulation of interferon-beta production	3	4	75	0.00295988855894613	0.0246725800822001	1	1	0.837656298553944	0.985614356857844	0.22892401332621
down	ARID1A; INO80; BPTF;	GO:0042766~nucleosome mobilization	3	4	75	0.00295988855894613	0.0246725800822001	1	1	0.837656298553944	0.985614356857844	0.22892401332621
down	ITGB2; ITGAM; PTAFR;	GO:0043315~positive regulation of neutrophil degranulation	3	4	75	0.00295988855894613	0.0246725800822001	1	1	0.837656298553944	0.985614356857844	0.22892401332621
down	TERF2; RTEL1; RTEL1-TNFRSF6B;	GO:1904430~negative regulation of t-circle formation	3	4	75	0.00295988855894613	0.0246725800822001	1	1	0.837656298553944	0.985614356857844	0.22892401332621
down	APP; PCSK9; ABCA2;	GO:1905598~negative regulation of low-density lipoprotein receptor activity	3	4	75	0.00295988855894613	0.0246725800822001	1	1	0.837656298553944	0.985614356857844	0.22892401332621
down	TLR4; CD36; HLA-G; CCR7; TIRAP; AGER;	GO:0032735~positive regulation of interleukin-12 production	6	26	23.0769230769231	0.00304510485913234	0.0248886700728474	1	1	0.841140932826172	0.985614356857844	0.230928999741648
down	ROCK1; CDK5R1; CDK5RAP3; CDK5RAP2; BCL11B; CASZ1;	GO:0045664~regulation of neuron differentiation	6	26	23.0769230769231	0.00304510485913234	0.0248886700728474	1	1	0.841140932826172	0.985614356857844	0.230928999741648
down	DLG4; SSH1; SHANK3; RIMS2; BAIAP2; SHANK2;	GO:2000463~positive regulation of excitatory postsynaptic potential	6	26	23.0769230769231	0.00304510485913234	0.0248886700728474	1	1	0.841140932826172	0.985614356857844	0.230928999741648
down	CDC45; CDT1; RAD9A; TIMELESS;	GO:0000076~DNA replication checkpoint	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	ADCY6; ADCY3; ADCY7; ADCY1;	GO:0006171~cAMP biosynthetic process	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	DAG1; CLASP1; PHLDB2; TGIF2;	GO:0010470~regulation of gastrulation	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	SRC; AKT1; AKT2; SLC45A3;	GO:0010907~positive regulation of glucose metabolic process	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	ACOT7; COASY; PPCDC; PANK4;	GO:0015937~coenzyme A biosynthetic process	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	HUWE1; UHRF1; CBX8; USP22;	GO:0016574~histone ubiquitination	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	EPHB2; CDC20; SSH1; ANAPC2;	GO:0031915~positive regulation of synaptic plasticity	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	TNRC6A; TNRC6C; AGO1; MOV10;	GO:0035194~posttranscriptional gene silencing by RNA	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	AP3D1; BLOC1S3; ANKRD27; AP1M1;	GO:0035646~endosome to melanosome transport	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	RHBDF1; MVB12B; WDR54; RHBDF2;	GO:0042058~regulation of epidermal growth factor receptor signaling pathway	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	CD74; MYO18A; SHPK; MFHAS1;	GO:0043030~regulation of macrophage activation	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	FGR; GATA2; FCER1G; SPHK2;	GO:0043306~positive regulation of mast cell degranulation	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	CHAMP1; KIF2C; CDT1; MAD1L1;	GO:0051315~attachment of mitotic spindle microtubules to kinetochore	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	SZT2; GGA3; SH3BP4; KPTN;	GO:0061462~protein localization to lysosome	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	TLR4; CD36; AKT1; SMPD3;	GO:0140052~cellular response to oxidised low-density lipoprotein particle stimulus	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	HIP1R; ZNF205; GSK3A; CHCHD10;	GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	ALOX5; E2F2; KLF2; EPN1;	GO:1903671~negative regulation of sprouting angiogenesis	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	KCNAB2; RAB11B; GBF1; ABCA2;	GO:2000008~regulation of protein localization to cell surface	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	EPCAM; NOTCH1; PPM1F; NOTCH4;	GO:2000048~negative regulation of cell-cell adhesion mediated by cadherin	4	10	40	0.00308520119871403	0.0248886700728474	1	1	0.842698168654787	0.985614356857844	0.230928999741648
down	DENND3; MGRN1; FAM160A2; TGFBRAP1; VPS33A; VPS39; VPS18; CLEC16A;	GO:0008333~endosome to lysosome transport	8	46	17.3913043478261	0.0031234781911248	0.0251299918723695	1	1	0.843908348389301	0.985614356857844	0.233168098962956
down	HNRNPL; POLR2E; POLR2A; PTBP1; GTF2F1; HNRNPM; HNRNPA0; DDX54;	GO:0016070~RNA metabolic process	8	46	17.3913043478261	0.0031234781911248	0.0251299918723695	1	1	0.843908348389301	0.985614356857844	0.233168098962956
down	CCL24; GRAP2; AMH; ITGB2; CGB7; FGF5; CCL4; CCL5; CCR1; PTGIR; GATA4; LHX1; CX3CR1; GRB2; LTB; ESR2; TSPAN32; ASH1L; FZD1; CCL26; ADGRG1; ADRA1B;	GO:0007267~cell-cell signaling	22	230	9.56521739130435	0.00324019596496494	0.026011327913883	1	1	0.846350489496398	0.985614356857844	0.241345556814551
down	MGRN1; CBL; TRIM25; HUWE1; ZNF598; RNF126; UBE2O;	GO:0006513~protein monoubiquitination	7	36	19.4444444444444	0.00325033398724228	0.026011327913883	1	1	0.846633144717126	0.985614356857844	0.241345556814551
down	CYB5R3; FLI1; COL4A3; E2F4; C3AR1; MYOF; F5;	GO:0008015~blood circulation	7	36	19.4444444444444	0.00325033398724228	0.026011327913883	1	1	0.846633144717126	0.985614356857844	0.241345556814551
down	CAPN3; AKT1; MTOR; RNF165; P2RX7; CLN6; BACE1;	GO:0030163~protein catabolic process	7	36	19.4444444444444	0.00325033398724228	0.026011327913883	1	1	0.846633144717126	0.985614356857844	0.241345556814551
down	MFNG; MFN2; FURIN; SUPT6H; PTPN18;	GO:0001825~blastocyst formation	5	18	27.7777777777778	0.00344743796910785	0.0274062198337806	1	1	0.85085296203898	0.985614356857844	0.254288032039898
down	STK25; EIF2AK2; SEMA4C; CARD9; TAOK2;	GO:0032874~positive regulation of stress-activated MAPK cascade	5	18	27.7777777777778	0.00344743796910785	0.0274062198337806	1	1	0.85085296203898	0.985614356857844	0.254288032039898
down	RPS6KA4; BRCA1; GLYR1; KAT2A; PPARGC1A;	GO:0035066~positive regulation of histone acetylation	5	18	27.7777777777778	0.00344743796910785	0.0274062198337806	1	1	0.85085296203898	0.985614356857844	0.254288032039898
down	PRKACA; PSME3; PKD1; NFE2L1; RHBDF1;	GO:0061136~regulation of proteasomal protein catabolic process	5	18	27.7777777777778	0.00344743796910785	0.0274062198337806	1	1	0.85085296203898	0.985614356857844	0.254288032039898
down	P2RY2; TRPM4; SSH1; P2RY11; P2RX7;	GO:0071318~cellular response to ATP	5	18	27.7777777777778	0.00344743796910785	0.0274062198337806	1	1	0.85085296203898	0.985614356857844	0.254288032039898
down	HYAL3; TIMP1; TYMS; PAX7; EVC; PKD1; ZBTB16; DLX2; GHRL;	GO:0051216~cartilage development	9	58	15.5172413793103	0.00349810092379499	0.027735602311356	1	1	0.851826142202892	0.985614356857844	0.257344200403105
down	CTNS; APP; NF1; MTOR; MECP2; SYNPO; SYNGAP1; RIC8A;	GO:0008542~visual learning	8	47	17.0212765957447	0.00351023210648682	0.0277951185243555	1	1	0.852156380516772	0.985614356857844	0.257896420328723
down	CD4; PTAFR; NFATC2IP; KAT2A; NFATC1; NFATC3;	GO:0001816~cytokine production	6	27	22.2222222222222	0.00357885350443965	0.0281899207885744	1	1	0.853507630865309	0.985614356857844	0.26155958480095
down	CD3E; CD36; CCR7; DAG1; NINJ1; FERMT1;	GO:0001954~positive regulation of cell-matrix adhesion	6	27	22.2222222222222	0.00357885350443965	0.0281899207885744	1	1	0.853507630865309	0.985614356857844	0.26155958480095
down	DCPS; RBM22; SART1; WBP11; RBM19; SRSF4;	GO:0045292~mRNA cis splicing, via spliceosome	6	27	22.2222222222222	0.00357885350443965	0.0281899207885744	1	1	0.853507630865309	0.985614356857844	0.26155958480095
down	BRD1; NTRK1; CD14; SRC; P2RX7; GHRL;	GO:0051602~response to electrical stimulus	6	27	22.2222222222222	0.00357885350443965	0.0281899207885744	1	1	0.853507630865309	0.985614356857844	0.26155958480095
up	IGLV1-50; TRBV20-1; TRAV12-2; IGKV1D-8; TRBV30; TRBV7-2; TRBV28; TRBV29-1; JCHAIN; HLA-DQA2; TRGC2; CD3D; TRBV7-9; HLA-DQB2; CD1A; CD3G; TRGC1; CD8B; CD1E; CTLA4; HLA-DMB; CD1B; CD1C; CD79B; SLAMF1; TRAT1; SKAP1; CLEC10A; ZNF683; LILRB1; FCGR1B; SIGLEC10; CD84; CLEC4A; SIT1;	GO:0002250~adaptive immune response	35	347	10.0864553314121	0.00358932665466682	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	SMAD7; GDF11; RARA; EPCAM; WT1; LHX1; FOXC2;	GO:0001657~ureteric bud development	7	37	18.9189189189189	0.00371417412903763	0.0290275507353916	1	1	0.856364560173645	0.985614356857844	0.269331516575768
down	CLCN6; SLC26A6; TTYH3; SLC26A1; ANO8; CLIC5; CLCN2;	GO:0006821~chloride transport	7	37	18.9189189189189	0.00371417412903763	0.0290275507353916	1	1	0.856364560173645	0.985614356857844	0.269331516575768
down	GDF11; GATA2; GATA3; BTK; FZD5; RUNX2; EPAS1;	GO:0048469~cell maturation	7	37	18.9189189189189	0.00371417412903763	0.0290275507353916	1	1	0.856364560173645	0.985614356857844	0.269331516575768
down	KIF3B; GAS8; PSKH1; NOTCH1; AP1B1; STIL; NEK8; CFAP53; IFT140;	GO:0007368~determination of left/right symmetry	9	59	15.2542372881356	0.00387022250140523	0.0301295819086081	1	1	0.859447780912344	0.985614356857844	0.279556689546848
down	FBP1; CERS1; CAD; PDE4A; PPM1F; CXCR4; KCNH2; EFTUD2; RBM22;	GO:0035690~cellular response to drug	9	59	15.2542372881356	0.00387022250140523	0.0301295819086081	1	1	0.859447780912344	0.985614356857844	0.279556689546848
down	TYMS; IL6R; RARA; PML; OSMR; CXCL16; RELA; TIMP1;	GO:0034097~response to cytokine	8	48	16.6666666666667	0.00393303954677515	0.0305790008746684	1	1	0.861082822213169	0.985614356857844	0.283726613933867
down	MCM5; MCM2; MCM3; CDC45;	GO:0000727~double-strand break repair via break-induced replication	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	MAN2B2; ENGASE; MAN2A2; MAN2B1;	GO:0006517~protein deglycosylation	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	EXOSC10; RBM15B; UPF1; BRCA1;	GO:0009048~dosage compensation by inactivation of X chromosome	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	MAN2B1; MAN2C1; NEU3; MAN2B2;	GO:0009313~oligosaccharide catabolic process	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	DCTN1; ODF2; SGO1; CEP250;	GO:0010457~centriole-centriole cohesion	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	HMGA2; E4F1; SND1; RPRD1B;	GO:0010564~regulation of cell cycle process	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	CTNS; AKT1; AKT2; VCP;	GO:0010918~positive regulation of mitochondrial membrane potential	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	IFIT3; IFIT2; GATA3; PYHIN1;	GO:0035457~cellular response to interferon-alpha	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	IL2RB; SHC1; STAT5B; JAK3;	GO:0038110~interleukin-2-mediated signaling pathway	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	CD74; CD3E; CCR7; DOCK2;	GO:0045060~negative thymic T cell selection	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	CD4; CD74; FES; ACIN1;	GO:0045657~positive regulation of monocyte differentiation	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	GPI; G6PD; HK1; NFE2L1;	GO:0051156~glucose 6-phosphate metabolic process	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	MEN1; SRC; CERS1; PIF1;	GO:0051974~negative regulation of telomerase activity	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	BAG6; VCP; UGGT1; POMT2;	GO:0071712~ER-associated misfolded protein catabolic process	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	DNMT1; TRIM28; SETDB1; MORC2;	GO:0090309~positive regulation of DNA methylation-dependent heterochromatin assembly	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	TLR4; CYBA; CD36; HDAC4;	GO:1903428~positive regulation of reactive oxygen species biosynthetic process	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	GATA2; RAPGEF1; KDM2B; NR2E1;	GO:2000178~negative regulation of neural precursor cell proliferation	4	11	36.3636363636364	0.00405499441652601	0.0308097553012912	1	1	0.863663121766034	0.985614356857844	0.28586766400886
down	NFATC1; GATA3; GATA4; NOTCH1; ROCK1; GATA5;	GO:0003180~aortic valve morphogenesis	6	28	21.4285714285714	0.00417902041725804	0.0309858909578416	1	1	0.865939856665621	0.985614356857844	0.287501934979023
down	ZFP36L2; METTL16; KHSRP; NUDT16; YTHDF2; DIS3L2;	GO:0006402~mRNA catabolic process	6	28	21.4285714285714	0.00417902041725804	0.0309858909578416	1	1	0.865939856665621	0.985614356857844	0.287501934979023
down	ITGB2; CCL5; PECAM1; ITGAL; ROCK1; FERMT3;	GO:0007159~leukocyte cell-cell adhesion	6	28	21.4285714285714	0.00417902041725804	0.0309858909578416	1	1	0.865939856665621	0.985614356857844	0.287501934979023
down	CDK9; BLM; RFWD3; BOD1L1; TONSL; RTEL1;	GO:0031297~replication fork processing	6	28	21.4285714285714	0.00417902041725804	0.0309858909578416	1	1	0.865939856665621	0.985614356857844	0.287501934979023
down	TNFSF14; CACNA1F; STAT5B; JAK3; TCIRG1; P2RX7;	GO:0043029~T cell homeostasis	6	28	21.4285714285714	0.00417902041725804	0.0309858909578416	1	1	0.865939856665621	0.985614356857844	0.287501934979023
down	SLC9A1; SLC4A8; TM9SF4; SLC26A6; SLC4A3; SLC4A2;	GO:0051453~regulation of intracellular pH	6	28	21.4285714285714	0.00417902041725804	0.0309858909578416	1	1	0.865939856665621	0.985614356857844	0.287501934979023
down	MEN1; HDAC4; RUNX2; LIMD1; LRP5;	GO:0002076~osteoblast development	5	19	26.3157894736842	0.00419160222108572	0.0309858909578416	1	1	0.866409892257793	0.985614356857844	0.287501934979023
down	MAP2K7; AQP9; EGFR; LRRC8A; TSC22D3;	GO:0006970~response to osmotic stress	5	19	26.3157894736842	0.00419160222108572	0.0309858909578416	1	1	0.866409892257793	0.985614356857844	0.287501934979023
down	KDM1A; RAD51AP1; SETD2; RTEL1; RTEL1-TNFRSF6B;	GO:0010569~regulation of double-strand break repair via homologous recombination	5	19	26.3157894736842	0.00419160222108572	0.0309858909578416	1	1	0.866409892257793	0.985614356857844	0.287501934979023
down	PTPN6; MYH9; EP300; NBEAL2; VPS33A;	GO:0030220~platelet formation	5	19	26.3157894736842	0.00419160222108572	0.0309858909578416	1	1	0.866409892257793	0.985614356857844	0.287501934979023
down	SMAD7; LRP4; MDK; NOTCH1; SOST;	GO:0030279~negative regulation of ossification	5	19	26.3157894736842	0.00419160222108572	0.0309858909578416	1	1	0.866409892257793	0.985614356857844	0.287501934979023
down	MBTPS2; RELA; MBTPS1; SPPL2B; NCSTN;	GO:0031293~membrane protein intracellular domain proteolysis	5	19	26.3157894736842	0.00419160222108572	0.0309858909578416	1	1	0.866409892257793	0.985614356857844	0.287501934979023
down	RARA; TNFRSF1B; AKT1; MTOR; LGI4;	GO:0031641~regulation of myelination	5	19	26.3157894736842	0.00419160222108572	0.0309858909578416	1	1	0.866409892257793	0.985614356857844	0.287501934979023
down	CST7; TPPP; TNFRSF1B; ITGAX; DAG1;	GO:0031643~positive regulation of myelination	5	19	26.3157894736842	0.00419160222108572	0.0309858909578416	1	1	0.866409892257793	0.985614356857844	0.287501934979023
down	HOXA11; RELA; ZBTB16; RUNX2; ZNF219;	GO:0032332~positive regulation of chondrocyte differentiation	5	19	26.3157894736842	0.00419160222108572	0.0309858909578416	1	1	0.866409892257793	0.985614356857844	0.287501934979023
down	EGFR; ITGB2; ITGAM; CYBA; PRKCD;	GO:0032930~positive regulation of superoxide anion generation	5	19	26.3157894736842	0.00419160222108572	0.0309858909578416	1	1	0.866409892257793	0.985614356857844	0.287501934979023
down	CD36; HCFC1; DAB2IP; HJURP; NCLN;	GO:0043254~regulation of protein-containing complex assembly	5	19	26.3157894736842	0.00419160222108572	0.0309858909578416	1	1	0.866409892257793	0.985614356857844	0.287501934979023
down	CAPN3; FGFR4; PLK1; CYFIP2; CLN6;	GO:0045862~positive regulation of proteolysis	5	19	26.3157894736842	0.00419160222108572	0.0309858909578416	1	1	0.866409892257793	0.985614356857844	0.287501934979023
down	EGFR; APP; ITGB2; BST1; PPP2R5B;	GO:0050730~regulation of peptidyl-tyrosine phosphorylation	5	19	26.3157894736842	0.00419160222108572	0.0309858909578416	1	1	0.866409892257793	0.985614356857844	0.287501934979023
down	SMAD7; CALM3; PRKACA; ADRA1B; GJA5;	GO:0055117~regulation of cardiac muscle contraction	5	19	26.3157894736842	0.00419160222108572	0.0309858909578416	1	1	0.866409892257793	0.985614356857844	0.287501934979023
down	ADCY6; NPR1; P2RY2; ROCK1; FOXC2;	GO:0097746~regulation of blood vessel diameter	5	19	26.3157894736842	0.00419160222108572	0.0309858909578416	1	1	0.866409892257793	0.985614356857844	0.287501934979023
down	AGRN; GPC1; HSPG2; GALNT5; PXYLP1; XYLT2; B4GALT7;	GO:0006024~glycosaminoglycan biosynthetic process	7	38	18.4210526315789	0.0042265873332954	0.0310915420723443	1	1	0.866885009315828	0.985614356857844	0.288482216614093
down	MAP2K7; MAP4K2; MAP3K11; DAB2IP; MAP4K1; DAXX; MAPK8IP3;	GO:0007257~activation of JUN kinase activity	7	38	18.4210526315789	0.0042265873332954	0.0310915420723443	1	1	0.866885009315828	0.985614356857844	0.288482216614093
down	GJA5; KCNJ2; KCNH2; DSG2; SCN4B; TRPM4; SCN3B;	GO:0086091~regulation of heart rate by cardiac conduction	7	38	18.4210526315789	0.0042265873332954	0.0310915420723443	1	1	0.866885009315828	0.985614356857844	0.288482216614093
down	ABL1; MDK; DMTN; ARHGEF7; UNC13D; PREX1; HAS2;	GO:1900026~positive regulation of substrate adhesion-dependent cell spreading	7	38	18.4210526315789	0.0042265873332954	0.0310915420723443	1	1	0.866885009315828	0.985614356857844	0.288482216614093
down	TLR4; AKAP8; RARA; PTPN6; ARRB2; HSF1; CACTIN; C5AR2;	GO:0032720~negative regulation of tumor necrosis factor production	8	49	16.3265306122449	0.00439406052576441	0.0322052484876148	1	1	0.87036030375156	0.985614356857844	0.298815718072044
down	SLC6A6; LRRC8D; LRRC8A;	GO:0015734~taurine transport	3	5	60	0.00457415094930824	0.033001977437386	1	1	0.874120125217118	0.985614356857844	0.306208150809405
down	SCRIB; DLG5; ZDHHC7;	GO:0030859~polarized epithelial cell differentiation	3	5	60	0.00457415094930824	0.033001977437386	1	1	0.874120125217118	0.985614356857844	0.306208150809405
down	PARP1; LONP1; TOP3A;	GO:0032042~mitochondrial DNA metabolic process	3	5	60	0.00457415094930824	0.033001977437386	1	1	0.874120125217118	0.985614356857844	0.306208150809405
down	DNMT1; TRIM28; PICK1;	GO:0043045~DNA methylation involved in embryo development	3	5	60	0.00457415094930824	0.033001977437386	1	1	0.874120125217118	0.985614356857844	0.306208150809405
down	PLK1; DCTN1; AKAP8L;	GO:0051081~nuclear envelope disassembly	3	5	60	0.00457415094930824	0.033001977437386	1	1	0.874120125217118	0.985614356857844	0.306208150809405
down	CDK9; CAMK1; SUPT6H;	GO:0051147~regulation of muscle cell differentiation	3	5	60	0.00457415094930824	0.033001977437386	1	1	0.874120125217118	0.985614356857844	0.306208150809405
down	SORBS3; PLXNA3; P2RX7;	GO:0051495~positive regulation of cytoskeleton organization	3	5	60	0.00457415094930824	0.033001977437386	1	1	0.874120125217118	0.985614356857844	0.306208150809405
down	NTN1; PTCH1; SCRIB;	GO:0060603~mammary gland duct morphogenesis	3	5	60	0.00457415094930824	0.033001977437386	1	1	0.874120125217118	0.985614356857844	0.306208150809405
down	SEMA3A; PLXNA1; PLXND1;	GO:0060666~dichotomous subdivision of terminal units involved in salivary gland branching	3	5	60	0.00457415094930824	0.033001977437386	1	1	0.874120125217118	0.985614356857844	0.306208150809405
down	WT1; LHX1; PAX8;	GO:0072284~metanephric S-shaped body morphogenesis	3	5	60	0.00457415094930824	0.033001977437386	1	1	0.874120125217118	0.985614356857844	0.306208150809405
down	MECP2; CKAP5; DCTN1;	GO:0090063~positive regulation of microtubule nucleation	3	5	60	0.00457415094930824	0.033001977437386	1	1	0.874120125217118	0.985614356857844	0.306208150809405
down	DYNC1H1; NUMA1; MAD1L1;	GO:0090235~regulation of metaphase plate congression	3	5	60	0.00457415094930824	0.033001977437386	1	1	0.874120125217118	0.985614356857844	0.306208150809405
down	DAG1; CLASP1; PHLDB2;	GO:1904261~positive regulation of basement membrane assembly involved in embryonic body morphogenesis	3	5	60	0.00457415094930824	0.033001977437386	1	1	0.874120125217118	0.985614356857844	0.306208150809405
down	GAK; ADCY6; PTPRS; CRMP1; SEMA3A; RAP1GAP2; TSC1; GFI1; CTSZ;	GO:0010977~negative regulation of neuron projection development	9	61	14.7540983606557	0.00470684860035508	0.0339186571800169	1	1	0.876999850780239	0.985614356857844	0.314713544445529
down	CCDC22; VPS53; DENND1A; PTPN23; GGA3; EHD2; DENND1C;	GO:0032456~endocytic recycling	7	39	17.9487179487179	0.0047906804386344	0.0343579826207551	1	1	0.878812487852486	0.985614356857844	0.318789816270973
down	SLC2A1; SZT2; MYBBP1A; NUAK2; PICK1; TBL2; KPTN;	GO:0042149~cellular response to glucose starvation	7	39	17.9487179487179	0.0047906804386344	0.0343579826207551	1	1	0.878812487852486	0.985614356857844	0.318789816270973
down	TLR4; ITGB2; CD36; AKT1; MTOR; HBB; KLF2;	GO:0045429~positive regulation of nitric oxide biosynthetic process	7	39	17.9487179487179	0.0047906804386344	0.0343579826207551	1	1	0.878812487852486	0.985614356857844	0.318789816270973
down	EGFR; FOS; MMP9; AKT1; PPP5C; HSF1; DAXX;	GO:0071276~cellular response to cadmium ion	7	39	17.9487179487179	0.0047906804386344	0.0343579826207551	1	1	0.878812487852486	0.985614356857844	0.318789816270973
up	UGT1A9; UGT1A3; UGT1A8; UGT1A10;	GO:0052697~xenobiotic glucuronidation	4	9	44.4444444444444	0.00480300166039238	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
up	ADAMDEC1; IL18RAP; IL2RA; JCHAIN; IGKC; TRBC1; HLA-DQA2; C1QC; TRGC2; TRBV7-9; HLA-DQB2; CD1A; CD8B; GZMA; CD1E; CTLA4; HRH2; FCGR2B; CD79B; DEFB1; MS4A2; IRF8; RGS1; CLNK; GPR65; FCGR1B; CCL19; CYSLTR2; ICOS; IGKV1D-8; CD80; TLR7; CD1C; CCR5; TLR8; CXCR3; RAET1G; IGLV1-50; CCR8; CD1B; CCR2;	GO:0006955~immune response	41	433	9.46882217090069	0.0048053092964091	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	RARA; WT1; AKT1; MTOR; FANCC; CELF1;	GO:0007281~germ cell development	6	29	20.6896551724138	0.00485034413943897	0.0344162553459601	1	1	0.880058441285169	0.985614356857844	0.319330498521348
down	DIAPH1; CORO7; CTTN; PREX1; DIAPH3; MSRB1;	GO:0030041~actin filament polymerization	6	29	20.6896551724138	0.00485034413943897	0.0344162553459601	1	1	0.880058441285169	0.985614356857844	0.319330498521348
down	EN2; CXCR2; EN1; KDM2B; DLG5; KAT2A;	GO:0030901~midbrain development	6	29	20.6896551724138	0.00485034413943897	0.0344162553459601	1	1	0.880058441285169	0.985614356857844	0.319330498521348
down	TLR4; CD14; TRAF3; IKBKE; IRF3; IKBKG;	GO:0035666~TRIF-dependent toll-like receptor signaling pathway	6	29	20.6896551724138	0.00485034413943897	0.0344162553459601	1	1	0.880058441285169	0.985614356857844	0.319330498521348
down	PML; BAG6; EP300; ATAD5; CDIP1; TMEM109;	GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	6	29	20.6896551724138	0.00485034413943897	0.0344162553459601	1	1	0.880058441285169	0.985614356857844	0.319330498521348
down	EGFR; CTC1; KCTD13; ATAD5; CDT1; BRPF3;	GO:0045740~positive regulation of DNA replication	6	29	20.6896551724138	0.00485034413943897	0.0344162553459601	1	1	0.880058441285169	0.985614356857844	0.319330498521348
down	ABL1; EGFR; SCRIB; NLE1; TRIM35; BRINP1;	GO:0045930~negative regulation of mitotic cell cycle	6	29	20.6896551724138	0.00485034413943897	0.0344162553459601	1	1	0.880058441285169	0.985614356857844	0.319330498521348
down	DAPK3; DIAPH1; ABL1; EGFR; FES; ROCK1;	GO:2000145~regulation of cell motility	6	29	20.6896551724138	0.00485034413943897	0.0344162553459601	1	1	0.880058441285169	0.985614356857844	0.319330498521348
down	APP; CAPN1; DAPK1; DLG4; CNIH2; PPARGC1A;	GO:2000310~regulation of NMDA receptor activity	6	29	20.6896551724138	0.00485034413943897	0.0344162553459601	1	1	0.880058441285169	0.985614356857844	0.319330498521348
down	HOXC11; GATA4; NOTCH1; BPTF; MED12;	GO:0007492~endoderm development	5	20	25	0.00504357398264266	0.0355773235160591	1	1	0.883989223405053	0.985614356857844	0.330103445021424
down	PARP1; PRKCA; SLC9A1; CDK9; ROCK1;	GO:0010613~positive regulation of cardiac muscle hypertrophy	5	20	25	0.00504357398264266	0.0355773235160591	1	1	0.883989223405053	0.985614356857844	0.330103445021424
down	SIPA1L1; EPHB3; MARK2; BRSK2; ARHGAP35;	GO:0050770~regulation of axonogenesis	5	20	25	0.00504357398264266	0.0355773235160591	1	1	0.883989223405053	0.985614356857844	0.330103445021424
down	NTN1; EPCAM; AKT2; CCR7; DUOX1;	GO:2000147~positive regulation of cell motility	5	20	25	0.00504357398264266	0.0355773235160591	1	1	0.883989223405053	0.985614356857844	0.330103445021424
down	KMT2D; ARPC1B; ARSB; GATA3; BRCA1; EP300; TRIM25; ABCC2; GHRL;	GO:0043627~response to estrogen	9	62	14.5161290322581	0.0051746216061046	0.0358367425272121	1	1	0.886783289282763	0.985614356857844	0.332510458838723
down	PLXNB1; EGFR; CTTN; DAB2IP; MAP1S; ZNF335; CNTNAP2; MINK1; ANKRD27;	GO:0048812~neuron projection morphogenesis	9	62	14.5161290322581	0.0051746216061046	0.0358367425272121	1	1	0.886783289282763	0.985614356857844	0.332510458838723
down	ADGRL1; NTRK1; EPHB2; EPHB3; EPHB1; DLG5; GHRL; CLSTN1; FLRT1;	GO:0051965~positive regulation of synapse assembly	9	62	14.5161290322581	0.0051746216061046	0.0358367425272121	1	1	0.886783289282763	0.985614356857844	0.332510458838723
down	MAP4K2; TAB1; DAB2IP; MAP4K1;	GO:0000185~activation of MAPKKK activity	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	PLOD3; PECAM1; NOTCH4; COL18A1;	GO:0001886~endothelial cell morphogenesis	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	SOX1; SKI; SHROOM2; NECTIN1;	GO:0002089~lens morphogenesis in camera-type eye	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	TLR4; IKBKE; DAB2IP; ERC1;	GO:0007252~I-kappaB phosphorylation	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	RARA; TRAF3IP1; PPP1R13L; IFT140;	GO:0031076~embryonic camera-type eye development	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	YY1; PTPRS; TRAF3IP1; CACTIN;	GO:0032688~negative regulation of interferon-beta production	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	HDAC4; PIAS4; RASD2; PIAS3;	GO:0033235~positive regulation of protein sumoylation	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	CCL5; CXCR2; PRKCD; PREX1;	GO:0042119~neutrophil activation	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	ABL1; GRB2; ATAD5; STK33;	GO:0042770~signal transduction in response to DNA damage	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	UNC119B; PRKCB; CD36; UNC119;	GO:0042953~lipoprotein transport	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	CCL4; CCL5; HMGA2; TFAP4;	GO:0043922~negative regulation by host of viral transcription	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	WHAMM; WIPF1; WIPF2; TIGD5;	GO:0051127~positive regulation of actin nucleation	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	MMP9; MTOR; IQSEC1; HAS2;	GO:0051549~positive regulation of keratinocyte migration	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	TCIRG1; STIM1; NECTIN1; WDR72;	GO:0070166~enamel mineralization	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	ABL1; APP; CX3CR1; AGER;	GO:1900272~negative regulation of long-term synaptic potentiation	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	PLK1; CDC20; GORASP1; FZR1;	GO:1904668~positive regulation of ubiquitin protein ligase activity	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	ITGB2; MDK; IRAK1; RELA;	GO:1904996~positive regulation of leukocyte adhesion to vascular endothelial cell	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
down	FOXM1; NUDT16; WRAP53; TIMELESS;	GO:2000781~positive regulation of double-strand break repair	4	12	33.3333333333333	0.0052115329398974	0.0358367425272121	1	1	0.887505089634505	0.985614356857844	0.332510458838723
up	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.00529803205363688	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	MAZ; CPSF1; CPSF7; SYMPK; WDR33; TTF2; SCAF8;	GO:0006369~termination of RNA polymerase II transcription	7	40	17.5	0.00540959524882001	0.0370292339924923	1	1	0.892046416847547	0.985614356857844	0.343574965719628
down	NUP62; KIF22; PSRC1; CHMP7; KIF2C; KIFC1; VPS4A;	GO:0007080~mitotic metaphase plate congression	7	40	17.5	0.00540959524882001	0.0370292339924923	1	1	0.892046416847547	0.985614356857844	0.343574965719628
down	ADCY6; ADCY3; ADORA3; CALM3; ADCY7; ADCY1; P2RY11;	GO:0007190~activation of adenylate cyclase activity	7	40	17.5	0.00540959524882001	0.0370292339924923	1	1	0.892046416847547	0.985614356857844	0.343574965719628
down	ARID1A; MMP9; RXRA; BSG; PPARD; DDR1; TRIM28;	GO:0007566~embryo implantation	7	40	17.5	0.00540959524882001	0.0370292339924923	1	1	0.892046416847547	0.985614356857844	0.343574965719628
up	TYROBP; CTLA4; FCGR2B; MNDA; CD300A;	GO:0030889~negative regulation of B cell proliferation	5	16	31.25	0.00543663133244543	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	KDM1A; PARP1; YY1; POLD1; EP300; CREBBP; INO80; NOC2L;	GO:0034644~cellular response to UV	8	51	15.6862745098039	0.00543956148863389	0.0371497324394201	1	1	0.892088084135958	0.985614356857844	0.344693008015099
down	NSUN2; CTU2; TRMT61A; TRMT1; FTSJ1; AARS2;	GO:0006400~tRNA modification	6	30	20	0.00559757961111629	0.0380129417658858	1	1	0.895612737778606	0.985614356857844	0.352702277523872
down	SPTBN2; TPGS1; NCSTN; SHANK3; CNTNAP2; SHANK2;	GO:0030534~adult behavior	6	30	20	0.00559757961111629	0.0380129417658858	1	1	0.895612737778606	0.985614356857844	0.352702277523872
down	MFN2; NPR1; PTGIR; PPARD; SF1; PPARGC1A;	GO:0048662~negative regulation of smooth muscle cell proliferation	6	30	20	0.00559757961111629	0.0380129417658858	1	1	0.895612737778606	0.985614356857844	0.352702277523872
down	LRP5; SKI; HAS2; GLG1; PAPPA2; RARA;	GO:0060349~bone morphogenesis	6	30	20	0.00559757961111629	0.0380129417658858	1	1	0.895612737778606	0.985614356857844	0.352702277523872
down	TERT; PDPK1; PAK4; ABL1; GATA2; GATA3;	GO:2000352~negative regulation of endothelial cell apoptotic process	6	30	20	0.00559757961111629	0.0380129417658858	1	1	0.895612737778606	0.985614356857844	0.352702277523872
down	GATA4; NOTCH1; NOTCH2; STIL; C2CD3; CCDC40; SMO; IFT172; EOMES;	GO:0001947~heart looping	9	63	14.2857142857143	0.00567759070940677	0.0384693575688102	1	1	0.897059332086269	0.985614356857844	0.356937121913995
down	PSMD3; PSMB9; AKT1; PSMB10; PSME3; IKBKE; PSMF1; MAP3K14; RELA;	GO:0038061~NIK/NF-kappaB signaling	9	63	14.2857142857143	0.00567759070940677	0.0384693575688102	1	1	0.897059332086269	0.985614356857844	0.356937121913995
down	MYO10; CCDC88B; KIF1C; MAP6D1; CCDC88C;	GO:0030705~cytoskeleton-dependent intracellular transport	5	21	23.8095238095238	0.0060112294078063	0.040456314379525	1	1	0.902609721197537	0.985614356857844	0.375373058727221
down	SASH3; CD3E; RARA; GATA3; FCER1G;	GO:0032753~positive regulation of interleukin-4 production	5	21	23.8095238095238	0.0060112294078063	0.040456314379525	1	1	0.902609721197537	0.985614356857844	0.375373058727221
down	HCFC1; WDR5; KAT8; JADE2; KANSL3;	GO:0043984~histone H4-K16 acetylation	5	21	23.8095238095238	0.0060112294078063	0.040456314379525	1	1	0.902609721197537	0.985614356857844	0.375373058727221
down	VCP; CDH8; IL10RA; DAG1; IGSF9;	GO:0050807~regulation of synapse organization	5	21	23.8095238095238	0.0060112294078063	0.040456314379525	1	1	0.902609721197537	0.985614356857844	0.375373058727221
down	ARID1A; KDM6B; SLC9A1; AKAP13; TSC1;	GO:0055007~cardiac muscle cell differentiation	5	21	23.8095238095238	0.0060112294078063	0.040456314379525	1	1	0.902609721197537	0.985614356857844	0.375373058727221
down	ABL1; GATA2; HDAC7; MAP3K3; FOXC2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	5	21	23.8095238095238	0.0060112294078063	0.040456314379525	1	1	0.902609721197537	0.985614356857844	0.375373058727221
down	LRP5; AKT1; PPARD; ZBTB16; ASXL2; CARM1; TRPM4; CMKLR1;	GO:0045600~positive regulation of fat cell differentiation	8	52	15.3846153846154	0.00602852502971485	0.0405273326941681	1	1	0.903373768663571	0.985614356857844	0.37603200066007
down	CASQ2; CALM3; PRKACA; SEMA3A; EPAS1; RANGRF;	GO:0002027~regulation of heart rate	6	31	19.3548387096774	0.00642547726889875	0.041796153730402	1	1	0.909926239732277	0.985614356857844	0.387804729853356
down	BUB1; INTS3; TICRR; PRCC; CHFR; MAD1L1;	GO:0007093~mitotic cell cycle checkpoint	6	31	19.3548387096774	0.00642547726889875	0.041796153730402	1	1	0.909926239732277	0.985614356857844	0.387804729853356
down	MFNG; HOXD12; LHX1; RNF111; DCHS1; SYNGAP1;	GO:0007389~pattern specification process	6	31	19.3548387096774	0.00642547726889875	0.041796153730402	1	1	0.909926239732277	0.985614356857844	0.387804729853356
down	AP3D1; KIF3B; KIF4A; HAP1; BLOC1S3; SPG7;	GO:0008089~anterograde axonal transport	6	31	19.3548387096774	0.00642547726889875	0.041796153730402	1	1	0.909926239732277	0.985614356857844	0.387804729853356
down	EGFR; SRC; PRKCA; SHC1; GRB2; PTPN18;	GO:0038128~ERBB2 signaling pathway	6	31	19.3548387096774	0.00642547726889875	0.041796153730402	1	1	0.909926239732277	0.985614356857844	0.387804729853356
up	CYP2C9; CYP2C19; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	4	10	40	0.00642637622479159	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	PRPF6; SART3; PRPF8; PRPF19;	GO:0000244~spliceosomal tri-snRNP complex assembly	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	CASQ2; CALM3; STIM1; KCNMB3;	GO:0005513~detection of calcium ion	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	NTN1; FHOD1; DYNC1H1; CLMN;	GO:0007097~nuclear migration	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	TNFRSF1B; RGS2; NOTCH1; GATA5;	GO:0010614~negative regulation of cardiac muscle hypertrophy	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	TLR4; MDK; NOTCH2; HAS2;	GO:0010838~positive regulation of keratinocyte proliferation	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	INTS3; INTS5; INTS1; TUT1;	GO:0016180~snRNA processing	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	RPS6KA4; PRKCD; BAZ1B; INCENP;	GO:0016572~histone phosphorylation	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	PAX7; LHX1; LHX5; LHX3;	GO:0021527~spinal cord association neuron differentiation	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	TOX; EOMES; ZNF335; NR2E1;	GO:0021895~cerebral cortex neuron differentiation	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	ARAF; RAD23A; GNA12; FOXF2;	GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	TLR4; IRF3; MAVS; SETD2;	GO:0032727~positive regulation of interferon-alpha production	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	DYNC1H1; PATL1; LIMD1; PATL2;	GO:0033962~cytoplasmic mRNA processing body assembly	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	TNRC6A; NOTCH4; TNRC6C; AGO1;	GO:0035278~miRNA mediated inhibition of translation	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	MBD3; PARP1; BRCA1; MBD1;	GO:0044030~regulation of DNA methylation	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	CYBA; NCF2; CD52; SLC11A1;	GO:0045730~respiratory burst	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	MGRN1; PLEK; CCL5; RGS2;	GO:0045744~negative regulation of G protein-coupled receptor signaling pathway	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	CCND3; TSC2; MZB1; SIK2;	GO:0046626~regulation of insulin receptor signaling pathway	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	GIGYF1; IGF2R; AKT1; TSC2;	GO:0048009~insulin-like growth factor receptor signaling pathway	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	NTRK1; BACE1; CXCR4; ASIC3;	GO:0050966~detection of mechanical stimulus involved in sensory perception of pain	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	KIF22; TRAPPC12; KIF2C; INCENP;	GO:0051310~metaphase plate congression	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	GJA5; GATA4; NOTCH2; SMO;	GO:0060413~atrial septum morphogenesis	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	SRC; PML; DDR1; LRP5;	GO:0060444~branching involved in mammary gland duct morphogenesis	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	PLK1; CARM1; LEMD2; CHMP7;	GO:0071168~protein localization to chromatin	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	ITGB2; ITGAM; PECAM1; EPCAM;	GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	ACTN4; MELTF; DMTN; RCC2;	GO:1900025~negative regulation of substrate adhesion-dependent cell spreading	4	13	30.7692307692308	0.00656955664907188	0.041796153730402	1	1	0.912604965097456	0.985614356857844	0.387804729853356
down	TIGD5; WIPF1; WIPF2;	GO:0000147~actin cortical patch assembly	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	SF3A2; SF3A1; SF1;	GO:0000389~mRNA 3'-splice site recognition	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	TLR4; ABL1; PLCL2;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	MTA2; CHD3; BAZ1B;	GO:0006333~chromatin assembly or disassembly	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	WIZ; DBF4B; INO80;	GO:0010571~positive regulation of nuclear cell cycle DNA replication	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	BAG6; EP300; KAT2A;	GO:0018393~internal peptidyl-lysine acetylation	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	TICRR; CDT1; WDR18;	GO:0030174~regulation of DNA-dependent DNA replication initiation	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	STIM1; CRACR2A; STIM2;	GO:0032237~activation of store-operated calcium channel activity	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	CYBA; TIRAP; MFHAS1;	GO:0034137~positive regulation of toll-like receptor 2 signaling pathway	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	HIP1R; PICK1; GMFG;	GO:0034316~negative regulation of Arp2/3 complex-mediated actin nucleation	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	SMG6; SMG7; SMG5;	GO:0035303~regulation of dephosphorylation	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	NUP62; FOXM1; FLCN;	GO:0046578~regulation of Ras protein signal transduction	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	ABL1; PRR7; BCL11B;	GO:0046632~alpha-beta T cell differentiation	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	TOP3A; NCAPD3; NCAPD2;	GO:0051304~chromosome separation	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	TUBGCP6; TUBGCP3; TUBGCP2;	GO:0051415~microtubule nucleation by interphase microtubule organizing center	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	KDM1A; BRCA1; WDR5;	GO:0051572~negative regulation of histone H3-K4 methylation	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	STK25; STK11; ARHGAP21;	GO:0051645~Golgi localization	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	SMAD7; GJA5; SCN3B;	GO:0060373~regulation of ventricular cardiac muscle cell membrane depolarization	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	KDM6B; KDM1A; EHMT1;	GO:0060992~response to fungicide	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	WT1; PAX8; NSMF;	GO:0071371~cellular response to gonadotropin stimulus	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	FLT3LG; HMGA2; MAP3K3;	GO:0071864~positive regulation of cell proliferation in bone marrow	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	GATA3; LHX1; LZTS2;	GO:0072197~ureter morphogenesis	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	C1QL1; DCTN1; CHCHD10;	GO:0099558~maintenance of synapse structure	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	PIAS4; NACC2; RAD9A;	GO:1902231~positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	SOX15; PAX7; PPARD;	GO:2000288~positive regulation of myoblast proliferation	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	GATA3; IL17RA; IL17RB;	GO:2000664~positive regulation of interleukin-5 secretion	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	GATA3; IL17RA; IL17RB;	GO:2000667~positive regulation of interleukin-13 secretion	3	6	50	0.00662757645675094	0.041796153730402	1	1	0.913527391187393	0.985614356857844	0.387804729853356
down	TET3; PLOD3; GALNT18; GALNT6; POFUT1; POMK; POMT2; POMT1;	GO:0006493~protein O-linked glycosylation	8	53	15.0943396226415	0.00666465901110946	0.0418981178418074	1	1	0.913527391187393	0.985614356857844	0.388750801708038
down	SMAD7; U2AF2; AKT1; ARRB2; MTOR; NXN; PRR7; RASD2;	GO:0031397~negative regulation of protein ubiquitination	8	53	15.0943396226415	0.00666465901110946	0.0418981178418074	1	1	0.913527391187393	0.985614356857844	0.388750801708038
down	CASQ2; ATP2A1; NPR1; ATP2A2; PRKACA; STIM1; ITPR3; ATP2A3;	GO:1903779~regulation of cardiac conduction	8	53	15.0943396226415	0.00666465901110946	0.0418981178418074	1	1	0.913527391187393	0.985614356857844	0.388750801708038
down	PML; CSNK1D; MTA1; RAI1; HUWE1; KDM8; MYBBP1A; PPARGC1A; KDM2A;	GO:0032922~circadian regulation of gene expression	9	65	13.8461538461538	0.00679591919963352	0.0425896500414989	1	1	0.915325419458553	0.985614356857844	0.395167168621034
down	TOP3A; SMC1A; NUMA1; ZNF318; RAD54L; TUBGCP2; TUBGCP3; TUBGCP6; REC8;	GO:0051321~meiotic cell cycle	9	65	13.8461538461538	0.00679591919963352	0.0425896500414989	1	1	0.915325419458553	0.985614356857844	0.395167168621034
down	MAP2K7; CD14; AKT1; ABCC2; DNAJA3; ASIC3; TRPV2;	GO:0009408~response to heat	7	42	16.6666666666667	0.00682457350262067	0.0425915750267396	1	1	0.915325419458553	0.985614356857844	0.395185029555944
down	MEN1; MAP2K7; ERCC3; POLD1; PML; CDKN2D; CCAR2;	GO:0009411~response to UV	7	42	16.6666666666667	0.00682457350262067	0.0425915750267396	1	1	0.915325419458553	0.985614356857844	0.395185029555944
down	SKI; WT1; RXRA; SHROOM2; VAX1; FOXC2; ARHGAP35;	GO:0043010~camera-type eye development	7	42	16.6666666666667	0.00682457350262067	0.0425915750267396	1	1	0.915325419458553	0.985614356857844	0.395185029555944
down	MEN1; BRINP1; GATA3; TAF6; ZBTB17; RUNX3; SIPA1;	GO:0045786~negative regulation of cell cycle	7	42	16.6666666666667	0.00682457350262067	0.0425915750267396	1	1	0.915325419458553	0.985614356857844	0.395185029555944
down	CD4; PARP1; MMP9; IL31RA; EIF2AK1;	GO:0030225~macrophage differentiation	5	22	22.7272727272727	0.00710228252681333	0.0442328683794281	1	1	0.918459119929777	0.985614356857844	0.410413735272625
down	HIP1; AP2A1; CBL; LDLRAP1; HIP1R;	GO:0048260~positive regulation of receptor-mediated endocytosis	5	22	22.7272727272727	0.00710228252681333	0.0442328683794281	1	1	0.918459119929777	0.985614356857844	0.410413735272625
down	BRINP1; MDK; DRD4; MECP2; EIF4G1; NR2E1;	GO:0001662~behavioral fear response	6	32	18.75	0.00733876250620746	0.0454943778277479	1	1	0.921162277205825	0.985614356857844	0.422118624051835
down	CTSS; LONP1; ADAMTS7; CTSW; RNF123; CTSZ;	GO:0051603~proteolysis involved in cellular protein catabolic process	6	32	18.75	0.00733876250620746	0.0454943778277479	1	1	0.921162277205825	0.985614356857844	0.422118624051835
down	BLM; GRB2; RAD51AP1; RAD9A; TNKS1BP1; INO80;	GO:0071479~cellular response to ionizing radiation	6	32	18.75	0.00733876250620746	0.0454943778277479	1	1	0.921162277205825	0.985614356857844	0.422118624051835
down	TRABD2B; TPPP; VCP; TIRAP; PPP2R5B; DAB2IP; AJUBA; CDT1;	GO:0031334~positive regulation of protein-containing complex assembly	8	54	14.8148148148148	0.00735025638448306	0.0454943778277479	1	1	0.921162277205825	0.985614356857844	0.422118624051835
down	PI4KA; PIP4K2A; PIP4K2C; IP6K1; EFR3B; PIK3CB; SOCS7; SOCS1;	GO:0046854~phosphatidylinositol phosphorylation	8	54	14.8148148148148	0.00735025638448306	0.0454943778277479	1	1	0.921162277205825	0.985614356857844	0.422118624051835
down	AQP9; KDM1A; APP; WT1; PTAFR; DMTN; RAPGEF1; SLC26A6;	GO:0071320~cellular response to cAMP	8	54	14.8148148148148	0.00735025638448306	0.0454943778277479	1	1	0.921162277205825	0.985614356857844	0.422118624051835
down	KCNJ2; KCNH2; KCNJ12; SLC12A7; KCNJ4; SLC12A4; SLC12A9;	GO:1990573~potassium ion import across plasma membrane	7	43	16.2790697674419	0.00762700728085908	0.0471587590102501	1	1	0.924060256627893	0.985614356857844	0.437561549709939
down	VGF; FABP3; SLC2A1; CAD; MTOR; RELA; SRSF4; SCAP; TSC1;	GO:0032868~response to insulin	9	67	13.4328358208955	0.00807561249160349	0.0493329486773642	1	1	0.928821222821293	0.985614356857844	0.457734722627806
down	BLM; CDKN2D; CDK5R1; CDK5RAP3; PKMYT1; CCNF; CCNJL; CCND3;	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity	8	55	14.5454545454545	0.00808762099487126	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	KDM6B; PML; NR2E1; SOX13; GATA5; GATA2; GATA3; GATA4;	GO:0045165~cell fate commitment	8	55	14.5454545454545	0.00808762099487126	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	BRCA1; TFAP4; FOXM1; KAT5;	GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	SRC; SLC9A1; CTSS; ASIC3;	GO:0010447~response to acidic pH	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	AKT1; MTOR; SMCR8; TSC1;	GO:0016242~negative regulation of macroautophagy	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	PLEK; CCR7; MTOR; TCIRG1;	GO:0031529~ruffle organization	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	PTAFR; P2RY2; P2RY14; P2RY11;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	ZBTB7A; G6PD; MAEA; KLF2;	GO:0043249~erythrocyte maturation	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	NCOR1; FBP1; HDAC4; PPARGC1A;	GO:0045820~negative regulation of glycolytic process	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	DGKQ; DGKZ; DGKD; PGS1;	GO:0046339~diacylglycerol metabolic process	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	TPPP; CKAP5; CENPJ; FBXO5;	GO:0046785~microtubule polymerization	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	DGKQ; DGKZ; DGKD; SPHK2;	GO:0046834~lipid phosphorylation	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	GATA4; STK11; PHLPP1; NTRK1;	GO:0051896~regulation of protein kinase B signaling	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	ADAR; NLRC5; CACTIN; YTHDF2;	GO:0060339~negative regulation of type I interferon-mediated signaling pathway	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	NOTCH1; NOTCH2; SMO; IFT172;	GO:0070986~left/right axis specification	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	LDLR; ITGB2; ITGAM; C5AR1;	GO:0097242~amyloid-beta clearance	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	OS9; SYVN1; UGGT1; MAN1B1;	GO:1904380~endoplasmic reticulum mannose trimming	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	EN2; EN1; MED12; IFT140;	GO:1990403~embryonic brain development	4	14	28.5714285714286	0.00814280949882618	0.0493329486773642	1	1	0.929668125461464	0.985614356857844	0.457734722627806
down	MFSD2B; SLC37A4; AKT1; AKT2; MFSD12;	GO:0008643~carbohydrate transport	5	23	21.7391304347826	0.00832423970319218	0.0498866814703992	1	1	0.932309455477842	0.985614356857844	0.462872520655802
down	SNRNP70; PRPF19; THRAP3; SF3B4; DAZAP1;	GO:0048026~positive regulation of mRNA splicing, via spliceosome	5	23	21.7391304347826	0.00832423970319218	0.0498866814703992	1	1	0.932309455477842	0.985614356857844	0.462872520655802
down	TNFRSF1B; MDK; MTOR; CXCR4; DAG1;	GO:0048714~positive regulation of oligodendrocyte differentiation	5	23	21.7391304347826	0.00832423970319218	0.0498866814703992	1	1	0.932309455477842	0.985614356857844	0.462872520655802
down	DAPK3; SLC9A1; ROCK1; CLASP1; LDB1;	GO:0051893~regulation of focal adhesion assembly	5	23	21.7391304347826	0.00832423970319218	0.0498866814703992	1	1	0.932309455477842	0.985614356857844	0.462872520655802
down	MTOR; CAMK1; DLG5; SHANK3; SHANK2;	GO:0060999~positive regulation of dendritic spine development	5	23	21.7391304347826	0.00832423970319218	0.0498866814703992	1	1	0.932309455477842	0.985614356857844	0.462872520655802
down	ADAR; IKBKE; RRP1B; GBF1; VWCE;	GO:0098586~cellular response to virus	5	23	21.7391304347826	0.00832423970319218	0.0498866814703992	1	1	0.932309455477842	0.985614356857844	0.462872520655802
down	INHBB; CASP2; PRKCD; DAB2IP; ING5;	GO:2001235~positive regulation of apoptotic signaling pathway	5	23	21.7391304347826	0.00832423970319218	0.0498866814703992	1	1	0.932309455477842	0.985614356857844	0.462872520655802
down	GATA3; GJA5; GATA4; AP2B1; PAX8; NPRL3;	GO:0003281~ventricular septum development	6	33	18.1818181818182	0.00834211562025811	0.0498866814703992	1	1	0.932309455477842	0.985614356857844	0.462872520655802
down	APP; CPSF1; SYMPK; TUT1; SCAF8; WDR33;	GO:0006378~mRNA polyadenylation	6	33	18.1818181818182	0.00834211562025811	0.0498866814703992	1	1	0.932309455477842	0.985614356857844	0.462872520655802
down	CTNS; LDLR; MTOR; MECP2; ADCY1; KAT2A;	GO:0007616~long-term memory	6	33	18.1818181818182	0.00834211562025811	0.0498866814703992	1	1	0.932309455477842	0.985614356857844	0.462872520655802
down	BAG3; NF1; DAPK1; DAB2IP; DIABLO; DAXX;	GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors	6	33	18.1818181818182	0.00834211562025811	0.0498866814703992	1	1	0.932309455477842	0.985614356857844	0.462872520655802
down	SUPT5H; TSC2; LARP1; TSC1; PIM2; IKBKG;	GO:0016239~positive regulation of macroautophagy	6	33	18.1818181818182	0.00834211562025811	0.0498866814703992	1	1	0.932309455477842	0.985614356857844	0.462872520655802
down	STAT5B; DIO3; HSF1; SMO; ATP8A2; GHRL;	GO:0040018~positive regulation of multicellular organism growth	6	33	18.1818181818182	0.00834211562025811	0.0498866814703992	1	1	0.932309455477842	0.985614356857844	0.462872520655802
up	S100A8; S100A9; SELE; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	4	11	36.3636363636364	0.00837594676127718	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	EGFR; NTRK1; EIF2AK2; RAPGEF1; MAP3K14; MAP3K3; TAOK2;	GO:0000186~activation of MAPKK activity	7	44	15.9090909090909	0.0084969836497123	0.0505612591433375	1	1	0.934159275826013	0.985614356857844	0.469131575350317
down	EIF2AK2; HTT; PPP2R5D; PPP2R5B; TSC1; PPP6R1; PPP6R2;	GO:0043666~regulation of phosphoprotein phosphatase activity	7	44	15.9090909090909	0.0084969836497123	0.0505612591433375	1	1	0.934159275826013	0.985614356857844	0.469131575350317
down	WWP2; RNF126; UBE2O; PRPF19; PELI3; TRAF5; TRAF3;	GO:0070534~protein K63-linked ubiquitination	7	44	15.9090909090909	0.0084969836497123	0.0505612591433375	1	1	0.934159275826013	0.985614356857844	0.469131575350317
down	PDPK1; TNFSF12; IL6R; TNFRSF1B; PML; GSK3A; P2RX7;	GO:0097191~extrinsic apoptotic signaling pathway	7	44	15.9090909090909	0.0084969836497123	0.0505612591433375	1	1	0.934159275826013	0.985614356857844	0.469131575350317
down	TRAV26-1; EOMES; CD4; IGHM; HLA-B; PRKCB; CD3E; CD7; HLA-C; TFEB; CD247; CTSS; HLA-DMA; CD86; JAK3; BTK; LAIR1; LAX1; LILRB4; PRR7; TRPM4; TSC1; ORAI1; TNFRSF13C; CRACR2A; PRKD2; CD244; LAT2;	GO:0002250~adaptive immune response	28	347	8.06916426512968	0.00876078945652037	0.0520794704586423	1	1	0.937078523562969	0.985614356857844	0.483218266982036
down	KCNAB3; GJA5; KCNJ4; KCNJ2; KCNC4; KCNJ12; TSC1; KCNMB3; KCNH3;	GO:0006813~potassium ion transport	9	68	13.2352941176471	0.00878033652447729	0.0520926184719729	1	1	0.937078523562969	0.985614356857844	0.483340260546101
down	ALOX5; SLC2A1; CCL5; PRKCA; TCIRG1; ITPR3; SLC8B1; PICK1; SSTR5;	GO:0050796~regulation of insulin secretion	9	68	13.2352941176471	0.00878033652447729	0.0520926184719729	1	1	0.937078523562969	0.985614356857844	0.483340260546101
down	AURKA; PSMD3; PSMB9; PSMB10; PSME3; MIIP; PSMF1; GPR132;	GO:0010972~negative regulation of G2/M transition of mitotic cell cycle	8	56	14.2857142857143	0.00887906214613166	0.0526263939824963	1	1	0.938092578040017	0.985614356857844	0.488292885349715
down	CD74; CCR7; SLC11A1;	GO:0002606~positive regulation of dendritic cell antigen processing and presentation	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	MCM3; MCM2; MCM5;	GO:0006267~pre-replicative complex assembly involved in nuclear cell cycle DNA replication	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	ADAR; ADARB1; NUDT16;	GO:0006382~adenosine to inosine editing	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	FMNL1; EPHA8; ANKS1A;	GO:0006929~substrate-dependent cell migration	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	PHLPP1; GNA11; ARNTL2;	GO:0009649~entrainment of circadian clock	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	DNMT1; CTCF; UHRF1;	GO:0010216~maintenance of DNA methylation	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	CD4; CXCR4; NECTIN2;	GO:0019064~fusion of virus membrane with host plasma membrane	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	PTCH1; TRAF3IP1; IFT140;	GO:0021532~neural tube patterning	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	EOMES; DMRTA2; ADGRG1;	GO:0021796~cerebral cortex regionalization	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	TERF2; ACD; TFIP11;	GO:0031848~protection from non-homologous end joining at telomere	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	TAZ; PGS1; PTPMT1;	GO:0032049~cardiolipin biosynthetic process	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	PLEK; SRC; PIEZO1;	GO:0033625~positive regulation of integrin activation	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	IGF2BP3; GATA3; IGF2BP1;	GO:0042035~regulation of cytokine biosynthetic process	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	HTT; SHANK3; CNTNAP2;	GO:0042297~vocal learning	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	CD22; GPS2; PLCL2;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	PAX7; AGER; HJURP;	GO:0051101~regulation of DNA binding	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	FZD9; SRC; HSH2D;	GO:0051902~negative regulation of mitochondrial depolarization	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	CXCR4; CCM2; PRKD2;	GO:0061154~endothelial tube morphogenesis	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	FBP1; SLC41A1; SMPD3;	GO:0071286~cellular response to magnesium ion	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	CD36; DAPK1; PRKCD;	GO:0071447~cellular response to hydroperoxide	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	GATA3; NOTCH1; NOTCH2;	GO:0072602~interleukin-4 secretion	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	ATP2A2; SLC9A1; SLC8B1;	GO:0086036~regulation of cardiac muscle cell membrane potential	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	LRP4; LDLR; CD36;	GO:0150094~amyloid-beta clearance by cellular catabolic process	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	CLEC16A; SMCR8; FYCO1;	GO:1901098~positive regulation of autophagosome maturation	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	DAB2IP; RGP1; CDK5RAP3;	GO:1903363~negative regulation of cellular protein catabolic process	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	HTT; CAMKK2; FBXO7;	GO:1903599~positive regulation of autophagy of mitochondrion	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	HMGA2; HSF1; TFIP11;	GO:2001033~negative regulation of double-strand break repair via nonhomologous end joining	3	7	42.8571428571429	0.00914635033068067	0.052753901619377	1	1	0.941267009446428	0.985614356857844	0.489475962266163
down	POM121C; NUP62; NUP188; NUP210; POM121; NOL6;	GO:0006409~tRNA export from nucleus	6	34	17.6470588235294	0.00944015236125306	0.0543441721179415	1	1	0.944015236125306	0.985614356857844	0.504231253508213
down	ATP2A1; PML; BAG6; DAB2IP; BRSK2; ATP2A3;	GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	6	34	17.6470588235294	0.00944015236125306	0.0543441721179415	1	1	0.944015236125306	0.985614356857844	0.504231253508213
down	PREX1; GBA2; COTL1; FCHSD1; CTTN;	GO:0030833~regulation of actin filament polymerization	5	24	20.8333333333333	0.00968435777009558	0.0555902485179316	1	1	0.947044231354647	0.985614356857844	0.515792947074368
down	CALM3; SRC; RASSF2; TNKS1BP1; TAOK2;	GO:0031954~positive regulation of protein autophosphorylation	5	24	20.8333333333333	0.00968435777009558	0.0555902485179316	1	1	0.947044231354647	0.985614356857844	0.515792947074368
down	MTOR; SLC11A1; ELAVL1; LARP1; THRAP3;	GO:0048255~mRNA stabilization	5	24	20.8333333333333	0.00968435777009558	0.0555902485179316	1	1	0.947044231354647	0.985614356857844	0.515792947074368
down	LCAT; PIP4K2A; PLCB2; LPCAT4; PCSK9; PLA2G15; PROCA1; PLPPR2;	GO:0006644~phospholipid metabolic process	8	57	14.0350877192982	0.00972688912555053	0.0556748606138654	1	1	0.947044231354647	0.985614356857844	0.516578018619888
down	NTN1; GATA2; GATA3; EPHB2; GBX2; FOXG1; PAX8; ATP8A2;	GO:0042472~inner ear morphogenesis	8	57	14.0350877192982	0.00972688912555053	0.0556748606138654	1	1	0.947044231354647	0.985614356857844	0.516578018619888
down	EGFR; CCL5; C5AR1; NOTCH1; STOX1; SMO; TCF7L2; C5AR2;	GO:0050679~positive regulation of epithelial cell proliferation	8	57	14.0350877192982	0.00972688912555053	0.0556748606138654	1	1	0.947044231354647	0.985614356857844	0.516578018619888
down	EP300; ING5; CREBBP; KAT6A;	GO:0006473~protein acetylation	4	15	26.6666666666667	0.00994395887924338	0.0561156740509415	1	1	0.949545428604323	0.985614356857844	0.520668096787934
down	PODXL; ABL1; CDH1; NF2;	GO:0022408~negative regulation of cell-cell adhesion	4	15	26.6666666666667	0.00994395887924338	0.0561156740509415	1	1	0.949545428604323	0.985614356857844	0.520668096787934
down	PDPK1; ARRB2; GPS2; CACTIN;	GO:0034122~negative regulation of toll-like receptor signaling pathway	4	15	26.6666666666667	0.00994395887924338	0.0561156740509415	1	1	0.949545428604323	0.985614356857844	0.520668096787934
down	CCDC187; PEX14; DAG1; CLASP1;	GO:0034453~microtubule anchoring	4	15	26.6666666666667	0.00994395887924338	0.0561156740509415	1	1	0.949545428604323	0.985614356857844	0.520668096787934
down	ENTPD6; NUDT18; NUDT16; ENTPD2;	GO:0034656~nucleobase-containing small molecule catabolic process	4	15	26.6666666666667	0.00994395887924338	0.0561156740509415	1	1	0.949545428604323	0.985614356857844	0.520668096787934
down	WFS1; NUP62; DCPS; DNAJA3;	GO:0043069~negative regulation of programmed cell death	4	15	26.6666666666667	0.00994395887924338	0.0561156740509415	1	1	0.949545428604323	0.985614356857844	0.520668096787934
down	CR1; KAT2A; DROSHA; FANCA;	GO:0045589~regulation of regulatory T cell differentiation	4	15	26.6666666666667	0.00994395887924338	0.0561156740509415	1	1	0.949545428604323	0.985614356857844	0.520668096787934
down	NTRK1; NF1; GATA3; SEMA3A;	GO:0048485~sympathetic nervous system development	4	15	26.6666666666667	0.00994395887924338	0.0561156740509415	1	1	0.949545428604323	0.985614356857844	0.520668096787934
down	FOXF2; FZD5; KDM2B; IFT172;	GO:0048596~embryonic camera-type eye morphogenesis	4	15	26.6666666666667	0.00994395887924338	0.0561156740509415	1	1	0.949545428604323	0.985614356857844	0.520668096787934
down	DIAPH1; CYBA; PTPN6; CASQ2;	GO:0051279~regulation of release of sequestered calcium ion into cytosol	4	15	26.6666666666667	0.00994395887924338	0.0561156740509415	1	1	0.949545428604323	0.985614356857844	0.520668096787934
down	SLC9A1; ROCK1; TSC1; FHOD1;	GO:0051492~regulation of stress fiber assembly	4	15	26.6666666666667	0.00994395887924338	0.0561156740509415	1	1	0.949545428604323	0.985614356857844	0.520668096787934
down	NCOR1; ZBTB7A; SMARCA4; NCOR2;	GO:0060766~negative regulation of androgen receptor signaling pathway	4	15	26.6666666666667	0.00994395887924338	0.0561156740509415	1	1	0.949545428604323	0.985614356857844	0.520668096787934
down	L1CAM; DDR1; MARK2; MAPK8IP3;	GO:0061564~axon development	4	15	26.6666666666667	0.00994395887924338	0.0561156740509415	1	1	0.949545428604323	0.985614356857844	0.520668096787934
down	HGS; ATP13A2; SMPD3; VPS4A;	GO:1903543~positive regulation of exosomal secretion	4	15	26.6666666666667	0.00994395887924338	0.0561156740509415	1	1	0.949545428604323	0.985614356857844	0.520668096787934
down	PDPK1; PLCG1; MDK; GHRL;	GO:1905564~positive regulation of vascular endothelial cell proliferation	4	15	26.6666666666667	0.00994395887924338	0.0561156740509415	1	1	0.949545428604323	0.985614356857844	0.520668096787934
down	IGHMBP2; BLM; NONO; NFRKB; INO80E; RAD54L; PAGR1; PIF1; APEX2;	GO:0006310~DNA recombination	9	70	12.8571428571429	0.0103283393483325	0.0582301308475409	1	1	0.953525992519967	0.985614356857844	0.540287039528002
down	BRINP1; NUP62; EMP3; MAP3K11; PRKD2; NDOR1;	GO:0008219~cell death	6	35	17.1428571428571	0.0106374051826101	0.0597484160256887	1	1	0.957366466434912	0.985614356857844	0.55437441649455
down	TMEM63A; CALHM3; PIEZO1; P2RX5; SLC41A3; ATP13A2;	GO:0098655~cation transmembrane transport	6	35	17.1428571428571	0.0106374051826101	0.0597484160256887	1	1	0.957366466434912	0.985614356857844	0.55437441649455
down	NTRK1; APP; CBL; AKT1; RAPGEF1; KAT2A;	GO:1990090~cellular response to nerve growth factor stimulus	6	35	17.1428571428571	0.0106374051826101	0.0597484160256887	1	1	0.957366466434912	0.985614356857844	0.55437441649455
down	AGRN; GUSB; GPC1; SGSH; HSPG2;	GO:0006027~glycosaminoglycan catabolic process	5	25	20	0.0111896059235169	0.0612088330360962	1	1	0.962306109422455	0.985614356857844	0.567924864888617
down	NUP62; MTOR; DNAJA3; MNT; ZMIZ1;	GO:0007569~cell aging	5	25	20	0.0111896059235169	0.0612088330360962	1	1	0.962306109422455	0.985614356857844	0.567924864888617
down	RAC2; MTOR; HDAC4; CARMIL2; AUTS2;	GO:0010592~positive regulation of lamellipodium assembly	5	25	20	0.0111896059235169	0.0612088330360962	1	1	0.962306109422455	0.985614356857844	0.567924864888617
down	SMAD7; PPM1F; RASSF2; DMTN; MLXIPL;	GO:0033137~negative regulation of peptidyl-serine phosphorylation	5	25	20	0.0111896059235169	0.0612088330360962	1	1	0.962306109422455	0.985614356857844	0.567924864888617
down	PLXNA3; SEMA4D; SEMA3A; SEMA3D; SEMA4C;	GO:0048843~negative regulation of axon extension involved in axon guidance	5	25	20	0.0111896059235169	0.0612088330360962	1	1	0.962306109422455	0.985614356857844	0.567924864888617
down	ABL1; PPM1F; PTPRJ; ROCK1; TSC1;	GO:0051894~positive regulation of focal adhesion assembly	5	25	20	0.0111896059235169	0.0612088330360962	1	1	0.962306109422455	0.985614356857844	0.567924864888617
down	GATA3; PML; FASN; MCM2; SHPK;	GO:0071353~cellular response to interleukin-4	5	25	20	0.0111896059235169	0.0612088330360962	1	1	0.962306109422455	0.985614356857844	0.567924864888617
down	ADGRL1; ITGAL; NECTIN1; JAML; DCHS1; TENM2; PVR;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	7	47	14.8936170212766	0.0115437316473077	0.0612088330360962	1	1	0.964700643887861	0.985614356857844	0.567924864888617
down	TRABD2B; SOX30; NFATC1; TLE1; NXN; NOTUM; TSC2;	GO:0030178~negative regulation of Wnt signaling pathway	7	47	14.8936170212766	0.0115437316473077	0.0612088330360962	1	1	0.964700643887861	0.985614356857844	0.567924864888617
down	RNF40; LRP5; TIMP1; BSG; DAG1; STAT6; STAT5B;	GO:0043434~response to peptide hormone	7	47	14.8936170212766	0.0115437316473077	0.0612088330360962	1	1	0.964700643887861	0.985614356857844	0.567924864888617
down	CACNA1F; KCNJ4; SLC4A3; KCNJ2; CACNB1; KCNH2; KCNJ12;	GO:0061337~cardiac conduction	7	47	14.8936170212766	0.0115437316473077	0.0612088330360962	1	1	0.964700643887861	0.985614356857844	0.567924864888617
down	GDF11; APP; FOXG1; ISL2; CDK5RAP2; EIF4ENIF1; NR2E1; HES4;	GO:0045665~negative regulation of neuron differentiation	8	59	13.5593220338983	0.0116009046613071	0.0612088330360962	1	1	0.964700643887861	0.985614356857844	0.567924864888617
down	GDF11; FOS; SKI; ZMIZ2; RBM14; ZMIZ1; INHBE; INHBB;	GO:0060395~SMAD protein signal transduction	8	59	13.5593220338983	0.0116009046613071	0.0612088330360962	1	1	0.964700643887861	0.985614356857844	0.567924864888617
up	UGT1A9; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	3	6	50	0.0116759237754718	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
up	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.0116759237754718	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	ARID1A; BRCA1; KAT5; PPARGC1A; DAXX; ZMIZ1;	GO:0030521~androgen receptor signaling pathway	6	36	16.6666666666667	0.0119383052787934	0.0612088330360962	1	1	0.967002727582262	0.985614356857844	0.567924864888617
down	ATP6V0D1; ARHGAP1; TCIRG1; RAB11B; STEAP3; TFR2;	GO:0033572~transferrin transport	6	36	16.6666666666667	0.0119383052787934	0.0612088330360962	1	1	0.967002727582262	0.985614356857844	0.567924864888617
down	FES; CELA1; RUNX3; PTBP1; RUNX2; PLEKHB1;	GO:0045595~regulation of cell differentiation	6	36	16.6666666666667	0.0119383052787934	0.0612088330360962	1	1	0.967002727582262	0.985614356857844	0.567924864888617
down	ITGB3; PLXNA3; SEMA4D; SEMA4C; SEMA3A; SEMA3D;	GO:0050919~negative chemotaxis	6	36	16.6666666666667	0.0119383052787934	0.0612088330360962	1	1	0.967002727582262	0.985614356857844	0.567924864888617
down	CLDN3; SIPA1L3; FLNB; BCL11B;	GO:0003382~epithelial cell morphogenesis	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	DGCR8; KHSRP; DROSHA; AGO1;	GO:0010586~miRNA metabolic process	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	AKT1; MLLT6; SCN4B; SCN3B;	GO:0010765~positive regulation of sodium ion transport	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	PRKDC; TERF2; CTC1; ACD;	GO:0016233~telomere capping	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	VCP; SYVN1; NPLOC4; OS9;	GO:0030970~retrograde protein transport, ER to cytosol	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	SUPT5H; ELL; DDX39B; SCAF8;	GO:0032786~positive regulation of DNA-templated transcription, elongation	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	VCP; SYVN1; BRSK2; DNAJB12;	GO:0036503~ERAD pathway	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	MMP7; MDK; HAS2; NCOR2;	GO:0044849~estrous cycle	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	EPHB2; NSMF; JPH3; NCDN;	GO:0048168~regulation of neuronal synaptic plasticity	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	ACTN4; RARA; RXRA; PML;	GO:0048384~retinoic acid receptor signaling pathway	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	CDC20; CSMD3; CAMK1D; PREX1;	GO:0050773~regulation of dendrite development	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	CEP152; STIL; NDE1; CKAP5;	GO:0051298~centrosome duplication	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	KCNH2; SLC12A4; SLC12A7; SLC12A9;	GO:0055075~potassium ion homeostasis	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	CLDN3; ALOX5; EPPK1; AJAP1;	GO:0061045~negative regulation of wound healing	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	DSCAM; BSG; IGSF9; MYPN;	GO:0070593~dendrite self-avoidance	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	RELA; SELPLG; ABCC2; PPARGC1A;	GO:0071354~cellular response to interleukin-6	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	KDM1A; CD74; ATAD5; BCL2L12;	GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	CLEC16A; SIK3; TELO2; FLCN;	GO:1904263~positive regulation of TORC1 signaling	4	16	25	0.0119845358540644	0.0612088330360962	1	1	0.967456931441827	0.985614356857844	0.567924864888617
down	UTP20; NOP14; KRI1;	GO:0000447~endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	AKT1; MTOR; PPP1R3F;	GO:0005979~regulation of glycogen biosynthetic process	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	CD3E; SRC; PXN;	GO:0007172~signal complex assembly	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	GRK2; GRK5; TAC4;	GO:0007217~tachykinin receptor signaling pathway	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	HGS; PTGIR; PTPRJ;	GO:0010642~negative regulation of platelet-derived growth factor receptor signaling pathway	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	SLC9A1; HDAC4; ATP2A2;	GO:0010882~regulation of cardiac muscle contraction by calcium ion signaling	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	DNMT1; KMT2B; SRCAP;	GO:0016458~gene silencing	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	EPHB3; EPHB1; EPHB2;	GO:0021952~central nervous system projection neuron axonogenesis	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	SLC9A1; CARMIL2; DLG5;	GO:0030011~maintenance of cell polarity	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	TOX; FLT3LG; STAT5B;	GO:0032825~positive regulation of natural killer cell differentiation	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	ATP2A2; MYOF; DYSF;	GO:0033292~T-tubule organization	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	PLXNB1; SEMA4D; DCHS1;	GO:0043931~ossification involved in bone maturation	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	PC; IGF2R; CFL1;	GO:0044794~positive regulation by host of viral process	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	GATA3; LHX1; GRB2;	GO:0048646~anatomical structure formation involved in morphogenesis	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	SMAD7; ABL1; FBXO5;	GO:0051444~negative regulation of ubiquitin-protein transferase activity	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	MFN2; BRAT1; MARK2;	GO:0051646~mitochondrion localization	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	FURIN; ABCA2; ATP13A2;	GO:0052548~regulation of endopeptidase activity	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	BLM; TERF2; SLX4;	GO:0061820~telomeric D-loop disassembly	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	HYAL3; CRIP1; STK11;	GO:0071493~cellular response to UV-B	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	MELTF; CARMIL2; CLASP1;	GO:0090091~positive regulation of extracellular matrix disassembly	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	PRKAR1B; CDK5R1; BSN;	GO:0098693~regulation of synaptic vesicle cycle	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	DVL2; DLG4; DVL3;	GO:0150012~positive regulation of neuron projection arborization	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	PTPRF; ATP2A2; ATP2A3;	GO:1900121~negative regulation of receptor binding	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	LMNA; NF2; ATP13A2;	GO:1900180~regulation of protein localization to nucleus	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	CALM3; DGKQ; ROCK1;	GO:1900242~regulation of synaptic vesicle endocytosis	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	SUPT5H; RNF40; CDK9;	GO:1900364~negative regulation of mRNA polyadenylation	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	HAP1; CENPJ; WRAP73;	GO:1902857~positive regulation of non-motile cilium assembly	3	8	37.5	0.0121501061251352	0.0612088330360962	1	1	0.968425356798625	0.985614356857844	0.567924864888617
down	WT1; MYO1E; CUL7; HDAC7; HAS2; SMO; CCM2; ZMIZ1;	GO:0001570~vasculogenesis	8	60	13.3333333333333	0.0126316622826418	0.0634751591293287	1	1	0.971494310394114	0.985614356857844	0.588952923690745
down	DIRAS1; EGFR; SRC; ADAM8; MST1R; AKAP13; AJUBA; IRAK1;	GO:0043406~positive regulation of MAP kinase activity	8	60	13.3333333333333	0.0126316622826418	0.0634751591293287	1	1	0.971494310394114	0.985614356857844	0.588952923690745
down	MEN1; CYBA; PRKACA; GATA4; POLG; AACS; PPARGC1A; ZNF236;	GO:0071333~cellular response to glucose stimulus	8	60	13.3333333333333	0.0126316622826418	0.0634751591293287	1	1	0.971494310394114	0.985614356857844	0.588952923690745
down	MLYCD; GNB3; FOXK1; FOXK2; NFE2L1;	GO:0010906~regulation of glucose metabolic process	5	26	19.2307692307692	0.0128466313970638	0.0643938738084681	1	1	0.972575751184905	0.985614356857844	0.597477198442295
down	BAG3; HSF1; DAB2IP; DAXX; HSPA6;	GO:0034620~cellular response to unfolded protein	5	26	19.2307692307692	0.0128466313970638	0.0643938738084681	1	1	0.972575751184905	0.985614356857844	0.597477198442295
down	PPFIA1; PAK2; CLASP1; PHLDB2; ARAP1;	GO:0051497~negative regulation of stress fiber assembly	5	26	19.2307692307692	0.0128466313970638	0.0643938738084681	1	1	0.972575751184905	0.985614356857844	0.597477198442295
down	ADCY3; HOXD10; HOXA10; HOXA11; MST1R; IGSF8; TUBGCP3; ASH1L;	GO:0007338~single fertilization	8	61	13.1147540983607	0.0137279329681456	0.068754064282129	1	1	0.977229223678613	0.985614356857844	0.63793313368586
up	CYP2C9; CYP2C19; CYP4A11; CYP2F1; CYP2C18;	GO:0019373~epoxygenase P450 pathway	5	21	23.8095238095238	0.0139091684750082	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	VGF; PHKG2; PHKA2; OGDH; PPARD; DHTKD1; ACO2;	GO:0006091~generation of precursor metabolites and energy	7	49	14.2857142857143	0.0139698899660505	0.0697334208438237	1	1	0.978482081657688	0.985614356857844	0.647020072864233
down	AGRN; LRP4; APP; L1CAM; TSC1; PCDHGC3; PPFIA1;	GO:0050808~synapse organization	7	49	14.2857142857143	0.0139698899660505	0.0697334208438237	1	1	0.978482081657688	0.985614356857844	0.647020072864233
down	CTNS; APP; NF1; C5AR1; DGCR2; MGAT3; SETD5;	GO:0050890~cognition	7	49	14.2857142857143	0.0139698899660505	0.0697334208438237	1	1	0.978482081657688	0.985614356857844	0.647020072864233
down	ARRB2; EPHB1; PRKCD; ACKR2; CXCR2; CCR1; CXCR4; CCR7; CX3CR1;	GO:0060326~cell chemotaxis	9	74	12.1621621621622	0.0140278777067759	0.069964767649563	1	1	0.979774091448609	0.985614356857844	0.649166619316351
down	ALOX5; ALOX15; ALOX5AP; DPEP2;	GO:0006691~leukotriene metabolic process	4	17	23.5294117647059	0.0142748937821462	0.0706689552147435	1	1	0.981107117423369	0.985614356857844	0.655700408770817
down	ATP2A1; IFIT2; AKT1; PIM2;	GO:0008637~apoptotic mitochondrial changes	4	17	23.5294117647059	0.0142748937821462	0.0706689552147435	1	1	0.981107117423369	0.985614356857844	0.655700408770817
down	MEN1; NOTCH1; DMTN; TBCD;	GO:0010812~negative regulation of cell-substrate adhesion	4	17	23.5294117647059	0.0142748937821462	0.0706689552147435	1	1	0.981107117423369	0.985614356857844	0.655700408770817
down	WFS1; ATP2A2; PML; PACS2;	GO:0032469~endoplasmic reticulum calcium ion homeostasis	4	17	23.5294117647059	0.0142748937821462	0.0706689552147435	1	1	0.981107117423369	0.985614356857844	0.655700408770817
down	PTPN6; PIP4K2A; FLI1; EP300;	GO:0035855~megakaryocyte development	4	17	23.5294117647059	0.0142748937821462	0.0706689552147435	1	1	0.981107117423369	0.985614356857844	0.655700408770817
down	CD4; CD3E; CCL4; P2RX5;	GO:0050850~positive regulation of calcium-mediated signaling	4	17	23.5294117647059	0.0142748937821462	0.0706689552147435	1	1	0.981107117423369	0.985614356857844	0.655700408770817
down	ZFP36L2; UPF1; KHSRP; MOV10;	GO:0061158~3'-UTR-mediated mRNA destabilization	4	17	23.5294117647059	0.0142748937821462	0.0706689552147435	1	1	0.981107117423369	0.985614356857844	0.655700408770817
down	FLCN; LILRB4; LZTS2; MFHAS1;	GO:1900181~negative regulation of protein localization to nucleus	4	17	23.5294117647059	0.0142748937821462	0.0706689552147435	1	1	0.981107117423369	0.985614356857844	0.655700408770817
down	PTPN6; PKD1; INO80; PSME3;	GO:2000045~regulation of G1/S transition of mitotic cell cycle	4	17	23.5294117647059	0.0142748937821462	0.0706689552147435	1	1	0.981107117423369	0.985614356857844	0.655700408770817
down	APP; ITGB2; ITGAM; C5AR1; AGER;	GO:0001774~microglial cell activation	5	27	18.5185185185185	0.0146617289040868	0.0723456409799356	1	1	0.982335836573815	0.985614356857844	0.671257502239596
down	AKT1; NOTCH1; RELA; DAB2IP; PRKD2;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	5	27	18.5185185185185	0.0146617289040868	0.0723456409799356	1	1	0.982335836573815	0.985614356857844	0.671257502239596
down	CDH26; CDH24; CDH23; CDH1; CDH8;	GO:0044331~cell-cell adhesion mediated by cadherin	5	27	18.5185185185185	0.0146617289040868	0.0723456409799356	1	1	0.982335836573815	0.985614356857844	0.671257502239596
down	FANCA; ZBTB7A; FOS; HCK; STK36;	GO:0051090~regulation of DNA-binding transcription factor activity	5	27	18.5185185185185	0.0146617289040868	0.0723456409799356	1	1	0.982335836573815	0.985614356857844	0.671257502239596
down	TAF4; VGF; FANCG; INHBB; LFNG; KMT2B;	GO:0001541~ovarian follicle development	6	38	15.7894736842105	0.0148681641238302	0.0731241132440421	1	1	0.982569426819417	0.985614356857844	0.678480540704509
down	MTOR; PTCH1; TAB1; ASXL1; SYNPO2L; ZMIZ1;	GO:0003007~heart morphogenesis	6	38	15.7894736842105	0.0148681641238302	0.0731241132440421	1	1	0.982569426819417	0.985614356857844	0.678480540704509
down	CCDC40; DNAAF5; CFAP53; RSPH9; CELSR2; DNAH17;	GO:0003341~cilium movement	6	38	15.7894736842105	0.0148681641238302	0.0731241132440421	1	1	0.982569426819417	0.985614356857844	0.678480540704509
down	SLC4A2; SLC9A1; SLC4A3; LRRC8D; LRRC8A; SLC24A4;	GO:0098656~anion transmembrane transport	6	38	15.7894736842105	0.0148681641238302	0.0731241132440421	1	1	0.982569426819417	0.985614356857844	0.678480540704509
down	VPS37C; POM121C; NUP62; NUP188; NUP210; POM121; MVB12B;	GO:0075733~intracellular transport of virus	7	50	14	0.0153105060878248	0.0749579663459577	1	1	0.983500551601999	0.985614356857844	0.695495907988456
down	PRKCB; CALM3; BACE1; ADCY1; VPS18; GIT1; RIMS2;	GO:2000300~regulation of synaptic vesicle exocytosis	7	50	14	0.0153105060878248	0.0749579663459577	1	1	0.983500551601999	0.985614356857844	0.695495907988456
down	ITPKB; FANCC; NCSTN;	GO:0002262~myeloid cell homeostasis	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	MFNG; NOTCH2; LFNG;	GO:0002315~marginal zone B cell differentiation	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	ARSB; CLCN7; HVCN1;	GO:0009268~response to pH	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	LRRC8D; LRRC8A; SLC25A22;	GO:0015810~aspartate transmembrane transport	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	CHST14; CHST11; CHST12;	GO:0016051~carbohydrate biosynthetic process	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	CYB5R3; SLC2A1; SLC23A2;	GO:0019852~L-ascorbic acid metabolic process	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	SEC16A; TECPR2; RANGRF;	GO:0032527~protein exit from endoplasmic reticulum	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	FERMT3; MZB1; TLN1;	GO:0033622~integrin activation	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	AKT1; PKD1; P2RX7;	GO:0034405~response to fluid shear stress	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	CTBP1; NOC2L; BRCA1;	GO:0035067~negative regulation of histone acetylation	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	LRP5; MEGF8; RIC8A;	GO:0042074~cell migration involved in gastrulation	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	ITGB3; SRC; NF1;	GO:0045124~regulation of bone resorption	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	NF1; STIM1; ORAI1;	GO:0045762~positive regulation of adenylate cyclase activity	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	SYNJ1; PLCH2; PLEK;	GO:0046488~phosphatidylinositol metabolic process	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	LRP5; CTC1; ASXL1;	GO:0048539~bone marrow development	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	CD4; CCL5; KAT2A;	GO:0050863~regulation of T cell activation	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	BLM; PTCH1; SUSD2;	GO:0051782~negative regulation of cell division	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	WT1; GATA3; TCF15;	GO:0060231~mesenchymal to epithelial transition	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	APP; BACE1; ATP13A2;	GO:0071287~cellular response to manganese ion	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	PRKACA; HDAC4; SOST;	GO:0071374~cellular response to parathyroid hormone stimulus	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	SLC11A1; SLC39A8; ATP13A1;	GO:0071421~manganese ion transmembrane transport	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	GAK; RBSN; ANKFY1;	GO:0090160~Golgi to lysosome transport	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	DMTN; WHAMM; EFS;	GO:0090527~actin filament reorganization	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	CD4; AKT1; ZFP36L2;	GO:0097011~cellular response to granulocyte macrophage colony-stimulating factor stimulus	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	GRIN2D; GRIN2C; SSH1;	GO:0098976~excitatory chemical synaptic transmission	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	RELA; CRTC1; PRR7;	GO:0099527~postsynapse to nucleus signaling pathway	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	TLR4; CD36; DHX33;	GO:1900227~positive regulation of NLRP3 inflammasome complex assembly	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	PHLPP1; AGER; DAB2IP;	GO:1900744~regulation of p38MAPK cascade	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
down	PARP1; TERF2; SLX4;	GO:1904357~negative regulation of telomere maintenance via telomere lengthening	3	9	33.3333333333333	0.0156526202602624	0.0749579663459577	1	1	0.984492733747373	0.985614356857844	0.695495907988456
up	SPI1; LY6D; FLT3;	GO:0030098~lymphocyte differentiation	3	7	42.8571428571429	0.0159868933930187	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
up	POMC; SCTR; HTR4;	GO:0032098~regulation of appetite	3	7	42.8571428571429	0.0159868933930187	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
up	HP; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.0159868933930187	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
up	CTAGE4; CTAGE8; CTAGE3P; CTAGE6;	GO:0035459~vesicle cargo loading	4	14	28.5714285714286	0.0164057957897144	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
up	P2RY10; GPR171; P2RY13; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.0164057957897144	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
up	UGT1A9; UGT1A4; UGT1A3; UGT1A10;	GO:0052695~cellular glucuronidation	4	14	28.5714285714286	0.0164057957897144	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	PDPK1; PRKCA; PLCG1; GATA2; AKT1; PRKD2;	GO:0043536~positive regulation of blood vessel endothelial cell migration	6	39	15.3846153846154	0.0165053297839617	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	CLDN3; CFL1; STRIP1; BCL9L; QRICH1;	GO:0022604~regulation of cell morphogenesis	5	28	17.8571428571429	0.016640813796936	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	ITGB2; MMP9; HMGA2; COL7A1; SETD2;	GO:0035987~endodermal cell differentiation	5	28	17.8571428571429	0.016640813796936	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	AURKA; LRP5; NUP62; SH2B1; SMPD3;	GO:0045840~positive regulation of mitotic nuclear division	5	28	17.8571428571429	0.016640813796936	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	SLC4A2; PKD1; DCHS1; ALX4; CHD8;	GO:0048565~digestive tract development	5	28	17.8571428571429	0.016640813796936	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	CX3CR1; HAP1; SPEN; SRRT; ZNF335;	GO:0050769~positive regulation of neurogenesis	5	28	17.8571428571429	0.016640813796936	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	CD4; CXCR4; STIM1; IL16; ORAI1;	GO:0051924~regulation of calcium ion transport	5	28	17.8571428571429	0.016640813796936	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	CSNK2A2; GATA4; CX3CR1; MAZ; MNT;	GO:2001234~negative regulation of apoptotic signaling pathway	5	28	17.8571428571429	0.016640813796936	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	SOCS1; EGFR; DNMT1; MTOR; NSMF; RPTOR; SH3BP4;	GO:0071230~cellular response to amino acid stimulus	7	51	13.7254901960784	0.0167400178664312	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	SIAH2; TOB2; SF1; DDX54; TONSL; CENPJ; RERE;	GO:1903507~negative regulation of nucleic acid-templated transcription	7	51	13.7254901960784	0.0167400178664312	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	MELTF; SLC11A1; NECTIN1; TFR2;	GO:0006826~iron ion transport	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	WDR62; CEP152; CDK5RAP2; CENPJ;	GO:0007099~centriole replication	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	SCG5; FURIN; ECE1; PCSK7;	GO:0016486~peptide hormone processing	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	SKI; NF1; DAG1; LGI4;	GO:0022011~myelination in peripheral nervous system	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	EPHB2; EPHB3; EPHB1; ISL2;	GO:0031290~retinal ganglion cell axon guidance	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	SELL; DGKQ; P2RX5; P2RX7;	GO:0033198~response to ATP	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	SLC16A2; MFSD10; SLCO2A1; SLCO3A1;	GO:0043252~sodium-independent organic anion transport	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	SOX15; DYSF; PAX7; DAG1;	GO:0043403~skeletal muscle tissue regeneration	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	SOGA1; CLK2; EP300; MAEA;	GO:0045721~negative regulation of gluconeogenesis	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	FGD1; FGD3; FGD2; PPP1R9B;	GO:0046847~filopodium assembly	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	HIP1; FCHO1; AP2B1; HIP1R;	GO:0048268~clathrin coat assembly	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	NPRL3; TAZ; GATA4; GATA5;	GO:0048738~cardiac muscle tissue development	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	DLG4; KCTD13; CLSTN1; RIMS2;	GO:0050806~positive regulation of synaptic transmission	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	SRC; DMTN; PHLDB2; RCC2;	GO:0051895~negative regulation of focal adhesion assembly	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	AKT1; CASP2; MADD; CECR2;	GO:0097194~execution phase of apoptosis	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	CCL5; EPHB1; TSC1; CTSZ;	GO:1901214~regulation of neuron death	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	CCDC22; RAB11B; VPS39; ANKRD27;	GO:1990126~retrograde transport, endosome to plasma membrane	4	18	22.2222222222222	0.0168241830580261	0.078871560201823	1	1	0.985614356857844	0.985614356857844	0.731808105943782
down	APBA3; TIMP1; SCG5; NOTCH1; CCAR2; WDTC1; PPP1R12C;	GO:0043086~negative regulation of catalytic activity	7	52	13.4615384615385	0.0182612331480689	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	ABHD2; RARA; VDR; RXRA; PPARD; NR1I3; NR2E1;	GO:0043401~steroid hormone mediated signaling pathway	7	52	13.4615384615385	0.0182612331480689	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	MLYCD; BRCA1; FASN; ACACA; ACSF3; MCAT;	GO:0006633~fatty acid biosynthetic process	6	40	15	0.0182625271856696	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	ABL1; PLK1; VCP; DLG4; PHLDB2; RCC2;	GO:0045184~establishment of protein localization	6	40	15	0.0182625271856696	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	CIT; APP; ATN1; NCSTN; PIGT; DIABLO;	GO:0051402~neuron apoptotic process	6	40	15	0.0182625271856696	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	HOXC11; GDF11; NF1; HOXA11; FOXC2;	GO:0001656~metanephros development	5	29	17.2413793103448	0.0187893988623768	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	HLA-B; HLA-H; HLA-C; HLA-G; HLA-F;	GO:0002474~antigen processing and presentation of peptide antigen via MHC class I	5	29	17.2413793103448	0.0187893988623768	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	POLR1A; UBTF; POLR2E; ERCC3; TAF1C;	GO:0006362~transcription elongation from RNA polymerase I promoter	5	29	17.2413793103448	0.0187893988623768	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	SPPL2B; MADD; SHARPIN; SPATA2; IKBKG;	GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway	5	29	17.2413793103448	0.0187893988623768	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	GATA3; AKT1; BRSK2; FBXO7; GSK3A;	GO:0010975~regulation of neuron projection development	5	29	17.2413793103448	0.0187893988623768	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	MEN1; PLK1; CDKN2D; TFAP4; FBXO7;	GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity	5	29	17.2413793103448	0.0187893988623768	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	APP; BACE1; HSF1; NFE2L1; DAXX;	GO:0071280~cellular response to copper ion	5	29	17.2413793103448	0.0187893988623768	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	APP; EIF4G1; NTNG2; FZD1; LRFN3;	GO:1905606~regulation of presynapse assembly	5	29	17.2413793103448	0.0187893988623768	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	MFSD2B; APOBR; TEX2; SLCO2A1; SIGMAR1; ESYT1; SPNS1; ABCA2;	GO:0006869~lipid transport	8	65	12.3076923076923	0.0188121700050551	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	EVC; PTCH1; STIL; EVC2; TCTN2; SMO; CENPJ; IFT172;	GO:0007224~smoothened signaling pathway	8	65	12.3076923076923	0.0188121700050551	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	GYS1; PHKG2; AKT1; AKT2;	GO:0005978~glycogen biosynthetic process	4	19	21.0526315789474	0.0196403399188021	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	IGF2R; ARSB; VPS53; PCSK9;	GO:0007041~lysosomal transport	4	19	21.0526315789474	0.0196403399188021	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	SRC; CCL5; HDAC4; HAS2;	GO:0014911~positive regulation of smooth muscle cell migration	4	19	21.0526315789474	0.0196403399188021	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	PTCH1; NFE2L1; SCYL1; IFT172;	GO:0021522~spinal cord motor neuron differentiation	4	19	21.0526315789474	0.0196403399188021	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	MECP2; MBOAT7; CCDC134; CELSR2;	GO:0021591~ventricular system development	4	19	21.0526315789474	0.0196403399188021	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	HIP1R; PRKCD; SSH1; SSH2;	GO:0030837~negative regulation of actin filament polymerization	4	19	21.0526315789474	0.0196403399188021	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	SOCS1; SMARCA4; STAT5B; JAK3;	GO:0038111~interleukin-7-mediated signaling pathway	4	19	21.0526315789474	0.0196403399188021	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	CD74; MDK; GATA3; ZMIZ1;	GO:0045582~positive regulation of T cell differentiation	4	19	21.0526315789474	0.0196403399188021	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	IFITM1; TRIM25; TRIM11; TRIM8;	GO:0046597~negative regulation of viral entry into host cell	4	19	21.0526315789474	0.0196403399188021	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	SIPA1L1; CFL1; CDK5R1; SHANK3;	GO:0061001~regulation of dendritic spine morphogenesis	4	19	21.0526315789474	0.0196403399188021	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	SPTBN1; LDLRAP1; ZDHHC7; VPS4A;	GO:1903076~regulation of protein localization to plasma membrane	4	19	21.0526315789474	0.0196403399188021	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	DEPDC5; STK11; SZT2; KPTN;	GO:1904262~negative regulation of TORC1 signaling	4	19	21.0526315789474	0.0196403399188021	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	ZFP36L2; DCPS; CNOT3;	GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	PATL1; DCPS; PATL2;	GO:0000290~deadenylation-dependent decapping of nuclear-transcribed mRNA	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	CHAF1A; CHAF1B; ASF1B;	GO:0006335~DNA replication-dependent nucleosome assembly	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	AP2M1; P2RX7; VPS4A;	GO:0006900~vesicle budding from membrane	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	FLNB; DAG1; TLN1;	GO:0007016~cytoskeletal anchoring at plasma membrane	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	SMAD7; DACH1; KDM2A;	GO:0010944~negative regulation of transcription by competitive promoter binding	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	HDAC4; DAG1; MTMR4;	GO:0014894~response to denervation involved in regulation of muscle adaptation	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	SLC26A4; SLC26A6; SLC26A1;	GO:0019532~oxalate transport	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	XYLT2; CLN6; B4GALT7;	GO:0030203~glycosaminoglycan metabolic process	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	RARA; PTCH1; SMARCC1;	GO:0030850~prostate gland development	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	DGCR8; SRRT; DROSHA;	GO:0031053~primary miRNA processing	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	EMP3; ROCK1; P2RX7;	GO:0032060~bleb assembly	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	PML; PPP1R10; RTEL1;	GO:0032206~positive regulation of telomere maintenance	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	LDB1; CCAR2; SETD5;	GO:0032784~regulation of DNA-templated transcription, elongation	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	LIG1; LIG3; DCAF1;	GO:0033151~V(D)J recombination	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	CAPN3; RELA; PIAS3;	GO:0033234~negative regulation of protein sumoylation	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	HOXD10; ZBTB16; RNF165;	GO:0035136~forelimb morphogenesis	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	PTPN6; ZFP36L2; CARD11;	GO:0045577~regulation of B cell differentiation	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	STAT5B; LDB1; NCAPG2;	GO:0045647~negative regulation of erythrocyte differentiation	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	AKT1; MTOR; TSC1;	GO:0045792~negative regulation of cell size	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	HLA-G; HLA-F; ARRB2;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	DGKQ; DGKZ; DGKD;	GO:0046486~glycerolipid metabolic process	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	CD4; CD74; TRIM11;	GO:0046598~positive regulation of viral entry into host cell	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	NF1; MBD1; NR2E1;	GO:0048712~negative regulation of astrocyte differentiation	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	HOXD10; RUNX3; ISL2;	GO:0048935~peripheral nervous system neuron development	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	WFS1; APP; KLF2;	GO:0051247~positive regulation of protein metabolic process	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	NTN1; NECTIN1; SETD5;	GO:0051963~regulation of synapse assembly	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	CASQ2; KCNJ2; KCNH2;	GO:0060306~regulation of membrane repolarization	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	MEN1; ROCK1; RUNX3;	GO:0071559~response to transforming growth factor beta	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	PKD1; PTCH1; DLG5;	GO:0072205~metanephric collecting duct development	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	ITPKA; CTTN; PICK1;	GO:0097062~dendritic spine maintenance	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	MTOR; SMARCA4; SMARCB1;	GO:1901838~positive regulation of transcription of nucleolar large rRNA by RNA polymerase I	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	PIP4K2A; KIAA1324; PIP4K2C;	GO:2000786~positive regulation of autophagosome assembly	3	10	30	0.0196624498164164	0.0833366173460244	1	1	0.985614356857844	0.985614356857844	0.773237044375677
down	TLR4; IL6R; CYBA; CD36; FCER1G; P2RX7; CARD9;	GO:0032755~positive regulation of interleukin-6 production	7	53	13.2075471698113	0.0198768738428129	0.0841267688699334	1	1	0.985614356857844	0.985614356857844	0.780568448606059
down	PDPK1; EGFR; EPHB2; AKT1; SPTBN1; PPP1R9B; RANGRF;	GO:1903078~positive regulation of protein localization to plasma membrane	7	53	13.2075471698113	0.0198768738428129	0.0841267688699334	1	1	0.985614356857844	0.985614356857844	0.780568448606059
down	SLC7A1; SLC6A6; SLC43A2; SFXN5; SLC7A6; SLC7A7;	GO:0006865~amino acid transport	6	41	14.6341463414634	0.0201434440544204	0.0851350905534926	1	1	0.985614356857844	0.985614356857844	0.789924140056047
down	CBL; CAD; FOXK1; FOXK2; AACS; PPARGC1A;	GO:0042594~response to starvation	6	41	14.6341463414634	0.0201434440544204	0.0851350905534926	1	1	0.985614356857844	0.985614356857844	0.789924140056047
up	C1QA; C1QB; C1QC;	GO:0098883~synapse pruning	3	8	37.5	0.0210715811852697	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
up	SELE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	3	8	37.5	0.0210715811852697	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	POLR1A; UBTF; POLR2E; ERCC3; TAF1C;	GO:0006363~termination of RNA polymerase I transcription	5	30	16.6666666666667	0.0211125746494965	0.0886079424884593	1	1	0.985614356857844	0.985614356857844	0.82214692340467
down	REC8; PSMC3IP; MSH5; RAD54L; RAD51D;	GO:0007131~reciprocal meiotic recombination	5	30	16.6666666666667	0.0211125746494965	0.0886079424884593	1	1	0.985614356857844	0.985614356857844	0.82214692340467
down	VPS37C; FURIN; CHMP7; MVB12B; VPS4A;	GO:0019058~viral life cycle	5	30	16.6666666666667	0.0211125746494965	0.0886079424884593	1	1	0.985614356857844	0.985614356857844	0.82214692340467
down	MIS18BP1; HJURP; KNL1; CENPI; CENPO;	GO:0034080~CENP-A containing nucleosome assembly	5	30	16.6666666666667	0.0211125746494965	0.0886079424884593	1	1	0.985614356857844	0.985614356857844	0.82214692340467
down	CALM3; SKI; MMP9; TRIM28; PYHIN1;	GO:0043388~positive regulation of DNA binding	5	30	16.6666666666667	0.0211125746494965	0.0886079424884593	1	1	0.985614356857844	0.985614356857844	0.82214692340467
down	KDM1A; HMGA2; TFAP4; CPNE1; SMO;	GO:0043392~negative regulation of DNA binding	5	30	16.6666666666667	0.0211125746494965	0.0886079424884593	1	1	0.985614356857844	0.985614356857844	0.82214692340467
down	DNMT1; LHX2; PHF19; DNMT3B; MORC2;	GO:0045814~negative regulation of gene expression, epigenetic	5	30	16.6666666666667	0.0211125746494965	0.0886079424884593	1	1	0.985614356857844	0.985614356857844	0.82214692340467
down	ESPN; AGRN; CCR7; ARAP1; TENM2;	GO:0051491~positive regulation of filopodium assembly	5	30	16.6666666666667	0.0211125746494965	0.0886079424884593	1	1	0.985614356857844	0.985614356857844	0.82214692340467
down	LRP5; PPARD; AACS; PPARGC1A; DYRK1B;	GO:0060612~adipose tissue development	5	30	16.6666666666667	0.0211125746494965	0.0886079424884593	1	1	0.985614356857844	0.985614356857844	0.82214692340467
down	KDM1A; CYBA; ELK1; HSF1; TMEM109;	GO:0071480~cellular response to gamma radiation	5	30	16.6666666666667	0.0211125746494965	0.0886079424884593	1	1	0.985614356857844	0.985614356857844	0.82214692340467
up	ABRA; GPR55; LPAR4; GPR174; GPR65; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	6	33	18.1818181818182	0.0211759887252267	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	SHROOM2; SLC4A8; SLC8B1; SLC41A1; SCN4B; SLC24A4; SCN3B; CACNA1I; ASIC3;	GO:0035725~sodium ion transmembrane transport	9	80	11.25	0.0212936142440113	0.0893053884204523	1	1	0.985614356857844	0.985614356857844	0.828618160757956
down	ABL1; ITGB3; GPI; PRKCA; GATA3; FOXC2; PRKD2;	GO:0010595~positive regulation of endothelial cell migration	7	54	12.962962962963	0.0215895683580326	0.0904834768701367	1	1	0.985614356857844	0.985614356857844	0.839549029562779
down	FOS; TYMS; ABHD2; PTGER2; RELA; DSG2;	GO:0032570~response to progesterone	6	42	14.2857142857143	0.0221515790914746	0.0927742092960016	1	1	0.985614356857844	0.985614356857844	0.860803542006891
down	GMFG; NCF2; ALOX5AP; FGFR4; GTF2F1; PITRM1; SLX4; NCSTN; GTF3C4;	GO:0043085~positive regulation of catalytic activity	9	81	11.1111111111111	0.0227262289907366	0.094407619643987	1	1	0.985614356857844	0.985614356857844	0.875959105430886
down	REC8; CDC25B; FBXO5; YTHDF2;	GO:0001556~oocyte maturation	4	20	20	0.0227300874583776	0.094407619643987	1	1	0.985614356857844	0.985614356857844	0.875959105430886
down	FOXK1; FOXK2; PPARGC1A; HK1;	GO:0001678~cellular glucose homeostasis	4	20	20	0.0227300874583776	0.094407619643987	1	1	0.985614356857844	0.985614356857844	0.875959105430886
down	CYBA; NCF2; NRROS; PREX1;	GO:0006801~superoxide metabolic process	4	20	20	0.0227300874583776	0.094407619643987	1	1	0.985614356857844	0.985614356857844	0.875959105430886
down	HMGA2; BLM; CDK5RAP3; TAOK2;	GO:0007095~mitotic G2 DNA damage checkpoint	4	20	20	0.0227300874583776	0.094407619643987	1	1	0.985614356857844	0.985614356857844	0.875959105430886
down	GPS2; CARD16; PELI3; PIAS4;	GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway	4	20	20	0.0227300874583776	0.094407619643987	1	1	0.985614356857844	0.985614356857844	0.875959105430886
down	EP300; STOX1; ATP13A2; RHOT2;	GO:0010821~regulation of mitochondrion organization	4	20	20	0.0227300874583776	0.094407619643987	1	1	0.985614356857844	0.985614356857844	0.875959105430886
down	NTRK1; SRC; HAP1; GRB2;	GO:0048011~neurotrophin TRK receptor signaling pathway	4	20	20	0.0227300874583776	0.094407619643987	1	1	0.985614356857844	0.985614356857844	0.875959105430886
down	FANCC; SHANK3; ZNF335; SHANK2;	GO:0048854~brain morphogenesis	4	20	20	0.0227300874583776	0.094407619643987	1	1	0.985614356857844	0.985614356857844	0.875959105430886
down	TLR4; CD14; ITPK1; PGAM5;	GO:0070266~necroptotic process	4	20	20	0.0227300874583776	0.094407619643987	1	1	0.985614356857844	0.985614356857844	0.875959105430886
down	TIRAP; HNRNPA0; ELAVL1; RBM38;	GO:0070935~3'-UTR-mediated mRNA stabilization	4	20	20	0.0227300874583776	0.094407619643987	1	1	0.985614356857844	0.985614356857844	0.875959105430886
down	EGFR; PTAFR; GJA5; PPARD;	GO:0097755~positive regulation of blood vessel diameter	4	20	20	0.0227300874583776	0.094407619643987	1	1	0.985614356857844	0.985614356857844	0.875959105430886
down	SOCS1; PKD1; IL31RA; STAT5B; STAT6;	GO:0007259~receptor signaling pathway via JAK-STAT	5	31	16.1290322580645	0.023614993204083	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	CRIP1; ZACN; HVCN1; P2RX7; SLC30A3;	GO:0010043~response to zinc ion	5	31	16.1290322580645	0.023614993204083	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	TBXA2R; CBL; CAD; HOXD13; HSF1;	GO:0033574~response to testosterone	5	31	16.1290322580645	0.023614993204083	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	FGR; SRC; EPHA8; CCR7; VAV2;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	5	31	16.1290322580645	0.023614993204083	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	BRD1; GATA2; STAT5B; ANKRD54; INPP5D;	GO:0045648~positive regulation of erythrocyte differentiation	5	31	16.1290322580645	0.023614993204083	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	EGFR; BRCA1; TRIM28; WRAP53; CBX8;	GO:0045739~positive regulation of DNA repair	5	31	16.1290322580645	0.023614993204083	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	PLXNB1; DIAPH1; PAK2; MARK2; STMN3;	GO:0051493~regulation of cytoskeleton organization	5	31	16.1290322580645	0.023614993204083	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	AURKA; EGFR; TYMS; CSNK2A2; PTCH1;	GO:0097421~liver regeneration	5	31	16.1290322580645	0.023614993204083	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	GATA3; ZBTB16; PAX8;	GO:0001823~mesonephros development	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	RXRA; AKT1; DAZAP1;	GO:0001893~maternal placenta development	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	ITGB2; ALOX5; ADAM8;	GO:0002523~leukocyte migration involved in inflammatory response	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	KIF4A; ATP2A2; HPS6;	GO:0006996~organelle organization	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	SLC26A4; SLC26A6; SLC26A1;	GO:0008272~sulfate transport	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	CLASP1; CHMP7; CTDP1;	GO:0010458~exit from mitosis	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	PEX14; PEX5; PEX26;	GO:0016558~protein import into peroxisome matrix	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	SETD2; EHMT1; KMT5A;	GO:0018026~peptidyl-lysine monomethylation	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	CFL1; MICAL3; PPP1R9B;	GO:0030042~actin filament depolymerization	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	AKAP8; CTBP1; AKAP8L;	GO:0031065~positive regulation of histone deacetylation	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	ITPKA; ITPKB; IP6K1;	GO:0032958~inositol phosphate biosynthetic process	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	SMAD7; PAK2; TBCD;	GO:0034333~adherens junction assembly	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	MEN1; EHMT2; SUV39H1;	GO:0034968~histone lysine methylation	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	IFITM1; EIF2AK2; ADAR;	GO:0035455~response to interferon-alpha	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	IFITM1; IKBKE; XAF1;	GO:0035456~response to interferon-beta	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	DLG4; HSF1; PPARGC1A;	GO:0035865~cellular response to potassium ion	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	COL4A3; DDR1; COL4A4;	GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	PPARD; PTCH1; FERMT1;	GO:0043616~keratinocyte proliferation	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	CD74; APP; AGER;	GO:0045080~positive regulation of chemokine biosynthetic process	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	ANK1; LHX2; LIN7A;	GO:0045199~maintenance of epithelial cell apical/basal polarity	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	SOCS1; HLA-G; LILRB4;	GO:0045591~positive regulation of regulatory T cell differentiation	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	SASH3; AKT1; SMO;	GO:0046622~positive regulation of organ growth	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	KDM6B; ITGB3; HMGA2;	GO:0048333~mesodermal cell differentiation	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	LHX1; FOXC2; CHST11;	GO:0048703~embryonic viscerocranium morphogenesis	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	FGL2; TRAF3IP1; RNF26;	GO:0050687~negative regulation of defense response to virus	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	ADARB1; TCF15; ATP8A2;	GO:0050884~neuromuscular process controlling posture	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	TTLL11; LZTS2; KATNB1;	GO:0051013~microtubule severing	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	SLC12A9; SLC12A4; SLC12A7;	GO:0055064~chloride ion homeostasis	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	ARRB2; EP300; SAFB2;	GO:0060765~regulation of androgen receptor signaling pathway	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	EPHA8; NOTCH1; PPARGC1A;	GO:0071372~cellular response to follicle-stimulating hormone stimulus	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	BRCA1; PLK1; FZR1;	GO:0072425~signal transduction involved in G2 DNA damage checkpoint	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	STK11; AUTS2; CYFIP2;	GO:0097484~dendrite extension	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	ADCY6; ADCY3; ADCY1;	GO:1904322~cellular response to forskolin	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	PARP1; WRAP53; TIMELESS;	GO:1905168~positive regulation of double-strand break repair via homologous recombination	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	PRKCD; SPHK2; SMPD3;	GO:2000304~positive regulation of ceramide biosynthetic process	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	HIP1R; PIK3CB; TNK2;	GO:2000369~regulation of clathrin-dependent endocytosis	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	PUM1; AJUBA; LIMD1;	GO:2000637~positive regulation of gene silencing by miRNA	3	11	27.2727272727273	0.0241835176212384	0.0974148397477498	1	1	0.985614356857844	0.985614356857844	0.903861533665593
down	MMP7; FURIN; MMP9; CTSS; PHYKPL; ADAMTS14;	GO:0030574~collagen catabolic process	6	43	13.953488372093	0.0242902310339892	0.0977137138649766	1	1	0.985614356857844	0.985614356857844	0.906634630851495
down	IGF2R; C5AR1; CAD; NOTCH1; FPGS; PTPRU;	GO:0031100~animal organ regeneration	6	43	13.953488372093	0.0242902310339892	0.0977137138649766	1	1	0.985614356857844	0.985614356857844	0.906634630851495
down	PTCH1; C2CD3; CREBBP; IFT140;	GO:0008589~regulation of smoothened signaling pathway	4	21	19.047619047619	0.0260989471680301	0.104291670531822	1	1	0.985614356857844	0.985614356857844	0.967668062889947
down	BCKDK; IVD; SLC25A44; MCCC2;	GO:0009083~branched-chain amino acid catabolic process	4	21	19.047619047619	0.0260989471680301	0.104291670531822	1	1	0.985614356857844	0.985614356857844	0.967668062889947
down	CLDN3; CLDN9; CLDN15; CLDN23;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	4	21	19.047619047619	0.0260989471680301	0.104291670531822	1	1	0.985614356857844	0.985614356857844	0.967668062889947
down	ITGB3; RARA; ALOX15; CD36;	GO:0043277~apoptotic cell clearance	4	21	19.047619047619	0.0260989471680301	0.104291670531822	1	1	0.985614356857844	0.985614356857844	0.967668062889947
down	FGR; IRF1; TIRAP; TREML2;	GO:0045088~regulation of innate immune response	4	21	19.047619047619	0.0260989471680301	0.104291670531822	1	1	0.985614356857844	0.985614356857844	0.967668062889947
down	CCL5; KHDRBS1; LARP1; YTHDF1;	GO:0045948~positive regulation of translational initiation	4	21	19.047619047619	0.0260989471680301	0.104291670531822	1	1	0.985614356857844	0.985614356857844	0.967668062889947
down	STK11; NSMF; SEMA4D; NR2E1;	GO:0048814~regulation of dendrite morphogenesis	4	21	19.047619047619	0.0260989471680301	0.104291670531822	1	1	0.985614356857844	0.985614356857844	0.967668062889947
down	TERT; CALM3; AKT1; TERF2;	GO:0051000~positive regulation of nitric-oxide synthase activity	4	21	19.047619047619	0.0260989471680301	0.104291670531822	1	1	0.985614356857844	0.985614356857844	0.967668062889947
down	LMNA; AKT1; ARRB2; PAM16;	GO:0090201~negative regulation of release of cytochrome c from mitochondria	4	21	19.047619047619	0.0260989471680301	0.104291670531822	1	1	0.985614356857844	0.985614356857844	0.967668062889947
down	CNIH2; MINK1; SHANK2; SHANK3;	GO:2000311~regulation of AMPA receptor activity	4	21	19.047619047619	0.0260989471680301	0.104291670531822	1	1	0.985614356857844	0.985614356857844	0.967668062889947
down	MSH5; ABL1; LIG1; POLD1; SETD2;	GO:0006298~mismatch repair	5	32	15.625	0.0263008550688759	0.104819720798372	1	1	0.985614356857844	0.985614356857844	0.972567566138236
down	AQP9; CRIP1; RELA; DGKD; TIMP1;	GO:0010033~response to organic substance	5	32	15.625	0.0263008550688759	0.104819720798372	1	1	0.985614356857844	0.985614356857844	0.972567566138236
down	GAK; CD74; TOR2A; DNAJB12; HSPA6;	GO:0051085~chaperone cofactor-dependent protein refolding	5	32	15.625	0.0263008550688759	0.104819720798372	1	1	0.985614356857844	0.985614356857844	0.972567566138236
down	LRP4; RARA; KAT2A; IFT172; ZNRF3;	GO:0060173~limb development	5	32	15.625	0.0263008550688759	0.104819720798372	1	1	0.985614356857844	0.985614356857844	0.972567566138236
down	TNFSF14; CD3E; CD7; TREML2; HSH2D; CD4;	GO:0042110~T cell activation	6	44	13.6363636363636	0.0265624888184213	0.105190386149711	1	1	0.985614356857844	0.985614356857844	0.976006776773967
up	TDO2; KYNU; ACMSD;	GO:0006569~tryptophan catabolic process	3	9	33.3333333333333	0.0269355733291705	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
up	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.0269355733291705	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	SRC; TNC; GATA4; CLCN6; PTCH1; P2RX7; SOST;	GO:0009612~response to mechanical stimulus	7	57	12.280701754386	0.0273347086981438	0.105190386149711	1	1	0.985614356857844	0.985614356857844	0.976006776773967
up	TRPM2; CCR2; CCR5; CCL19;	GO:0002407~dendritic cell chemotaxis	4	17	23.5294117647059	0.0280623523018039	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
up	AIF1; CCL19; RARRES2; P2RY12;	GO:0050921~positive regulation of chemotaxis	4	17	23.5294117647059	0.0280623523018039	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	TLR4; CD14; CD36; CTSS; IRAK1; TRAF3;	GO:0002224~toll-like receptor signaling pathway	6	45	13.3333333333333	0.0289712228411511	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	SLC37A4; GPI; FBP1; PC; CRTC2; PPARGC1A;	GO:0006094~gluconeogenesis	6	45	13.3333333333333	0.0289712228411511	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	PAK4; CYBA; CCL5; AKT1; HCFC1; PAK2;	GO:0071407~cellular response to organic cyclic compound	6	45	13.3333333333333	0.0289712228411511	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	FPGS; CRMP1; DDX12P; SLC23A2; OAS3;	GO:0006139~nucleobase-containing compound metabolic process	5	33	15.1515151515152	0.0291738993966326	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	POLR1A; UBTF; POLR2E; ERCC3; TAF1C;	GO:0006361~transcription initiation from RNA polymerase I promoter	5	33	15.1515151515152	0.0291738993966326	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	PLEK; RAB8A; STXBP2; VPS33A; VPS18;	GO:0006904~vesicle docking involved in exocytosis	5	33	15.1515151515152	0.0291738993966326	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	SKIV2L; EXOSC6; EDC4; PATL1; DCPS;	GO:0043928~exonucleolytic catabolism of deadenylated mRNA	5	33	15.1515151515152	0.0291738993966326	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	ADAM8; CCL26; CCL5; CCL4; CCL24;	GO:0048247~lymphocyte chemotaxis	5	33	15.1515151515152	0.0291738993966326	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	PRF1; EPHB1; DOCK2;	GO:0001771~immunological synapse formation	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	MYH9; MYOF; DYSF;	GO:0001778~plasma membrane repair	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	IL6R; MDK; GPSM3;	GO:0002690~positive regulation of leukocyte chemotaxis	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	FBP1; HK1; NFE2L1;	GO:0006002~fructose 6-phosphate metabolic process	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	G6PD; TKT; SHPK;	GO:0006098~pentose-phosphate shunt	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	PRPF19; OLAH; DOLPP1;	GO:0008610~lipid biosynthetic process	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	CD4; P2RX5; P2RX7;	GO:0010524~positive regulation of calcium ion transport into cytosol	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	MTA2; GNA12; RCC2;	GO:0010762~regulation of fibroblast migration	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	TTLL4; TPGS1; TTLL11;	GO:0018095~protein polyglutamylation	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	GBX2; SMO; CNTNAP2;	GO:0021794~thalamus development	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	ST3GAL2; GBA2; GBGT1;	GO:0030259~lipid glycosylation	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	NOTCH1; RELA; CARD9;	GO:0032495~response to muramyl dipeptide	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	ARRB2; JAK3; CMKLR1;	GO:0032695~negative regulation of interleukin-12 production	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	TRIM14; TRIM11; TRIM8;	GO:0032897~negative regulation of viral transcription	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	KMT2D; PARP1; PAGR1;	GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	MFN2; PACS2; ATG9A;	GO:0034497~protein localization to phagophore assembly site	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	DLG4; BSN; BAIAP2;	GO:0035418~protein localization to synapse	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	SRC; PTAFR; AGER;	GO:0045056~transcytosis	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	PRKACA; RASSF2; TCIRG1;	GO:0045667~regulation of osteoblast differentiation	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	UBTF; DHX33; PHF8;	GO:0045943~positive regulation of transcription by RNA polymerase I	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	SCD; FASN; ACACA;	GO:0046949~fatty-acyl-CoA biosynthetic process	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	AKAP13; LZTS2; EIF4ENIF1;	GO:0051168~nuclear export	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	ATP2A2; RGS2; KCNJ2;	GO:0055119~relaxation of cardiac muscle	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	CD36; GATA2; STAP1;	GO:0060100~positive regulation of phagocytosis, engulfment	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	ARID1A; PKD1; NOTCH2;	GO:0060674~placenta blood vessel development	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	UPF1; KHSRP; MOV10;	GO:0061014~positive regulation of mRNA catabolic process	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	FES; TNC; GDAP1;	GO:0071305~cellular response to vitamin D	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	SRC; HAS2; KLF2;	GO:0071498~cellular response to fluid shear stress	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	ABL1; HSPG2; NXN;	GO:0072358~cardiovascular system development	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	KCNJ2; SCN4B; SCN3B;	GO:0086012~membrane depolarization during cardiac muscle cell action potential	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	CPSF1; CPSF7; TUT1;	GO:0098789~pre-mRNA cleavage required for polyadenylation	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	ITGB3; DRD4; SCRIB;	GO:0099149~regulation of postsynaptic neurotransmitter receptor internalization	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	USP19; F8A1; PSMF1;	GO:1901799~negative regulation of proteasomal protein catabolic process	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	VCP; TAZ; PPARGC1A;	GO:2001171~positive regulation of ATP biosynthetic process	3	12	25	0.0292156484224348	0.106804164853305	1	1	0.985614356857844	0.985614356857844	0.990980188400002
down	ALAS2; NFE2L1; IBA57; SLC25A39;	GO:0006783~heme biosynthetic process	4	22	18.1818181818182	0.0297512594880913	0.108039316932585	1	1	0.985614356857844	0.985614356857844	1
down	CAMK1; ANKRD54; RBM15B; NUP62CL;	GO:0006913~nucleocytoplasmic transport	4	22	18.1818181818182	0.0297512594880913	0.108039316932585	1	1	0.985614356857844	0.985614356857844	1
down	ITGB2; BAG6; IL18R1; ULBP3;	GO:0030101~natural killer cell activation	4	22	18.1818181818182	0.0297512594880913	0.108039316932585	1	1	0.985614356857844	0.985614356857844	1
down	FASN; NOTCH4; PYGO2; ARHGAP35;	GO:0030879~mammary gland development	4	22	18.1818181818182	0.0297512594880913	0.108039316932585	1	1	0.985614356857844	0.985614356857844	1
down	AP3D1; SHROOM2; BLOC1S3; AP1M1;	GO:0032438~melanosome organization	4	22	18.1818181818182	0.0297512594880913	0.108039316932585	1	1	0.985614356857844	0.985614356857844	1
down	AXIN1; HSF1; AP2M1; DNAJB12;	GO:0034622~cellular protein-containing complex assembly	4	22	18.1818181818182	0.0297512594880913	0.108039316932585	1	1	0.985614356857844	0.985614356857844	1
down	FLCN; KCTD13; ARHGAP35; KCTD10;	GO:0035024~negative regulation of Rho protein signal transduction	4	22	18.1818181818182	0.0297512594880913	0.108039316932585	1	1	0.985614356857844	0.985614356857844	1
down	WDR81; FAM160A2; ANKRD27; PTPN23;	GO:0045022~early endosome to late endosome transport	4	22	18.1818181818182	0.0297512594880913	0.108039316932585	1	1	0.985614356857844	0.985614356857844	1
down	SYNJ1; INPP5D; INPP5E; SYNJ2;	GO:0046856~phosphatidylinositol dephosphorylation	4	22	18.1818181818182	0.0297512594880913	0.108039316932585	1	1	0.985614356857844	0.985614356857844	1
down	BRINP1; NOTCH1; LHX2; TRIM11;	GO:0050768~negative regulation of neurogenesis	4	22	18.1818181818182	0.0297512594880913	0.108039316932585	1	1	0.985614356857844	0.985614356857844	1
down	FZD9; CDK9; TFAP4; MLXIPL;	GO:0071157~negative regulation of cell cycle arrest	4	22	18.1818181818182	0.0297512594880913	0.108039316932585	1	1	0.985614356857844	0.985614356857844	1
down	SIAH2; TNFSF14; SRC; AKT1; ARRB2; CDKN2D; RPS6KA1; CARD16;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	8	72	11.1111111111111	0.0307180252383268	0.111482688213976	1	1	0.985614356857844	0.985614356857844	1
down	CA1; LMNB1; CFL1; TYK2; IL12RB1; PAK2;	GO:0035722~interleukin-12-mediated signaling pathway	6	46	13.0434782608696	0.0315190773130508	0.114251902684822	1	1	0.985614356857844	0.985614356857844	1
down	GATA2; GATA3; ZFP36L2; GPS2; C1QL4; ASXL1;	GO:0045599~negative regulation of fat cell differentiation	6	46	13.0434782608696	0.0315190773130508	0.114251902684822	1	1	0.985614356857844	0.985614356857844	1
down	BAG3; TCIRG1; ATG2A; KIAA1324; ATG9A; PACS2; ATG16L2;	GO:0000045~autophagosome assembly	7	59	11.864406779661	0.0316934292292672	0.114814653205483	1	1	0.985614356857844	0.985614356857844	1
down	LIG1; HMGA2; HUWE1; APEX2; POLL;	GO:0006284~base-excision repair	5	34	14.7058823529412	0.032237397010844	0.116294571449684	1	1	0.985614356857844	0.985614356857844	1
down	MAP3K11; GTSE1; TUBB1; TUBG1; TUBA8;	GO:0007017~microtubule-based process	5	34	14.7058823529412	0.032237397010844	0.116294571449684	1	1	0.985614356857844	0.985614356857844	1
down	CD36; HBB; EIF4G1; PRR7; KATNB1;	GO:0010942~positive regulation of cell death	5	34	14.7058823529412	0.032237397010844	0.116294571449684	1	1	0.985614356857844	0.985614356857844	1
down	ZBTB7A; CTDNEP1; LMNA; ZBTB16; SMO;	GO:0034504~protein localization to nucleus	5	34	14.7058823529412	0.032237397010844	0.116294571449684	1	1	0.985614356857844	0.985614356857844	1
down	COL5A3; PKD1; LTB; TCF15; ATP8A2;	GO:0043588~skin development	5	34	14.7058823529412	0.032237397010844	0.116294571449684	1	1	0.985614356857844	0.985614356857844	1
down	DSCAM; LRP4; MINK1; CELSR2; RERE;	GO:0048813~dendrite morphogenesis	5	34	14.7058823529412	0.032237397010844	0.116294571449684	1	1	0.985614356857844	0.985614356857844	1
down	MAP2K7; HMBOX1; ACD; PNKP; WRAP53;	GO:0051973~positive regulation of telomerase activity	5	34	14.7058823529412	0.032237397010844	0.116294571449684	1	1	0.985614356857844	0.985614356857844	1
up	C1QA; NAMPT; AIF1; TLR8; TLR7;	GO:0001774~microglial cell activation	5	27	18.5185185185185	0.0322490190107404	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	POLG; POLE; REXO1; TATDN2; ATAD5; PNKP; RAD9A; APEX2;	GO:0090305~nucleic acid phosphodiester bond hydrolysis	8	73	10.958904109589	0.0327613335197584	0.118113745923064	1	1	0.985614356857844	0.985614356857844	1
up	IL18RAP; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	3	10	30	0.0335753448298258	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	LETM1; PMPCA; SLC8B1; SPG7;	GO:0006851~mitochondrial calcium ion transmembrane transport	4	23	17.3913043478261	0.0336902120030286	0.120451025662226	1	1	0.985614356857844	0.985614356857844	1
down	SPTBN1; BAIAP2; DYSF; MYOF;	GO:0007009~plasma membrane organization	4	23	17.3913043478261	0.0336902120030286	0.120451025662226	1	1	0.985614356857844	0.985614356857844	1
down	DSCAM; LHX1; SDK2; ATP8A2;	GO:0010842~retina layer formation	4	23	17.3913043478261	0.0336902120030286	0.120451025662226	1	1	0.985614356857844	0.985614356857844	1
down	EGFR; PIP4K2A; PPP2R5B; PIP4K2C;	GO:0014066~regulation of phosphatidylinositol 3-kinase signaling	4	23	17.3913043478261	0.0336902120030286	0.120451025662226	1	1	0.985614356857844	0.985614356857844	1
down	GRIN2D; APP; GRIN2C; CDK5R1;	GO:0035235~ionotropic glutamate receptor signaling pathway	4	23	17.3913043478261	0.0336902120030286	0.120451025662226	1	1	0.985614356857844	0.985614356857844	1
down	ADGRL1; PRKACA; DMTN; PTPRJ;	GO:0035584~calcium-mediated signaling using intracellular calcium source	4	23	17.3913043478261	0.0336902120030286	0.120451025662226	1	1	0.985614356857844	0.985614356857844	1
down	IL12RB1; STAT5B; AGER; TMIGD2;	GO:0042104~positive regulation of activated T cell proliferation	4	23	17.3913043478261	0.0336902120030286	0.120451025662226	1	1	0.985614356857844	0.985614356857844	1
down	EGFR; NTRK1; SHANK3; SHANK2;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	4	23	17.3913043478261	0.0336902120030286	0.120451025662226	1	1	0.985614356857844	0.985614356857844	1
down	MMP7; RGS2; MTOR; DSG2;	GO:0060135~maternal process involved in female pregnancy	4	23	17.3913043478261	0.0336902120030286	0.120451025662226	1	1	0.985614356857844	0.985614356857844	1
down	ATP2A1; ORAI1; CACNA1F; CACNA1I;	GO:0070509~calcium ion import	4	23	17.3913043478261	0.0336902120030286	0.120451025662226	1	1	0.985614356857844	0.985614356857844	1
down	PML; PRKCD; TERF2; KAT6A;	GO:0090398~cellular senescence	4	23	17.3913043478261	0.0336902120030286	0.120451025662226	1	1	0.985614356857844	0.985614356857844	1
down	NOTCH1; FANCC; SRRT; IGF2BP1;	GO:0097150~neuronal stem cell population maintenance	4	23	17.3913043478261	0.0336902120030286	0.120451025662226	1	1	0.985614356857844	0.985614356857844	1
down	RASSF2; RELA; HDAC7; CPNE1;	GO:1901223~negative regulation of NIK/NF-kappaB signaling	4	23	17.3913043478261	0.0336902120030286	0.120451025662226	1	1	0.985614356857844	0.985614356857844	1
down	ST6GAL1; ST3GAL2; GALNT5; GALNT6; MUC16; POFUT1; MUC12;	GO:0016266~O-glycan processing	7	60	11.6666666666667	0.0340375570955215	0.121548257958458	1	1	0.985614356857844	0.985614356857844	1
down	MEN1; EPPK1; PPARD; PTCH1; RUNX3; DAB2IP; IFT172;	GO:0050680~negative regulation of epithelial cell proliferation	7	60	11.6666666666667	0.0340375570955215	0.121548257958458	1	1	0.985614356857844	0.985614356857844	1
down	NUP62; CRHR2; GHRL; RARA; CGB7; PPARD;	GO:0009755~hormone-mediated signaling pathway	6	47	12.7659574468085	0.0342084636963408	0.122013570810094	1	1	0.985614356857844	0.985614356857844	1
down	EN2; EN1; ISL2; SCYL1; ATP8A2; TENM2;	GO:0048666~neuron development	6	47	12.7659574468085	0.0342084636963408	0.122013570810094	1	1	0.985614356857844	0.985614356857844	1
down	POLD1; CDKN2D; POLE;	GO:0000731~DNA synthesis involved in DNA repair	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	RPS6KA4; SLC11A1; BTK;	GO:0001818~negative regulation of cytokine production	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	NCAPG2; PALB2; PRPF19;	GO:0001833~inner cell mass cell proliferation	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	GATA3; GATA4; PPP1R13L;	GO:0003215~cardiac right ventricle morphogenesis	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	STX2; NF2; ZBTB17;	GO:0007398~ectoderm development	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	ERCC3; SCARA3; SDF4;	GO:0009650~UV protection	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	AKT1; DMTN; ARHGEF7;	GO:0010763~positive regulation of fibroblast migration	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	KAT2A; USP22; TRRAP;	GO:0016578~histone deubiquitination	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	EPHB2; EPHB3; PTPRS;	GO:0022038~corpus callosum development	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	PLEK; SYNPO; SYNPO2L;	GO:0032233~positive regulation of actin filament bundle assembly	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	IRF3; RNF26; ZBP1;	GO:0032479~regulation of type I interferon production	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	PLOD3; P2RX7; SMPD3;	GO:0032963~collagen metabolic process	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	PTCH1; IQCE; MEGF8;	GO:0035108~limb morphogenesis	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	CD36; NF1; FERMT1;	GO:0042308~negative regulation of protein import into nucleus	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	SCAP; ABHD2; ABHD15;	GO:0044255~cellular lipid metabolic process	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	STAT5B; BTK; INPP5D;	GO:0045579~positive regulation of B cell differentiation	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	HGS; SOCS1; NF2;	GO:0046426~negative regulation of receptor signaling pathway via JAK-STAT	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	NF1; NOTCH1; DLX2;	GO:0048715~negative regulation of oligodendrocyte differentiation	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	DAG1; FERMT1; RIC8A;	GO:0071711~basement membrane organization	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	FZD1; DVL3; DVL2;	GO:0090179~planar cell polarity pathway involved in neural tube closure	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	WHAMM; EHD2; BIN3;	GO:0097320~plasma membrane tubulation	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	SRC; CNIH2; BEGAIN;	GO:0098962~regulation of postsynaptic neurotransmitter receptor activity	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	HAP1; ROCK1; GGA3;	GO:1902430~negative regulation of amyloid-beta formation	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	SLC43A2; SLC7A6; SLC7A7;	GO:1902475~L-alpha-amino acid transmembrane transport	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	TSC1; FZD1; FBXO7;	GO:1903204~negative regulation of oxidative stress-induced neuron death	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	HMGA2; PRKCD; FXR2;	GO:2001022~positive regulation of response to DNA damage stimulus	3	13	23.0769230769231	0.0347550596876343	0.122079432333537	1	1	0.985614356857844	0.985614356857844	1
down	ATP2A1; PRKCB; VDR; CCL5; CCR1; ATP2A3; CDH23; CACNA1F;	GO:0006816~calcium ion transport	8	74	10.8108108108108	0.0348951893833537	0.122500051515161	1	1	0.985614356857844	0.985614356857844	1
down	FCMR; RUBCN; YTHDF1; IRF1; IRF3;	GO:0002376~immune system process	5	35	14.2857142857143	0.0354941462463625	0.124457303932695	1	1	0.985614356857844	0.985614356857844	1
down	SLC6A6; SLC7A6; SLC38A10; SLC7A7; SLC38A7;	GO:0003333~amino acid transmembrane transport	5	35	14.2857142857143	0.0354941462463625	0.124457303932695	1	1	0.985614356857844	0.985614356857844	1
down	EGFR; CD74; PML; PRKDC; CTC1; ZMIZ1;	GO:0048146~positive regulation of fibroblast proliferation	6	48	12.5	0.0370415552023802	0.126691819468861	1	1	0.985614356857844	0.985614356857844	1
down	LIG1; POLD1; LIG3; POLE;	GO:0006297~nucleotide-excision repair, DNA gap filling	4	24	16.6666666666667	0.0379178740530421	0.126691819468861	1	1	0.985614356857844	0.985614356857844	1
down	PLK1; CDC20; MAD1L1; BUB1;	GO:0007094~mitotic spindle assembly checkpoint	4	24	16.6666666666667	0.0379178740530421	0.126691819468861	1	1	0.985614356857844	0.985614356857844	1
down	NPR1; CD36; PRKAR1B; PRKAR2B;	GO:0019934~cGMP-mediated signaling	4	24	16.6666666666667	0.0379178740530421	0.126691819468861	1	1	0.985614356857844	0.985614356857844	1
down	POLD1; POLE; POLA2; UPF1;	GO:0032201~telomere maintenance via semi-conservative replication	4	24	16.6666666666667	0.0379178740530421	0.126691819468861	1	1	0.985614356857844	0.985614356857844	1
down	IFITM1; CIITA; SLC11A1; CXCL16;	GO:0034341~response to interferon-gamma	4	24	16.6666666666667	0.0379178740530421	0.126691819468861	1	1	0.985614356857844	0.985614356857844	1
down	CCDC88B; SLC11A1; BATF2; TSPAN32;	GO:0042832~defense response to protozoan	4	24	16.6666666666667	0.0379178740530421	0.126691819468861	1	1	0.985614356857844	0.985614356857844	1
down	LDLR; SRC; PTAFR; SMARCD1;	GO:0071398~cellular response to fatty acid	4	24	16.6666666666667	0.0379178740530421	0.126691819468861	1	1	0.985614356857844	0.985614356857844	1
down	PPBP; SLC2A1; PPARD; SLC2A6;	GO:1904659~glucose transmembrane transport	4	24	16.6666666666667	0.0379178740530421	0.126691819468861	1	1	0.985614356857844	0.985614356857844	1
up	LTF; APOA4; H2BFS; DEFB1;	GO:0002227~innate immune response in mucosa	4	19	21.0526315789474	0.037990144889072	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	FANCA; SOX15; WT1; CBL; GATA3; HOXA10; HOXA11; GATA4; PATZ1;	GO:0008584~male gonad development	9	90	10	0.0388303699194769	0.129148048265665	1	1	0.985614356857844	0.985614356857844	1
down	VGF; FOS; CDH8; PPARGC1A; UCP2;	GO:0009409~response to cold	5	36	13.8888888888889	0.0389464713940959	0.129248091153239	1	1	0.985614356857844	0.985614356857844	1
down	BAG6; VCP; PRPF19; PSMB10; PSMB9;	GO:0010498~proteasomal protein catabolic process	5	36	13.8888888888889	0.0389464713940959	0.129248091153239	1	1	0.985614356857844	0.985614356857844	1
down	NTN1; L1CAM; ANAPC2; TRPV2; CTTN;	GO:0045773~positive regulation of axon extension	5	36	13.8888888888889	0.0389464713940959	0.129248091153239	1	1	0.985614356857844	0.985614356857844	1
down	GCA; RABEP1; BET1L; MYOF; DYSF;	GO:0061025~membrane fusion	5	36	13.8888888888889	0.0389464713940959	0.129248091153239	1	1	0.985614356857844	0.985614356857844	1
down	MYO1C; RTP4; TAOK2; VPS37C; ZDHHC7; GOLGA7B;	GO:0006612~protein targeting to membrane	6	49	12.2448979591837	0.0400202823294558	0.1327383536424	1	1	0.985614356857844	0.985614356857844	1
down	ECE1; SCRIB; ARAP1;	GO:0001921~positive regulation of receptor recycling	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	CHST7; MGAT3; CHST3;	GO:0006044~N-acetylglucosamine metabolic process	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	CCDC22; APP; SLC31A2;	GO:0006878~cellular copper ion homeostasis	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	SLC11A1; ATP6V0D1; TCIRG1;	GO:0007035~vacuolar acidification	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	GPRC5A; ZFYVE28; CBL;	GO:0007175~negative regulation of epidermal growth factor-activated receptor activity	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	PML; PRKCD; DIABLO;	GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	TSC2; DAB2IP; INPP5E;	GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	CAMTA2; ATP2A2; HDAC4;	GO:0014898~cardiac muscle hypertrophy in response to stress	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	CD36; TBXA2R; DMTN;	GO:0030194~positive regulation of blood coagulation	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	ADAR; AGO1; DROSHA;	GO:0031054~pre-miRNA processing	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	MTOR; EIF4G1; RPTOR;	GO:0031669~cellular response to nutrient levels	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	ARRB2; CX3CR1; GHRL;	GO:0032691~negative regulation of interleukin-1 beta production	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	POLR2A; U2AF2; RBM22;	GO:0033120~positive regulation of RNA splicing	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	PUM1; ZC3H7B; AGO1;	GO:0035196~production of miRNAs involved in gene silencing by miRNA	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	KDM1A; MECP2; LGI4;	GO:0042551~neuron maturation	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	CBL; MILR1; LAT2;	GO:0043303~mast cell degranulation	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	ALOX5; GNB3; GPS2;	GO:0045598~regulation of fat cell differentiation	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	WDR5; KAT2A; PPARGC1A;	GO:0045722~positive regulation of gluconeogenesis	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	NF1; PTCH1; SMO;	GO:0048745~smooth muscle tissue development	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	CTBP1; AACS; PRDM16;	GO:0050872~white fat cell differentiation	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	VDR; CD36; SLC26A6;	GO:0050892~intestinal absorption	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	CD36; GNB1; CALHM3;	GO:0050909~sensory perception of taste	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	AGER; ARTN; IL16;	GO:0050930~induction of positive chemotaxis	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	PML; TAF3; CHCHD10;	GO:0051457~maintenance of protein location in nucleus	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	DMTN; MYO10; FXR2;	GO:0051489~regulation of filopodium assembly	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	RXRA; NOTCH1; FOXC2;	GO:0060038~cardiac muscle cell proliferation	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	STAT5B; JAK3; STAT6;	GO:0060397~growth hormone receptor signaling pathway via JAK-STAT	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	CDH1; GSK3A; ADCY7;	GO:0071285~cellular response to lithium ion	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	SART3; CTC1; YTHDF2;	GO:0071425~hematopoietic stem cell proliferation	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	LDLR; GNB3; DGKQ;	GO:0090181~regulation of cholesterol metabolic process	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	SLC26A4; SLC26A6; SLC26A1;	GO:1902358~sulfate transmembrane transport	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	MYO1C; PRKACA; FZD5;	GO:2000810~regulation of bicellular tight junction assembly	3	14	21.4285714285714	0.0407948103387215	0.132959224585529	1	1	0.985614356857844	0.985614356857844	1
down	SLC22A5; SLC5A12; SCN4B; SLC22A4; SLC38A10; SLC38A7; SCN3B; SLC23A2;	GO:0006814~sodium ion transport	8	77	10.3896103896104	0.0418540355709354	0.136263680271572	1	1	0.985614356857844	0.985614356857844	1
down	CCDC88B; EIF2AK2; SLC11A1; TMIGD2;	GO:0001819~positive regulation of cytokine production	4	25	16	0.0424352366582772	0.137782697091435	1	1	0.985614356857844	0.985614356857844	1
down	PABPC4; ISG20; SND1; SKIV2L;	GO:0006401~RNA catabolic process	4	25	16	0.0424352366582772	0.137782697091435	1	1	0.985614356857844	0.985614356857844	1
down	PTPRF; PTPRS; NTNG2; LRFN3;	GO:0099560~synaptic membrane adhesion	4	25	16	0.0424352366582772	0.137782697091435	1	1	0.985614356857844	0.985614356857844	1
down	TNFSF12; PML; LTBR; PAK2;	GO:2001238~positive regulation of extrinsic apoptotic signaling pathway	4	25	16	0.0424352366582772	0.137782697091435	1	1	0.985614356857844	0.985614356857844	1
down	SYNJ1; SCRIB; DENND1A; ACTL8; ACTBL2;	GO:0048488~synaptic vesicle endocytosis	5	37	13.5135135135135	0.0425962235718818	0.138156127181333	1	1	0.985614356857844	0.985614356857844	1
down	EGFR; HSF1; KAT5; PPP1R9B; PPARGC1A;	GO:0071392~cellular response to estradiol stimulus	5	37	13.5135135135135	0.0425962235718818	0.138156127181333	1	1	0.985614356857844	0.985614356857844	1
up	TAS2R41; TAS2R43; TAS2R50; TAS2R13; TAS2R10; RTP1;	GO:0001580~detection of chemical stimulus involved in sensory perception of bitter taste	6	40	15	0.0436693830995205	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	MARK2; PPARGC1A; FBXO7; ATG2A; ATG9A;	GO:0000422~autophagy of mitochondrion	5	38	13.1578947368421	0.0464447838460607	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	CIT; KIF3B; SVIL; CDC25B; SSTR5;	GO:0032467~positive regulation of cytokinesis	5	38	13.1578947368421	0.0464447838460607	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	CLDN3; ACTN4; PECAM1; PAK2; TBCD;	GO:0070830~bicellular tight junction assembly	5	38	13.1578947368421	0.0464447838460607	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
up	CD300LB; TYROBP; IGKC; TRBC1; CD3D; TRBV7-9; CD1A; CD3G; CD8B; KLRC1; CD1B; CD1C; CD40LG; FCGR2B; ICAM3; COLEC12; CD300LG; LILRB1; CD300LF; CD300A;	GO:0050776~regulation of immune response	20	216	9.25925925925926	0.0467380513211865	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
down	RGS3; GPS1; GPS2; LAX1;	GO:0000188~inactivation of MAPK activity	4	26	15.3846153846154	0.0472422567712705	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	CCDC78; ATP2A2; TNNI2; RCSD1;	GO:0003009~skeletal muscle contraction	4	26	15.3846153846154	0.0472422567712705	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	POLG; MAP1S; MYO18A; TATDN2;	GO:0006259~DNA metabolic process	4	26	15.3846153846154	0.0472422567712705	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	PLK1; SMC1A; KIF22; REC8;	GO:0007062~sister chromatid cohesion	4	26	15.3846153846154	0.0472422567712705	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	C2CD2L; LDLR; PITPNM2; OSBPL5;	GO:0015914~phospholipid transport	4	26	15.3846153846154	0.0472422567712705	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	TLR4; IRF1; IRF3; MAVS;	GO:0032728~positive regulation of interferon-beta production	4	26	15.3846153846154	0.0472422567712705	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	MRPL10; MYBBP1A; MTG2; DROSHA;	GO:0042254~ribosome biogenesis	4	26	15.3846153846154	0.0472422567712705	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	DSCAM; EGFR; APP; CCL5;	GO:0042327~positive regulation of phosphorylation	4	26	15.3846153846154	0.0472422567712705	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	MTOR; PPP5C; CXCR4; RELA;	GO:0043278~response to morphine	4	26	15.3846153846154	0.0472422567712705	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	ABL1; TCF3; MAPK12; CAMK1;	GO:0051149~positive regulation of muscle cell differentiation	4	26	15.3846153846154	0.0472422567712705	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	AGER; MINK1; MAP3K3; MFHAS1;	GO:1900745~positive regulation of p38MAPK cascade	4	26	15.3846153846154	0.0472422567712705	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	BRCA1; BLM; KAT5;	GO:0000729~DNA double-strand break processing	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	NFATC1; NOTCH1; NOTCH2;	GO:0003184~pulmonary valve morphogenesis	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	PAX8; CHST3; CHST7;	GO:0006790~sulfur compound metabolic process	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	GRK2; VCP; CTBP1;	GO:0019079~viral genome replication	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	MLYCD; ALOX15; PPARGC1A;	GO:0019395~fatty acid oxidation	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	ITGB3; PRKCB; PRKD2;	GO:0030949~positive regulation of vascular endothelial growth factor receptor signaling pathway	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	NF1; PLCL2; NISCH;	GO:0032228~regulation of synaptic transmission, GABAergic	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	CALM3; MTOR; VRK3;	GO:0032516~positive regulation of phosphoprotein phosphatase activity	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	GATA3; HDAC7; KAT5;	GO:0032703~negative regulation of interleukin-2 production	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	SASH3; CARD11; PRKD2;	GO:0032743~positive regulation of interleukin-2 production	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	AXIN1; SRC; CARM1;	GO:0033146~regulation of intracellular estrogen receptor signaling pathway	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	PTPN6; FOXC2; FERMT1;	GO:0033630~positive regulation of cell adhesion mediated by integrin	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	GJA5; TRAF3IP1; FOXC2;	GO:0035050~embryonic heart tube development	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	FOS; SLC9A1; RELA;	GO:0035994~response to muscle stretch	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	DENND3; SIAH2; DAB2IP;	GO:0044257~cellular protein catabolic process	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	TLR4; CD74; RELA;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	FURIN; TNFRSF1B; ADAM8;	GO:0051044~positive regulation of membrane protein ectodomain proteolysis	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	PKD1; CPSF7; FARSA;	GO:0051290~protein heterotetramerization	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	DAG1; DLG5; CTSZ;	GO:0060441~epithelial tube branching involved in lung morphogenesis	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	MEOX1; PTCH1; SMO;	GO:0061053~somite development	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	HLA-G; ALOX5AP; SIGMAR1;	GO:0070207~protein homotrimerization	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	PPM1F; PPP5C; PPTC7;	GO:0070262~peptidyl-serine dephosphorylation	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	PLEK; DGKQ; ADGRG1;	GO:0070528~protein kinase C signaling	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	FABP3; CD36; SCD;	GO:0070542~response to fatty acid	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	EXOSC10; UPF1; TUT1;	GO:0071044~histone mRNA catabolic process	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	RARA; ARID5A; PELP1;	GO:0071391~cellular response to estrogen stimulus	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	TBXA2R; NOTCH1; CARD10;	GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	PPP1R9B; SMPD3; KLF2;	GO:1901653~cellular response to peptide	3	15	20	0.0473252105067217	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
down	CCR1; SSTR5; PTGIR; CHRM3; HTR1D; DRD4; HRH4;	GO:0007187~G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	7	65	10.7692307692308	0.0474735146823798	0.148251679465249	1	1	0.985614356857844	0.985614356857844	1
up	ADH1B; ADH1C; ADH1A;	GO:0006069~ethanol oxidation	3	12	25	0.0491305245532192	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
up	ADRA2A; KCNB2; CHRM2;	GO:0006940~regulation of smooth muscle contraction	3	12	25	0.0491305245532192	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
up	IL2RA; CTLA4; FCGR2B;	GO:0050777~negative regulation of immune response	3	12	25	0.0491305245532192	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
up	TRPM2; FLT3; LILRB1;	GO:0097028~dendritic cell differentiation	3	12	25	0.0491305245532192	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
up	CYP2F1; CYP2C19; CYP2C9; CYP2C18;	GO:0006082~organic acid metabolic process	4	21	19.047619047619	0.0496804856921743	0.853654335577938	1	1	0.999999999859133	0.999999999859133	1
